data_6dl4_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6dl4 _Structure_validation_residue.Date_analyzed 2019-08-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 119.916 -0.087 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.421 ' NE1' ' CG ' ' A' ' 75' ' ' HIS . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' ARG . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 82' ' ' CYS . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.505 ' H ' ' C ' ' A' ' 80' ' ' VAL . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.411 ' HD1' HD12 ' A' ' 25' ' ' LEU . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 119.584 -0.246 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 23' ' ' ILE . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.505 ' HH ' ' CD ' ' A' ' 98' ' ' GLU . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CA ' ' O ' ' A' ' 89' ' ' GLU . 13.7 m120 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.629 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.629 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' CYS . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' CA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 3.3 m-80 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.462 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.434 ' C ' HD21 ' A' ' 53' ' ' ASN . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 52' ' ' VAL . 7.2 m120 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.757 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.509 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.722 ' HG ' ' H ' ' A' ' 65' ' ' LYS . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.722 ' H ' ' HG ' ' A' ' 64' ' ' SER . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HH ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.757 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.401 ' CG2' ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 51.0 tp . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG21 ' H ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.429 ' H ' HG21 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.505 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CE2' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CE2' ' ND2' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.754 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.754 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.658 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp . . . . . 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.405 HD11 ' HD1' ' A' ' 103' ' ' HIS . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.506 ' ND2' ' OH ' ' A' ' 55' ' ' TYR . 63.1 t-20 -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.503 ' CD2' ' N ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' OH ' ' ND2' ' A' ' 53' ' ' ASN . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.675 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.469 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.405 ' HD1' HD11 ' A' ' 23' ' ' ILE . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 88' ' ' GLY . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 109' ' ' ILE . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LEU . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.496 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.733 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 90' ' ' VAL . 8.6 m120 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.535 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.433 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.479 ' O ' ' O ' ' A' ' 70' ' ' ARG . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.733 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' ASP . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 57' ' ' ASN . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' A' ' 94' ' ' ALA . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 6.2 m-80 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.414 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HG ' ' HD1' ' A' ' 75' ' ' HIS . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.616 ' N ' ' NE2' ' A' ' 49' ' ' GLN . 0.1 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' NH2' ' CD2' ' A' ' 56' ' ' LEU . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.485 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.59 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.562 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.4 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 88' ' ' GLY . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.404 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.739 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.731 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.731 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.739 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.55 ' NE2' ' CG2' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.468 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.586 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 75.2 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.411 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.471 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.645 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.534 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.645 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.534 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.408 ' HG1' ' HH ' ' A' ' 55' ' ' TYR . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.425 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 11.4 t-20 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.638 ' NE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.638 ' H ' ' NE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.425 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 101' ' ' ILE . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.499 -0.185 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.721 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 58' ' ' GLY . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.672 ' HZ1' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.672 ' H ' ' HZ1' ' A' ' 63' ' ' LYS . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.721 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 101' ' ' ILE . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.45 ' O ' ' OG1' ' A' ' 93' ' ' THR . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.1 tp . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.446 ' H ' ' HB3' ' A' ' 25' ' ' LEU . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.9 m120 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' NE ' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.588 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 109' ' ' ILE . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 20' ' ' LYS . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.477 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 13.8 m120 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.4 m120 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.543 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 80' ' ' VAL . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' VAL . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.431 ' CG ' ' H ' ' A' ' 111' ' ' GLN . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt . . . . . 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.424 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.669 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 11.4 m120 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.724 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.669 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.724 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 86' ' ' ASP . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.687 ' NZ ' ' HZ1' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.432 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.533 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.526 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 2.6 p-80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.687 ' HZ1' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.503 ' CG2' ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.599 HD21 ' H ' ' A' ' 89' ' ' GLU . 2.3 t-20 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 67' ' ' PHE . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.541 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.599 ' H ' HD21 ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.489 ' CG2' ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.416 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.416 ' NE2' ' C ' ' A' ' 110' ' ' GLN . 22.0 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 58' ' ' GLY . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 26.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.641 ' ND1' ' CD2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 38' ' ' ALA . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 86' ' ' ASP . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 88' ' ' GLY . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' CD1' ' C ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.688 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 15.1 t-20 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.772 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.772 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 82' ' ' CYS . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' H ' ' CG2' ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 101' ' ' ILE . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.431 ' O ' ' OG1' ' A' ' 93' ' ' THR . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 40' ' ' PHE . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' H ' HG13 ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' C ' ' A' ' 41' ' ' ARG . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.633 ' CZ2' ' CD2' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.633 ' CD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' CYS . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 51' ' ' LYS . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 101' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.415 ' CD1' ' C ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.448 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.499 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 74' ' ' ILE . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.663 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.581 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' GLY . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 119.391 -0.338 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.469 ' H ' ' HB3' ' A' ' 25' ' ' LEU . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.621 ' HE ' ' NE2' ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.422 ' CB ' ' HD1' ' A' ' 75' ' ' HIS . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.648 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.648 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 82' ' ' CYS . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.465 ' OD2' ' N ' ' A' ' 37' ' ' THR . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.497 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.402 ' N ' ' CG1' ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.668 HD22 ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.668 ' N ' HD22 ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.482 ' CG2' ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.621 ' NE2' ' HE ' ' A' ' 31' ' ' ARG . 1.7 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 77.7 mtm -103.24 107.93 18.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.82 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.65 78.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.434 ' CD2' ' H ' ' A' ' 4' ' ' HIS . 9.8 p80 -83.59 124.86 31.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -157.15 -17.43 0.09 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.24 156.11 26.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.88 58.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.63 0.252 . . . . 0.0 111.291 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -85.71 125.3 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.712 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -69.6 134.25 48.55 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.14 156.58 33.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 13' ' ' THR . 61.7 t -106.32 -37.86 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -57.56 9.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.0 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.571 ' H ' ' C ' ' A' ' 11' ' ' VAL . 69.2 p -49.92 -37.46 31.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.298 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 24.8 p-10 -173.14 -54.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 110.886 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -117.48 175.26 5.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -111.72 -39.24 4.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.147 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -117.13 119.99 36.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.704 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -84.47 111.66 19.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.731 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -105.29 162.57 13.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.479 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -84.24 139.52 39.17 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.904 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' CG2' ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.421 ' NE1' ' CG ' ' A' ' 75' ' ' HIS . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 70' ' ' ARG . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 82' ' ' CYS . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.505 ' H ' ' C ' ' A' ' 80' ' ' VAL . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.411 ' HD1' HD12 ' A' ' 25' ' ' LEU . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp 88.58 -143.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' OE1' ' CE1' ' A' ' 114' ' ' HIS . 16.8 pt-20 -170.83 -28.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.831 0.348 . . . . 0.0 110.589 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CE1' ' OE1' ' A' ' 113' ' ' GLU . 72.7 m80 -86.98 135.83 33.14 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.629 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -86.31 158.72 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.664 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -66.78 154.87 39.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -147.51 155.42 41.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -151.64 -172.2 4.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -90.61 126.87 36.09 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.22 -60.16 1.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.507 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 5' ' ' GLU . 19.5 p-80 -152.46 -124.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.346 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.61 ' H ' ' CG ' ' A' ' 4' ' ' HIS . 79.8 mm-40 -59.5 129.55 42.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.25 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.97 96.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.6 55.24 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.693 -0.298 . . . . 0.0 110.528 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -97.96 128.77 44.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 111.74 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 m -97.35 124.15 41.4 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 -4.96 0.04 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.76 129.06 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 t -147.34 23.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.676 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -77.9 152.18 33.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 14' ' ' ASP . 11.4 p-10 -158.56 -53.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.896 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -112.16 154.61 25.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.809 0.338 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 7.54 7.22 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.094 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -71.76 130.45 41.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.353 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -67.19 135.95 54.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.95 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -134.49 -175.5 3.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -82.77 124.04 77.56 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.604 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 23' ' ' ILE . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.505 ' HH ' ' CD ' ' A' ' 98' ' ' GLU . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.403 ' CA ' ' O ' ' A' ' 89' ' ' GLU . 13.7 m120 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.629 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.629 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 82' ' ' CYS . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.403 ' O ' ' CA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 3.3 m-80 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp -101.39 -32.11 10.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.35 145.61 39.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -69.59 -174.69 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.774 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -63.75 -40.46 96.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -84.88 159.63 20.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.146 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -140.45 163.13 33.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.159 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -62.13 131.35 49.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.4 m80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.493 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.8 mtt -83.23 143.57 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.76 156.91 35.64 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.992 0.425 . . . . 0.0 111.137 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 81.2 t60 -157.8 47.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -93.72 90.8 6.72 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.582 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.39 -55.03 2.55 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.15 149.4 50.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.7 tp -87.41 129.22 35.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.347 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -89.14 160.26 17.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.481 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.74 163.52 23.72 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.5 m -83.34 133.76 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 t -67.51 66.71 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 14' ' ' ASP . 58.1 m -81.44 -115.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.118 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' N ' ' CG2' ' A' ' 13' ' ' THR . 52.0 t0 -151.41 140.58 21.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -93.57 117.57 30.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.759 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -125.86 5.97 7.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.157 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -100.04 122.27 42.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -85.16 133.16 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.028 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -107.16 172.06 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -85.27 140.76 36.65 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.424 ' C ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG2' ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.462 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.434 ' C ' HD21 ' A' ' 53' ' ' ASN . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 52' ' ' VAL . 7.2 m120 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.757 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.509 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.722 ' HG ' ' H ' ' A' ' 65' ' ' LYS . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.722 ' H ' ' HG ' ' A' ' 64' ' ' SER . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' HH ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.757 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.5 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.401 ' CG2' ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 51.0 tp -40.65 108.41 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.4 159.08 24.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 116' ' ' HIS . 91.7 m-70 -75.1 139.79 43.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.743 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -49.66 87.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.601 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 114' ' ' HIS . 86.3 t60 -64.98 -43.31 93.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.118 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -84.05 128.29 34.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.081 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -124.62 128.76 49.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.382 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.613 -179.804 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.9 ptp -82.33 -0.67 46.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.698 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.42 149.15 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.056 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -60.61 136.52 58.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.62 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 56.7 mp0 -80.43 39.99 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.325 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.06 96.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.15 42.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -73.76 137.1 43.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.005 0.431 . . . . 0.0 110.591 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.408 ' H ' ' HG1' ' A' ' 9' ' ' THR . 21.9 p -84.05 162.0 20.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.203 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.11 -53.57 0.4 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 13' ' ' THR . 14.8 p -68.46 144.82 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 14' ' ' ASP . 4.4 m -75.68 45.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' H ' ' C ' ' A' ' 11' ' ' VAL . 98.5 m 48.91 -90.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' THR . 16.6 p30 25.59 -120.9 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.635 0.584 . . . . 0.0 111.878 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.59 111.84 18.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -126.73 12.49 7.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.425 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.56 124.95 42.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.17 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -97.12 130.99 44.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.193 0.521 . . . . 0.0 110.77 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -144.78 155.38 43.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.932 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.38 109.72 23.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG21 ' H ' ' A' ' 33' ' ' LEU . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 ' H ' HG21 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.505 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CE2' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CE2' ' ND2' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.754 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.754 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.658 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.408 ' CG1' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp -17.7 -91.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.36 83.97 1.74 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 110.783 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -102.61 -15.5 16.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -117.03 128.81 55.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -94.62 24.12 4.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.52 -41.27 94.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.817 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -57.69 96.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 m170 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.934 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 49.0 ptt85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.171 0.51 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' HIS . 54.6 mtt -64.6 -39.31 93.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.38 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.726 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' C ' ' H ' ' A' ' 6' ' ' GLY . 73.0 t60 -74.48 -44.07 53.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.512 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.72 34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.466 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -82.95 -133.28 1.98 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.0 145.77 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.304 . . . . 0.0 110.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 8.6 mp -75.61 136.66 40.47 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.602 ' HG1' ' N ' ' A' ' 10' ' ' GLY . 2.5 t -65.38 155.91 33.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.471 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.602 ' N ' ' HG1' ' A' ' 9' ' ' THR . . . -164.64 -160.06 11.8 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.618 ' C ' ' H ' ' A' ' 13' ' ' THR . 18.4 m -86.41 134.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -59.0 10.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.509 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.618 ' H ' ' C ' ' A' ' 11' ' ' VAL . 44.3 m 52.09 93.38 0.02 OUTLIER 'General case' 0 C--O 1.228 -0.072 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 13' ' ' THR . 9.5 t0 83.73 121.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.752 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 15.4 mp0 -90.02 14.32 12.58 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.097 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 11.81 7.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.68 0.276 . . . . 0.0 110.326 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -80.95 148.49 29.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.485 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -95.59 116.84 29.41 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.071 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -107.98 179.64 4.16 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -83.18 139.72 42.27 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.405 HD11 ' HD1' ' A' ' 103' ' ' HIS . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.506 ' ND2' ' OH ' ' A' ' 55' ' ' TYR . 63.1 t-20 -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.503 ' CD2' ' N ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' OH ' ' ND2' ' A' ' 53' ' ' ASN . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.675 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.469 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.675 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.405 ' HD1' HD11 ' A' ' 23' ' ' ILE . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 88' ' ' GLY . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.453 HG21 HD11 ' A' ' 109' ' ' ILE . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp -80.31 99.29 7.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.57 ' C ' ' H ' ' A' ' 115' ' ' HIS . 44.3 tp10 -121.06 126.05 48.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.203 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -70.88 33.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.9 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.57 ' H ' ' C ' ' A' ' 113' ' ' GLU . 11.6 t-160 -58.72 -43.83 90.24 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.44 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 42.9 t-80 -114.74 28.36 8.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.605 0.241 . . . . 0.0 111.334 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -65.26 -43.45 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.374 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -122.87 131.56 53.8 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.283 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -98.86 120.0 38.57 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.91 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -67.77 -49.38 62.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -172.21 178.25 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.23 34.69 2.41 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.79 149.33 40.3 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.4 mp -80.24 127.78 32.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.037 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -83.91 152.0 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.356 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 47.55 4.9 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -117.32 120.06 63.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.335 0.588 . . . . 0.0 111.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -70.95 66.43 0.38 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.519 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.2 t -98.19 102.07 13.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.133 0.492 . . . . 0.0 112.277 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.1 t0 38.94 83.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.52 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -60.41 -94.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.132 0.491 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.49 5.45 8.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -63.94 135.89 56.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.587 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -58.02 128.48 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.254 0.55 . . . . 0.0 112.215 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.12 140.12 33.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.056 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp -85.81 135.67 37.58 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 33' ' ' LEU . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.496 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.733 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.54 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' H ' HG12 ' A' ' 90' ' ' VAL . 8.6 m120 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.535 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.433 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.479 ' O ' ' O ' ' A' ' 70' ' ' ARG . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.733 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.506 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.506 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 86' ' ' ASP . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.422 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 HG12 ' H ' ' A' ' 57' ' ' ASN . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.48 ' HG1' ' N ' ' A' ' 94' ' ' ALA . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' N ' ' HG1' ' A' ' 93' ' ' THR . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 6.2 m-80 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' CG2' ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.414 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp -112.94 120.99 43.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -86.4 119.48 26.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.221 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -84.2 134.02 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.637 ' CG ' ' H ' ' A' ' 116' ' ' HIS . 0.5 OUTLIER -80.54 -126.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.705 ' HD1' ' H ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -154.01 162.96 40.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.2 142.79 52.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.664 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.87 136.78 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.878 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 45.9 t-80 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.773 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 76.7 ttt-85 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.2 ttp -98.43 76.04 2.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.74 131.58 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.225 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -154.58 149.15 26.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 16.5 pt-20 -68.39 -39.31 81.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.156 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.4 138.24 4.88 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.29 57.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.844 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 2.7 mm? -76.31 140.5 41.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 m -72.15 137.05 46.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.507 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.14 133.1 1.51 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.29 125.63 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' THR . 42.7 p -56.85 -84.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.144 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' THR . 0.3 OUTLIER 77.6 96.86 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 55.5 p-10 -82.99 147.5 28.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.581 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -141.02 156.28 46.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.006 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -124.92 12.46 8.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -115.26 130.88 57.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.09 130.77 46.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.67 163.77 14.4 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.103 0.477 . . . . 0.0 111.293 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -85.61 139.13 35.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HG ' ' HD1' ' A' ' 75' ' ' HIS . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.476 ' CG2' ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.616 ' N ' ' NE2' ' A' ' 49' ' ' GLN . 0.1 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.59 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' NH2' ' CD2' ' A' ' 56' ' ' LEU . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.485 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OE1' ' A' ' 5' ' ' GLU . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.59 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.562 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.4 ' OD2' ' C ' ' A' ' 81' ' ' ASP . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 88' ' ' GLY . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -41.78 98.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -94.92 121.95 37.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.31 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -155.11 80.85 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -157.71 22.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -88.33 51.7 2.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.108 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.1 m80 -119.14 141.09 49.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.389 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.489 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 79.8 t60 -66.93 -45.75 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 57.1 p-80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.781 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 3' ' ' ALA . 3.5 ppp? -60.26 -40.64 91.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.942 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -74.68 152.38 39.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 111.036 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -76.78 147.32 37.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.62 125.68 24.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.021 0.438 . . . . 0.0 110.643 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.04 165.16 38.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -73.91 140.1 45.4 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.215 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -81.91 159.67 23.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' VAL . . . -98.19 13.08 63.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.6 m 46.18 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.776 0.322 . . . . 0.0 111.083 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.0 m 37.61 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.301 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -87.96 124.01 33.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -173.7 99.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.671 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -144.89 66.68 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.682 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.58 12.81 8.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.785 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.91 173.83 11.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.35 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.38 137.75 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.574 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -139.1 159.79 41.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -83.47 111.08 28.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 41' ' ' ARG . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.739 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.731 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.731 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.739 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.42 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.55 ' NE2' ' CG2' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.468 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.586 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 75.2 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.05 131.44 46.21 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -58.03 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.237 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -91.57 127.38 37.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.019 0.438 . . . . 0.0 110.724 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.799 ' HD1' ' H ' ' A' ' 116' ' ' HIS . 1.2 p80 -85.8 -55.8 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.799 ' H ' ' HD1' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -156.34 166.4 33.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.853 0.358 . . . . 0.0 110.797 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -69.41 137.93 53.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -74.34 135.26 42.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.638 -179.501 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.421 ' H1 ' ' H ' ' A' ' 2' ' ' MET . 84.5 mtp180 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -72.25 -21.71 61.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.039 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -59.13 -36.18 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -95.92 127.58 42.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE2' ' N ' ' A' ' 6' ' ' GLY . 0.3 OUTLIER -65.92 -40.92 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.16 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' N ' ' OE2' ' A' ' 5' ' ' GLU . . . -101.73 65.43 0.47 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.98 57.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -84.0 137.47 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.355 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.88 124.57 33.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.959 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.59 51.0 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.0 123.02 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 13' ' ' THR . 26.7 p -125.04 -60.41 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.541 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.688 ' H ' ' HG1' ' A' ' 12' ' ' THR . 64.6 p -93.12 134.89 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.461 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 17' ' ' GLU . 24.7 t70 -100.3 105.1 16.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.389 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.1 49.27 0.81 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.22 13.86 8.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.065 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 57.2 mp0 -86.99 145.6 26.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.173 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -68.47 125.17 25.63 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.824 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -119.31 172.04 7.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.714 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -84.21 139.5 39.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.411 ' N ' ' CG2' ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.471 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.645 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.534 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.645 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.534 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.408 ' HG1' ' HH ' ' A' ' 55' ' ' TYR . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' N ' ' CG2' ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' N ' ' CG1' ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -108.97 -77.4 0.6 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -85.68 124.72 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.283 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -61.9 -46.85 87.57 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -142.6 138.46 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -83.16 128.06 34.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.001 0.429 . . . . 0.0 110.122 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -160.59 -13.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.477 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -111.43 144.41 40.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.102 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.2 m170 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.79 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.552 ' C ' ' H ' ' A' ' 3' ' ' ALA . 39.0 ttm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.9 mtt -72.63 21.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.552 ' H ' ' C ' ' A' ' 1' ' ' ARG . . . -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.624 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -69.46 59.38 0.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.63 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.08 -58.67 4.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.02 -113.2 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.8 148.86 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 110.591 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.79 123.65 32.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.437 ' H ' ' HG1' ' A' ' 9' ' ' THR . 16.3 p -103.03 146.63 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.639 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.58 8.75 76.73 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.08 130.26 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.183 0.516 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 12' ' ' THR . 0.3 OUTLIER -105.36 60.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.131 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.5 p -112.83 -140.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.642 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 49.4 25.27 1.26 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -67.03 -124.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.653 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -125.42 8.75 7.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -63.08 148.34 48.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.096 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -73.44 140.89 46.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -135.45 170.41 15.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.58 116.05 59.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.553 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 11.4 t-20 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.638 ' NE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.638 ' H ' ' NE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.425 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.567 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 101' ' ' ILE . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' A' ' 88' ' ' GLY . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' CG1' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp -54.61 125.14 18.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.59 144.1 54.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -95.35 140.64 29.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.529 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -59.68 139.83 56.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.532 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 117' ' ' HIS . 53.5 p-80 -148.98 -45.67 0.14 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.467 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 58.9 t-80 -154.56 -57.34 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.83 125.23 33.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CG ' ' OXT' ' A' ' 119' ' ' HIS . 58.5 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.27 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -82.01 141.84 32.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.54 162.28 39.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.19 142.36 43.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.994 0.426 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 56.4 mp0 -65.38 -41.27 93.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.298 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.56 -21.22 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 139.68 58.34 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.375 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -97.24 130.75 44.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -79.88 129.25 34.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.15 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.83 -155.57 26.31 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -70.55 164.54 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 13' ' ' THR . 47.0 p -67.65 74.6 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.271 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 18.48 -107.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.702 179.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 13' ' ' THR . 58.5 t0 56.47 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.322 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -74.79 139.12 43.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.959 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.63 8.16 11.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.474 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -67.45 126.89 30.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.59 118.64 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.376 0.608 . . . . 0.0 111.528 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -114.57 141.84 47.21 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.859 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 151.93 58.42 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.499 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 ' CG2' ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.721 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 ' O ' ' N ' ' A' ' 58' ' ' GLY . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' HZ1' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.672 ' H ' ' HZ1' ' A' ' 63' ' ' LYS . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.721 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 101' ' ' ILE . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.45 ' O ' ' OG1' ' A' ' 93' ' ' THR . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.1 tp -101.8 -20.11 15.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.83 121.38 36.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.348 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.402 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 4.1 p80 -131.2 12.72 5.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.816 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -70.51 -23.25 62.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.439 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -88.14 97.14 10.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CE1' ' O ' ' A' ' 114' ' ' HIS . 73.7 m80 -95.14 -60.08 1.76 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -66.24 -45.53 80.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.285 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -41.18 97.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.8 47.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.927 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -100.96 3.11 41.35 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.63 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -67.09 -39.76 86.84 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.493 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.37 127.29 23.55 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.666 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.35 145.64 52.79 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 115.441 -0.379 . . . . 0.0 109.999 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.35 130.46 35.05 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.366 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.87 160.01 22.25 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.626 0.579 . . . . 0.0 111.022 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.08 154.02 26.08 Favored Glycine 0 C--O 1.218 -0.846 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.977 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 12' ' ' THR . 5.7 t 41.84 91.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 11' ' ' VAL . 30.1 m -25.68 -66.99 0.05 OUTLIER 'General case' 0 C--N 1.345 0.37 0 O-C-N 124.299 0.999 . . . . 0.0 111.261 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 m 47.98 74.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.087 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -43.79 -86.57 0.0 OUTLIER 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.114 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -143.11 -92.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.59 13.84 9.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.003 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.6 169.74 14.9 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 133.42 56.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.08 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 38.4 tt0 -138.77 174.64 10.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 54.1 mttm -81.06 145.5 56.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.586 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.446 ' H ' ' HB3' ' A' ' 25' ' ' LEU . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.464 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 19' ' ' GLN . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.479 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.9 m120 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' NE ' ' CE1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.462 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.588 ' CG ' ' CD1' ' A' ' 54' ' ' TRP . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.438 HD12 HG22 ' A' ' 109' ' ' ILE . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -66.71 130.92 44.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -111.79 -120.03 0.29 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -115.46 127.34 55.26 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.492 0.663 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.535 ' CD2' ' H ' ' A' ' 115' ' ' HIS . 4.7 p80 -66.75 123.39 20.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.066 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -77.56 2.55 16.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.132 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -74.66 118.81 18.03 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.689 ' H ' ' HD1' ' A' ' 118' ' ' HIS . 1.1 p-80 -80.66 -27.8 37.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.214 -0.795 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.023 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.83 -41.49 95.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.091 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.54 96.15 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.59 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 37.9 t-80 -85.21 -0.56 55.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.609 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -122.5 146.84 47.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.47 -171.64 6.72 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.15 140.6 49.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.029 0.442 . . . . 0.0 111.107 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.46 129.61 34.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -70.92 136.84 48.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.116 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.48 -84.64 0.13 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.57 ' C ' ' H ' ' A' ' 13' ' ' THR . 17.8 t -95.96 -26.43 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 p -59.42 10.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.444 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.57 ' H ' ' C ' ' A' ' 11' ' ' VAL . 13.6 p -75.3 164.03 26.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.423 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.55 -38.67 90.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -88.32 78.44 7.99 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -125.39 6.12 7.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.135 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.02 142.4 58.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.99 115.63 15.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.32 169.88 9.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt -84.09 138.29 39.81 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' O ' ' A' ' 20' ' ' LYS . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.485 ' O ' ' SG ' ' A' ' 42' ' ' CYS . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.463 ' CG2' ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.477 ' CG2' ' OD1' ' A' ' 22' ' ' ASP . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 13.8 m120 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.414 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.4 m120 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.543 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.435 ' CG1' ' N ' ' A' ' 80' ' ' VAL . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.414 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 90' ' ' VAL . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.431 ' CG ' ' H ' ' A' ' 111' ' ' GLN . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.431 ' H ' ' CG ' ' A' ' 110' ' ' GLN . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt -45.32 148.07 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -75.56 108.35 8.32 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.066 0.46 . . . . 0.0 110.723 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -85.57 127.06 34.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.143 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -64.22 -166.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.397 . . . . 0.0 110.513 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.49 138.83 45.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -75.98 -2.11 28.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.569 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -66.17 -43.46 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.672 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 C--O 1.217 -0.608 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.113 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.79 -42.32 99.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.777 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.93 145.78 28.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -104.87 121.37 43.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 0.0 111.293 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -91.48 -13.68 31.78 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.047 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.77 165.85 53.54 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.92 147.86 32.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.056 0.455 . . . . 0.0 110.44 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 mt -73.18 133.23 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.243 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -63.13 136.99 58.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.069 0.461 . . . . 0.0 110.968 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -137.05 46.42 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.297 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.0 p -65.95 129.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.782 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -50.79 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 t -143.39 150.72 39.5 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -166.89 12.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.188 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -154.33 97.7 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 109.923 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -123.9 -31.92 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.005 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.71 161.0 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.943 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.72 139.45 47.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.286 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -115.51 -173.76 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -84.39 118.75 71.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.424 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.669 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.549 ' C ' ' H ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 11.4 m120 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.724 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.564 ' N ' ' HG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.669 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.724 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 86' ' ' ASP . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.687 ' NZ ' ' HZ1' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.432 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.533 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 2.6 p-80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.687 ' HZ1' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.503 ' CG2' ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp -65.28 131.46 46.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' OE1' ' ND1' ' A' ' 115' ' ' HIS . 44.9 tp10 -146.61 102.82 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.319 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -93.67 -2.85 53.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.669 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.489 ' ND1' ' OE1' ' A' ' 113' ' ' GLU . 69.5 m80 -56.9 -14.9 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -105.98 41.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.694 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 25.1 t-80 -132.38 -98.85 0.29 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 78.8 t60 -70.1 -8.33 48.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.574 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.31 -40.49 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.648 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.79 137.34 56.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 110.615 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -68.9 81.74 0.3 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.673 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -167.3 50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.55 -1.67 61.95 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.19 136.39 58.05 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.405 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 2.5 mm? -75.17 137.23 41.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.958 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.09 160.43 24.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.813 0.34 . . . . 0.0 110.472 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.29 153.11 46.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.37 130.66 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.058 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p 48.38 -132.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.263 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 29.8 p -60.68 -116.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' N ' ' OG1' ' A' ' 13' ' ' THR . 96.9 m-20 44.92 47.04 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -166.59 95.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.07 8.07 8.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.6 152.08 23.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.647 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -70.11 133.79 47.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.679 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 47.3 tt0 -137.8 168.18 20.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 29.5 mtmm -81.64 116.32 62.35 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.442 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.494 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.599 HD21 ' H ' ' A' ' 89' ' ' GLU . 2.3 t-20 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' H ' ' CD2' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 67' ' ' PHE . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.599 ' H ' HD21 ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.489 ' CG2' ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.416 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.416 ' NE2' ' C ' ' A' ' 110' ' ' GLN . 22.0 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 114' ' ' HIS . 41.7 mt -64.51 144.46 57.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -63.27 5.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.652 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 112' ' ' LEU . 84.4 t60 -119.41 71.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -99.82 110.71 23.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.456 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -163.73 -51.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.057 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -81.04 143.81 32.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -143.99 150.75 38.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.41 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.816 179.498 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.61 136.21 53.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.56 59.03 1.26 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -59.95 -43.52 94.95 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.108 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -157.65 -77.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.673 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.08 140.79 18.79 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.642 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.53 154.33 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 121.24 18.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.852 -178.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -67.04 131.34 45.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.645 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.81 176.97 5.47 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 13' ' ' THR . 56.1 t -118.39 132.99 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -64.43 73.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.902 0.382 . . . . 0.0 110.601 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 11' ' ' VAL . 14.2 t -111.72 -9.57 14.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 35.9 p-10 -75.74 59.31 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -63.84 -52.01 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.756 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -126.56 12.31 7.44 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.389 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -69.05 151.65 46.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.341 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.419 ' NZ ' ' OE2' ' A' ' 98' ' ' GLU . 61.7 tttp -59.5 129.16 40.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' NE2' ' OD2' ' A' ' 14' ' ' ASP . 6.9 mm100 -113.7 -179.4 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 110.013 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -87.57 126.45 61.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.867 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 58' ' ' GLY . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 26.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.511 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.641 ' ND1' ' CD2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 ' CD2' ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 38' ' ' ALA . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.621 ' O ' ' N ' ' A' ' 86' ' ' ASP . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' OE2' ' NZ ' ' A' ' 18' ' ' LYS . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 88' ' ' GLY . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' CD1' ' C ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.688 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -46.26 91.25 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -61.33 143.3 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.703 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -86.36 137.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.775 ' HD1' ' H ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -63.6 -40.9 98.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.774 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.775 ' H ' ' HD1' ' A' ' 115' ' ' HIS . 96.0 m-70 -158.37 146.4 18.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.818 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -131.02 122.25 26.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -120.95 -81.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.336 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.684 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -86.12 139.4 31.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.824 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.48 151.3 19.42 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -65.35 -38.9 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.349 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -84.14 -13.71 52.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.822 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.14 83.46 0.52 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 136.12 57.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.28 135.87 43.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.022 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.667 ' HG1' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -65.18 155.37 35.21 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.004 0.431 . . . . 0.0 111.12 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.667 ' N ' ' HG1' ' A' ' 9' ' ' THR . . . -159.72 98.38 0.17 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 13' ' ' THR . 2.1 p -62.64 157.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.405 ' N ' ' CG2' ' A' ' 11' ' ' VAL . 25.2 p -57.69 86.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.792 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' VAL . 26.8 p -61.24 -83.21 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -74.91 123.93 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -129.42 165.51 21.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.56 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -122.38 13.09 10.22 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -69.19 131.5 45.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -76.65 134.47 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -141.45 154.09 45.37 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -88.57 109.5 29.8 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 15.1 t-20 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.772 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.772 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 82' ' ' CYS . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' H ' ' CG2' ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 101' ' ' ILE . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.441 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.431 ' O ' ' OG1' ' A' ' 93' ' ' THR . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.484 ' CG2' ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp -84.38 130.95 34.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -149.11 -50.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.589 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -87.15 127.53 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -155.36 166.63 32.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -89.79 133.04 34.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -66.19 -41.48 90.17 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -77.38 130.56 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.489 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.522 -179.762 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.6 mpt? -62.41 -40.23 95.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.13 134.23 56.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.719 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -82.13 -19.44 40.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.7 -70.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.29 170.58 43.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.92 145.33 56.03 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.163 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 2.5 mm? -75.26 138.56 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.09 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.96 144.87 52.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.91 -129.2 3.32 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.0 t -94.27 128.28 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.706 ' HG1' ' H ' ' A' ' 13' ' ' THR . 29.4 p -119.56 -77.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.104 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.706 ' H ' ' HG1' ' A' ' 12' ' ' THR . 2.4 m 65.42 -133.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 15' ' ' GLN . 11.9 t0 -168.56 -169.3 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' A' ' 14' ' ' ASP . 14.5 pt20 -76.91 152.65 35.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.307 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -124.72 11.55 8.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.056 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -71.66 177.83 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.185 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -53.86 147.26 12.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 46' ' ' GLY . 84.5 mt-30 -145.28 146.41 31.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt -93.3 107.92 29.43 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' OG1' ' A' ' 45' ' ' THR . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 40' ' ' PHE . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' H ' HG13 ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' C ' ' A' ' 41' ' ' ARG . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.633 ' CZ2' ' CD2' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.719 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.633 ' CD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.416 HG13 ' H ' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 82' ' ' CYS . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 51' ' ' LYS . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 101' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.415 ' CD1' ' C ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER -93.24 118.4 31.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.22 110.73 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -100.85 98.85 9.3 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.94 -40.68 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.689 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -84.9 147.84 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.702 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -67.22 123.73 21.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.815 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -103.84 133.72 48.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.6 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.269 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 ttp -91.02 120.04 31.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.57 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -110.72 147.38 34.51 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.946 0.403 . . . . 0.0 110.836 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.35 157.96 44.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.37 -171.41 28.49 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.9 143.07 52.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.863 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 10.0 mp -88.79 126.6 35.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.185 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.451 ' OG1' ' OE2' ' A' ' 17' ' ' GLU . 7.3 p -85.55 160.07 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.174 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.18 -142.79 4.24 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.5 t 54.17 94.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.726 0.298 . . . . 0.0 110.812 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.9 p 44.98 -160.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m 56.33 15.21 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.523 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -89.15 9.87 23.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.242 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -63.37 -44.6 94.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.931 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -122.99 12.65 9.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' OE2' ' OG1' ' A' ' 9' ' ' THR . 76.9 tt0 -76.64 154.53 34.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.079 0.466 . . . . 0.0 110.736 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.25 151.89 46.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.789 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -142.08 169.17 18.1 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -81.72 112.84 37.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 58' ' ' GLY . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.499 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.519 ' O ' ' O ' ' A' ' 74' ' ' ILE . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.663 ' CE1' ' CD2' ' A' ' 54' ' ' TRP . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.583 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.448 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.581 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' O ' ' O ' ' A' ' 88' ' ' GLY . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp -73.34 122.37 21.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -113.48 124.26 51.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.952 0.406 . . . . 0.0 110.867 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.717 ' HD1' ' H ' ' A' ' 116' ' ' HIS . 32.0 t-80 -157.81 161.76 38.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -81.05 -9.31 59.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.717 ' H ' ' HD1' ' A' ' 114' ' ' HIS . 49.8 t-80 -75.88 138.39 41.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 110.959 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' CE1' ' A' ' 116' ' ' HIS . 92.5 m-70 -96.94 141.39 30.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.699 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.67 ' HD1' ' N ' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -75.79 -17.29 59.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.271 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 72.4 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.635 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.8 mtp -82.59 147.5 28.55 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.198 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.82 149.21 30.94 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -87.01 169.27 12.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.959 0.409 . . . . 0.0 111.547 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 6' ' ' GLY . 2.8 pp20? -68.08 -35.71 78.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' N ' ' CD ' ' A' ' 5' ' ' GLU . . . -134.13 123.72 3.35 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.38 53.27 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 111.45 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 tp -72.35 133.82 45.16 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 m -72.55 133.27 44.67 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.1 166.21 12.19 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' THR . 26.8 m -102.43 7.89 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.256 0.222 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -65.62 66.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.356 0.598 . . . . 0.0 111.721 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' VAL . 41.6 p -130.6 -84.27 0.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.921 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 66.3 t0 45.61 30.36 0.77 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.112 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -68.43 -42.21 79.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.265 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -124.46 -32.06 3.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.839 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 81.0 tt0 -65.57 128.55 36.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.34 128.94 34.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -107.33 177.67 4.77 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.011 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -84.46 130.38 53.95 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.448 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' H ' ' HB3' ' A' ' 25' ' ' LEU . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.621 ' HE ' ' NE2' ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' CB ' ' HD1' ' A' ' 75' ' ' HIS . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.648 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 58' ' ' GLY . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.648 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 82' ' ' CYS . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' OD2' ' N ' ' A' ' 37' ' ' THR . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.497 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.604 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.402 ' N ' ' CG1' ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.668 HD22 ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.668 ' N ' HD22 ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.482 ' CG2' ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.621 ' NE2' ' HE ' ' A' ' 31' ' ' ARG . 1.7 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 114' ' ' HIS . 2.2 pp -63.97 134.41 55.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -41.02 90.27 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 121.082 0.468 . . . . 0.0 110.758 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 42.7 t60 -63.51 -39.91 95.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.93 137.69 58.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 116' ' ' HIS . 2.6 p80 -149.75 -45.72 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -136.74 34.55 2.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 0.0 111.507 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -62.82 140.31 58.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' CD2' ' OXT' ' A' ' 119' ' ' HIS . 22.5 p-80 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 116.92 -1.514 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 119.916 -0.087 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.451 HD12 HD12 ' A' ' 25' ' ' LEU . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.69 ' C ' HD13 ' A' ' 25' ' ' LEU . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 32' ' ' VAL . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.541 ' N ' HG22 ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.491 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.447 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' VAL . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASP . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 107' ' ' LEU . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 90' ' ' VAL . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 84' ' ' SER . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 119.584 -0.246 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.598 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 36' ' ' GLU . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 32' ' ' VAL . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' HG13 ' A' ' 24' ' ' VAL . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HB3' HD22 ' A' ' 96' ' ' ASN . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 90.0 m-20 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.637 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 79' ' ' ILE . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 80' ' ' VAL . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 107' ' ' LEU . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' H ' HG12 ' A' ' 52' ' ' VAL . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 50' ' ' PRO . 6.4 m120 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 21' ' ' PRO . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.704 ' C ' HD12 ' A' ' 107' ' ' LEU . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 106' ' ' LYS . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.409 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.495 HG23 HD12 ' A' ' 101' ' ' ILE . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' C ' HD13 ' A' ' 25' ' ' LEU . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 36' ' ' GLU . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB2' HG22 ' A' ' 32' ' ' VAL . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 107' ' ' LEU . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.775 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.775 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 80' ' ' VAL . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.574 ' N ' HG22 ' A' ' 79' ' ' ILE . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.606 HG22 ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 23' ' ' ILE . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.728 ' C ' HD12 ' A' ' 107' ' ' LEU . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.0 tp . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.506 HG22 HG22 ' A' ' 44' ' ' VAL . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' C ' HD13 ' A' ' 25' ' ' LEU . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 44' ' ' VAL . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 23' ' ' ILE . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.428 ' OD1' ' CE2' ' A' ' 55' ' ' TYR . 20.9 t-20 -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.428 ' CE2' ' OD1' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.749 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.779 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 69' ' ' VAL . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.779 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.749 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 107' ' ' LEU . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' LEU . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.654 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.639 ' N ' HD12 ' A' ' 109' ' ' ILE . 28.8 mm100 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp . . . . . 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.462 HD12 HD12 ' A' ' 25' ' ' LEU . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 ' C ' HD13 ' A' ' 25' ' ' LEU . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.805 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 47' ' ' TYR . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.783 HD21 ' N ' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.783 ' N ' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.713 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.713 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD13 HD11 ' A' ' 56' ' ' LEU . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 38' ' ' ALA . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 107' ' ' LEU . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 102' ' ' GLU . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 101' ' ' ILE . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.641 ' C ' HD12 ' A' ' 107' ' ' LEU . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' SER . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 25' ' ' LEU . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.741 ' O ' HG21 ' A' ' 105' ' ' VAL . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.616 ' N ' HG22 ' A' ' 44' ' ' VAL . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 75' ' ' HIS . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.784 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' H ' HG12 ' A' ' 90' ' ' VAL . 70.7 m-20 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.483 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.784 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.6 ' O ' HG21 ' A' ' 109' ' ' ILE . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 107' ' ' LEU . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 26' ' ' TYR . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.772 ' C ' HD12 ' A' ' 107' ' ' LEU . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 22.2 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' C ' ' HG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 25' ' ' LEU . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HD12 ' A' ' 25' ' ' LEU . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.674 ' CE1' HD21 ' A' ' 107' ' ' LEU . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' N ' HG13 ' A' ' 32' ' ' VAL . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 109' ' ' ILE . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 32' ' ' VAL . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 25' ' ' LEU . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 44' ' ' VAL . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.0 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 60' ' ' LEU . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.608 ' CZ ' HD13 ' A' ' 60' ' ' LEU . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.58 HH11 ' N ' ' A' ' 78' ' ' ASP . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.58 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG22 ' A' ' 80' ' ' VAL . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 107' ' ' LEU . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' VAL . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.71 ' C ' HD12 ' A' ' 107' ' ' LEU . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.588 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.471 ' N ' HD12 ' A' ' 109' ' ' ILE . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.779 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 36' ' ' GLU . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' CB ' HD12 ' A' ' 79' ' ' ILE . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 45' ' ' THR . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.773 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.804 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.804 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.773 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.598 HG22 ' NE2' ' A' ' 103' ' ' HIS . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.598 ' NE2' HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.732 ' C ' HD12 ' A' ' 107' ' ' LEU . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' SER . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.483 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.436 ' OE1' ' CZ ' ' A' ' 85' ' ' TYR . 33.6 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 92' ' ' VAL . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' C ' HD13 ' A' ' 25' ' ' LEU . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.613 ' N ' HG12 ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 75' ' ' HIS . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.522 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 38' ' ' ALA . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 23' ' ' ILE . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HB2' HD11 ' A' ' 101' ' ' ILE . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 25' ' ' LEU . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.701 ' C ' HD13 ' A' ' 25' ' ' LEU . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 40' ' ' PHE . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' C ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.438 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE2' HG11 ' A' ' 30' ' ' VAL . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.476 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.77 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 54' ' ' TRP . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.698 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.476 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 107' ' ' LEU . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 21' ' ' PRO . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' C ' HD12 ' A' ' 107' ' ' LEU . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.534 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.477 ' N ' HD12 ' A' ' 109' ' ' ILE . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.456 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.499 -0.185 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' C ' HD13 ' A' ' 25' ' ' LEU . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.793 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 112' ' ' LEU . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.449 ' HB1' ' CE1' ' A' ' 40' ' ' PHE . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE1' ' HB1' ' A' ' 38' ' ' ALA . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 5.0 p-10 -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.769 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HZ2' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.769 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 81' ' ' ASP . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' H ' HG12 ' A' ' 80' ' ' VAL . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.42 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 21' ' ' PRO . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.714 ' C ' HD12 ' A' ' 107' ' ' LEU . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.427 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 57.1 tp . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 25' ' ' LEU . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 24' ' ' VAL . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 33' ' ' LEU . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.734 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' ARG . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.7 m-20 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' SER . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' VAL . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.78 ' NE2' HD21 ' A' ' 77' ' ' LEU . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 38' ' ' ALA . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 84' ' ' SER . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.459 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 45' ' ' THR . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 HD12 ' A' ' 25' ' ' LEU . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.66 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 105' ' ' VAL . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 37' ' ' THR . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.646 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.631 HG13 ' CZ2' ' A' ' 54' ' ' TRP . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 93' ' ' THR . 88.6 m-20 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 93.3 m-20 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.659 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 102' ' ' GLU . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 101' ' ' ILE . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.716 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt . . . . . 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 92' ' ' VAL . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.654 ' HG ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.593 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.459 HG11 ' CE1' ' A' ' 75' ' ' HIS . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.692 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 96.1 m-20 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' TRP . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.741 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.692 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.741 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 38' ' ' ALA . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 81' ' ' ASP . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 80' ' ' VAL . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 109' ' ' ILE . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 92' ' ' VAL . 2.5 p80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 26' ' ' TYR . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.68 ' C ' HD12 ' A' ' 107' ' ' LEU . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.628 HG21 ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' CG1' ' A' ' 92' ' ' VAL . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' C ' HD12 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 34.5 t30 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 77' ' ' LEU . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.646 HD21 ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 38' ' ' ALA . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 23' ' ' ILE . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.484 ' C ' HD12 ' A' ' 107' ' ' LEU . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 106' ' ' LYS . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 2.4 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 25' ' ' LEU . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 92' ' ' VAL . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 111' ' ' GLN . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CZ ' HD12 ' A' ' 107' ' ' LEU . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.422 HH12 ' HB3' ' A' ' 43' ' ' ARG . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HB3' HH12 ' A' ' 41' ' ' ARG . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.467 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CE2' HD13 ' A' ' 60' ' ' LEU . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 77' ' ' LEU . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 89.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 55' ' ' TYR . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.724 ' NE2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 80' ' ' VAL . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 80' ' ' VAL . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.742 ' O ' HD12 ' A' ' 109' ' ' ILE . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.626 HG21 HD21 ' A' ' 25' ' ' LEU . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.594 ' C ' HD22 ' A' ' 107' ' ' LEU . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 106' ' ' LYS . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.43 ' O ' HD22 ' A' ' 33' ' ' LEU . 24.6 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 44' ' ' VAL . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.421 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.797 ' H ' HD23 ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.799 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 38' ' ' ALA . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' N ' ' A' ' 81' ' ' ASP . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.588 ' N ' HG22 ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.639 HG21 HD12 ' A' ' 107' ' ' LEU . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.426 HD21 ' HE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 102' ' ' GLU . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 101' ' ' ILE . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.639 HD12 HG21 ' A' ' 90' ' ' VAL . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 101' ' ' ILE . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.787 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 107' ' ' LEU . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 75' ' ' HIS . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.83 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.405 ' CE1' HD13 ' A' ' 60' ' ' LEU . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 54' ' ' TRP . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.742 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.83 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 81' ' ' ASP . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 80' ' ' VAL . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.617 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 107' ' ' LEU . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HG2' HG13 ' A' ' 100' ' ' VAL . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 95' ' ' GLU . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.617 HG21 ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.422 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 45' ' ' THR . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.52 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 45' ' ' THR . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 60' ' ' LEU . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.909 ' N ' HD23 ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.53 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.53 HH12 ' NH1' ' A' ' 68' ' ' ARG . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.774 ' CE1' HD22 ' A' ' 77' ' ' LEU . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' C ' HD23 ' A' ' 77' ' ' LEU . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 80' ' ' VAL . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 107' ' ' LEU . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 90' ' ' VAL . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 119.391 -0.338 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 105' ' ' VAL . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' HE22 ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 45' ' ' THR . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.5 ' OH ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.69 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.87 HD13 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.69 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 ' CZ ' ' A' ' 62' ' ' ARG . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 38' ' ' ALA . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 81' ' ' ASP . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 80' ' ' VAL . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.619 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.653 HD22 ' HB2' ' A' ' 98' ' ' GLU . 2.5 p-10 -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.653 ' HB2' HD22 ' A' ' 96' ' ' ASN . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 26' ' ' TYR . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.529 ' O ' ' NE2' ' A' ' 110' ' ' GLN . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.58 HE22 ' HB2' ' A' ' 31' ' ' ARG . 4.3 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.2 pp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 77.7 mtm -103.24 107.93 18.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.82 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.65 78.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -83.59 124.86 31.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -157.15 -17.43 0.09 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.24 156.11 26.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.88 58.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.63 0.252 . . . . 0.0 111.291 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -85.71 125.3 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.712 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -69.6 134.25 48.55 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.14 156.58 33.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' THR . 61.7 t -106.32 -37.86 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -57.56 9.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.0 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' VAL . 69.2 p -49.92 -37.46 31.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.298 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 24.8 p-10 -173.14 -54.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 110.886 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -117.48 175.26 5.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -111.72 -39.24 4.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.147 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -117.13 119.99 36.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.704 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -84.47 111.66 19.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.731 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -105.29 162.57 13.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.479 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -84.24 139.52 39.17 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.904 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.451 HD12 HD12 ' A' ' 25' ' ' LEU . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.69 ' C ' HD13 ' A' ' 25' ' ' LEU . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 32' ' ' VAL . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.541 ' N ' HG22 ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.491 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.447 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' VAL . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASP . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 107' ' ' LEU . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 90' ' ' VAL . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 84' ' ' SER . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp 88.58 -143.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' OE1' ' CE1' ' A' ' 114' ' ' HIS . 16.8 pt-20 -170.83 -28.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.831 0.348 . . . . 0.0 110.589 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CE1' ' OE1' ' A' ' 113' ' ' GLU . 72.7 m80 -86.98 135.83 33.14 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.629 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -86.31 158.72 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.664 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -66.78 154.87 39.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -147.51 155.42 41.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 14.8 p-80 -151.64 -172.2 4.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -90.61 126.87 36.09 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.22 -60.16 1.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.507 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 5' ' ' GLU . 19.5 p-80 -152.46 -124.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.346 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 79.8 mm-40 -59.5 129.55 42.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.25 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.97 96.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.6 55.24 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.693 -0.298 . . . . 0.0 110.528 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -97.96 128.77 44.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 111.74 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 m -97.35 124.15 41.4 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 -4.96 0.04 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.76 129.06 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 t -147.34 23.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.676 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -77.9 152.18 33.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 14' ' ' ASP . 11.4 p-10 -158.56 -53.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.896 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -112.16 154.61 25.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.809 0.338 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -126.14 7.54 7.22 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.094 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -71.76 130.45 41.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.353 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -67.19 135.95 54.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.95 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -134.49 -175.5 3.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -82.77 124.04 77.56 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.604 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.598 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 36' ' ' GLU . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 32' ' ' VAL . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' HG13 ' A' ' 24' ' ' VAL . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HB3' HD22 ' A' ' 96' ' ' ASN . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 90.0 m-20 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.637 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 79' ' ' ILE . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 80' ' ' VAL . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 107' ' ' LEU . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' H ' HG12 ' A' ' 52' ' ' VAL . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 50' ' ' PRO . 6.4 m120 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 21' ' ' PRO . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.704 ' C ' HD12 ' A' ' 107' ' ' LEU . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 106' ' ' LYS . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.409 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp -101.39 -32.11 10.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.35 145.61 39.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -69.59 -174.69 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.774 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -63.75 -40.46 96.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -84.88 159.63 20.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.146 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -140.45 163.13 33.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.159 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -62.13 131.35 49.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.4 m80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.493 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.8 mtt -83.23 143.57 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.76 156.91 35.64 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.992 0.425 . . . . 0.0 111.137 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 81.2 t60 -157.8 47.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -93.72 90.8 6.72 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.582 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.39 -55.03 2.55 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.15 149.4 50.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.7 tp -87.41 129.22 35.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.347 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -89.14 160.26 17.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.481 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.74 163.52 23.72 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 13' ' ' THR . 3.5 m -83.34 133.76 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 t -67.51 66.71 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 14' ' ' ASP . 58.1 m -81.44 -115.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.118 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.61 ' N ' HG22 ' A' ' 13' ' ' THR . 52.0 t0 -151.41 140.58 21.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -93.57 117.57 30.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.759 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -125.86 5.97 7.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.157 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -100.04 122.27 42.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -85.16 133.16 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.028 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -107.16 172.06 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -85.27 140.76 36.65 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.495 HG23 HD12 ' A' ' 101' ' ' ILE . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' C ' HD13 ' A' ' 25' ' ' LEU . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 36' ' ' GLU . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB2' HG22 ' A' ' 32' ' ' VAL . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 107' ' ' LEU . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.775 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.775 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 80' ' ' VAL . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.574 ' N ' HG22 ' A' ' 79' ' ' ILE . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.606 HG22 ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 23' ' ' ILE . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.728 ' C ' HD12 ' A' ' 107' ' ' LEU . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.0 tp -40.65 108.41 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.4 159.08 24.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 116' ' ' HIS . 91.7 m-70 -75.1 139.79 43.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.743 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -49.66 87.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.601 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 114' ' ' HIS . 86.3 t60 -64.98 -43.31 93.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.118 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -84.05 128.29 34.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.081 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -124.62 128.76 49.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.382 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.613 -179.804 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.9 ptp -82.33 -0.67 46.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.698 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.42 149.15 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.056 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -60.61 136.52 58.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.62 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 56.7 mp0 -80.43 39.99 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.325 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.06 96.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.15 42.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -73.76 137.1 43.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.005 0.431 . . . . 0.0 110.591 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -84.05 162.0 20.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.203 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.11 -53.57 0.4 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 13' ' ' THR . 14.8 p -68.46 144.82 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 14' ' ' ASP . 4.4 m -75.68 45.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 14' ' ' ASP . 98.5 m 48.91 -90.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' THR . 16.6 p30 25.59 -120.9 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.635 0.584 . . . . 0.0 111.878 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.59 111.84 18.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -126.73 12.49 7.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.425 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.56 124.95 42.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.17 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -97.12 130.99 44.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.193 0.521 . . . . 0.0 110.77 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -144.78 155.38 43.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.932 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.38 109.72 23.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.506 HG22 HG22 ' A' ' 44' ' ' VAL . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' C ' HD13 ' A' ' 25' ' ' LEU . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 44' ' ' VAL . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 23' ' ' ILE . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.428 ' OD1' ' CE2' ' A' ' 55' ' ' TYR . 20.9 t-20 -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.428 ' CE2' ' OD1' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.749 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.779 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 69' ' ' VAL . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.779 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.749 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 107' ' ' LEU . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' LEU . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.654 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.639 ' N ' HD12 ' A' ' 109' ' ' ILE . 28.8 mm100 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp -17.7 -91.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.36 83.97 1.74 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 110.783 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -102.61 -15.5 16.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -117.03 128.81 55.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -94.62 24.12 4.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.52 -41.27 94.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.817 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -57.69 96.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 m170 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.934 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 1' ' ' ARG . 49.0 ptt85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.171 0.51 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' HIS . 54.6 mtt -64.6 -39.31 93.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.38 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.726 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 6' ' ' GLY . 73.0 t60 -74.48 -44.07 53.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.512 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.72 34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.466 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -82.95 -133.28 1.98 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.0 145.77 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.304 . . . . 0.0 110.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.6 mp -75.61 136.66 40.47 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -65.38 155.91 33.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.471 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.64 -160.06 11.8 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 13' ' ' THR . 18.4 m -86.41 134.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -59.0 10.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.509 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 11' ' ' VAL . 44.3 m 52.09 93.38 0.02 OUTLIER 'General case' 0 C--O 1.228 -0.072 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 13' ' ' THR . 9.5 t0 83.73 121.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.752 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 15.4 mp0 -90.02 14.32 12.58 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.097 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 11.81 7.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.68 0.276 . . . . 0.0 110.326 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -80.95 148.49 29.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.485 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -95.59 116.84 29.41 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.071 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -107.98 179.64 4.16 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -83.18 139.72 42.27 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.462 HD12 HD12 ' A' ' 25' ' ' LEU . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 ' C ' HD13 ' A' ' 25' ' ' LEU . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.805 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 47' ' ' TYR . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.783 HD21 ' N ' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.783 ' N ' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.713 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.713 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD13 HD11 ' A' ' 56' ' ' LEU . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 38' ' ' ALA . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 107' ' ' LEU . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 102' ' ' GLU . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 101' ' ' ILE . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.641 ' C ' HD12 ' A' ' 107' ' ' LEU . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' SER . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp -80.31 99.29 7.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 115' ' ' HIS . 44.3 tp10 -121.06 126.05 48.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.203 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -70.88 33.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.9 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.559 ' H ' ' C ' ' A' ' 113' ' ' GLU . 11.6 t-160 -58.72 -43.83 90.24 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.44 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 42.9 t-80 -114.74 28.36 8.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.605 0.241 . . . . 0.0 111.334 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -65.26 -43.45 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.374 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -122.87 131.56 53.8 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.283 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -98.86 120.0 38.57 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.91 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -67.77 -49.38 62.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -172.21 178.25 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.23 34.69 2.41 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.79 149.33 40.3 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -80.24 127.78 32.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.037 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -83.91 152.0 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.356 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 47.55 4.9 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -117.32 120.06 63.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.335 0.588 . . . . 0.0 111.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -70.95 66.43 0.38 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.519 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 13' ' ' THR . 5.2 t -98.19 102.07 13.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.133 0.492 . . . . 0.0 112.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.1 t0 38.94 83.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.52 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -60.41 -94.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.132 0.491 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.49 5.45 8.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -63.94 135.89 56.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.587 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -58.02 128.48 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.254 0.55 . . . . 0.0 112.215 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.12 140.12 33.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.056 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp -85.81 135.67 37.58 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 25' ' ' LEU . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.741 ' O ' HG21 ' A' ' 105' ' ' VAL . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.616 ' N ' HG22 ' A' ' 44' ' ' VAL . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 75' ' ' HIS . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.784 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' H ' HG12 ' A' ' 90' ' ' VAL . 70.7 m-20 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.483 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.784 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.6 ' O ' HG21 ' A' ' 109' ' ' ILE . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 107' ' ' LEU . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 26' ' ' TYR . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.772 ' C ' HD12 ' A' ' 107' ' ' LEU . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 22.2 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp -112.94 120.99 43.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -86.4 119.48 26.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.221 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -84.2 134.02 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 116' ' ' HIS . 0.0 OUTLIER -80.54 -126.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -154.01 162.96 40.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.2 142.79 52.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.664 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -76.87 136.78 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 45.9 t-80 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.773 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 76.7 ttt-85 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.2 ttp -98.43 76.04 2.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HB2' ' NH2' ' A' ' 1' ' ' ARG . . . -168.74 131.58 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.225 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -154.58 149.15 26.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 16.5 pt-20 -68.39 -39.31 81.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.156 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.4 138.24 4.88 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.29 57.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.844 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD22 ' A' ' 8' ' ' LEU . 2.7 mm? -76.31 140.5 41.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 m -72.15 137.05 46.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.507 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.14 133.1 1.51 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.29 125.63 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' THR . 42.7 p -56.85 -84.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.144 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' THR . 0.3 OUTLIER 77.6 96.86 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 55.5 p-10 -82.99 147.5 28.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.581 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -141.02 156.28 46.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.006 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -124.92 12.46 8.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -115.26 130.88 57.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.09 130.77 46.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.67 163.77 14.4 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.103 0.477 . . . . 0.0 111.293 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -85.61 139.13 35.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' C ' ' HG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 25' ' ' LEU . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HD12 ' A' ' 25' ' ' LEU . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.674 ' CE1' HD21 ' A' ' 107' ' ' LEU . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' N ' HG13 ' A' ' 32' ' ' VAL . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 109' ' ' ILE . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 32' ' ' VAL . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 25' ' ' LEU . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 44' ' ' VAL . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.0 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 60' ' ' LEU . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.608 ' CZ ' HD13 ' A' ' 60' ' ' LEU . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.58 HH11 ' N ' ' A' ' 78' ' ' ASP . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OE1' ' A' ' 5' ' ' GLU . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.58 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG22 ' A' ' 80' ' ' VAL . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 107' ' ' LEU . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' VAL . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.71 ' C ' HD12 ' A' ' 107' ' ' LEU . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.588 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.471 ' N ' HD12 ' A' ' 109' ' ' ILE . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -41.78 98.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -94.92 121.95 37.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.31 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -155.11 80.85 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -157.71 22.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -88.33 51.7 2.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.108 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.1 m80 -119.14 141.09 49.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.389 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.489 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 79.8 t60 -66.93 -45.75 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 57.1 p-80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.781 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 3' ' ' ALA . 3.5 ppp? -60.26 -40.64 91.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.942 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -74.68 152.38 39.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 111.036 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -76.78 147.32 37.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.62 125.68 24.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.021 0.438 . . . . 0.0 110.643 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.04 165.16 38.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -73.91 140.1 45.4 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.215 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -81.91 159.67 23.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' VAL . . . -98.19 13.08 63.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.6 m 46.18 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.776 0.322 . . . . 0.0 111.083 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.0 m 37.61 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.301 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -87.96 124.01 33.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -173.7 99.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.671 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -144.89 66.68 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.682 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.58 12.81 8.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.785 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.91 173.83 11.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.35 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.38 137.75 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.574 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -139.1 159.79 41.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -83.47 111.08 28.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.779 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 36' ' ' GLU . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' CB ' HD12 ' A' ' 79' ' ' ILE . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 45' ' ' THR . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.773 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.804 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.804 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.773 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.556 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.598 HG22 ' NE2' ' A' ' 103' ' ' HIS . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.598 ' NE2' HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.732 ' C ' HD12 ' A' ' 107' ' ' LEU . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' SER . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.483 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.436 ' OE1' ' CZ ' ' A' ' 85' ' ' TYR . 33.6 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.05 131.44 46.21 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -58.03 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.237 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -91.57 127.38 37.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.019 0.438 . . . . 0.0 110.724 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -85.8 -55.8 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 166.4 33.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.853 0.358 . . . . 0.0 110.797 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -69.41 137.93 53.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -74.34 135.26 42.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.638 -179.501 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -72.25 -21.71 61.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.039 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -59.13 -36.18 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -95.92 127.58 42.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE2' ' N ' ' A' ' 6' ' ' GLY . 0.3 OUTLIER -65.92 -40.92 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.16 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' N ' ' OE2' ' A' ' 5' ' ' GLU . . . -101.73 65.43 0.47 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.98 57.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 8' ' ' LEU . 11.2 mp -84.0 137.47 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.355 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -86.88 124.57 33.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.959 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.59 51.0 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.0 123.02 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 p -125.04 -60.41 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.541 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.6 p -93.12 134.89 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 17' ' ' GLU . 24.7 t70 -100.3 105.1 16.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.389 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.1 49.27 0.81 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.22 13.86 8.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.065 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 57.2 mp0 -86.99 145.6 26.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.173 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -68.47 125.17 25.63 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.824 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -119.31 172.04 7.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.714 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -84.21 139.5 39.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 92' ' ' VAL . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' C ' HD13 ' A' ' 25' ' ' LEU . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.613 ' N ' HG12 ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 75' ' ' HIS . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.522 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 38' ' ' ALA . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 23' ' ' ILE . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -108.97 -77.4 0.6 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -85.68 124.72 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.283 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -61.9 -46.85 87.57 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -142.6 138.46 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -83.16 128.06 34.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.001 0.429 . . . . 0.0 110.122 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -160.59 -13.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.477 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -111.43 144.41 40.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.102 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.2 m170 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.79 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' ALA . 39.0 ttm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.9 mtt -72.63 21.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 1' ' ' ARG . . . -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.624 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.46 59.38 0.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.63 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.08 -58.67 4.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.02 -113.2 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.8 148.86 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 110.591 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -86.79 123.65 32.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.659 ' N ' HD13 ' A' ' 8' ' ' LEU . 16.3 p -103.03 146.63 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.639 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.58 8.75 76.73 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.08 130.26 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.183 0.516 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.36 60.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.131 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.5 p -112.83 -140.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.642 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 49.4 25.27 1.26 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -67.03 -124.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.653 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -125.42 8.75 7.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -63.08 148.34 48.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.096 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -73.44 140.89 46.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -135.45 170.41 15.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.58 116.05 59.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HB2' HD11 ' A' ' 101' ' ' ILE . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 25' ' ' LEU . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.701 ' C ' HD13 ' A' ' 25' ' ' LEU . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 40' ' ' PHE . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' C ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.438 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE2' HG11 ' A' ' 30' ' ' VAL . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.77 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.549 ' O ' ' ND2' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 54' ' ' TRP . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.698 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.476 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 107' ' ' LEU . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 21' ' ' PRO . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.709 ' C ' HD12 ' A' ' 107' ' ' LEU . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.534 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.477 ' N ' HD12 ' A' ' 109' ' ' ILE . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.456 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp -54.61 125.14 18.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.59 144.1 54.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -95.35 140.64 29.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.529 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -59.68 139.83 56.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.532 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 117' ' ' HIS . 53.5 p-80 -148.98 -45.67 0.14 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.467 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 58.9 t-80 -154.56 -57.34 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.83 125.23 33.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CG ' ' OXT' ' A' ' 119' ' ' HIS . 58.5 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.27 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -82.01 141.84 32.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.54 162.28 39.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.19 142.36 43.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.994 0.426 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 56.4 mp0 -65.38 -41.27 93.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.298 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.56 -21.22 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 139.68 58.34 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.375 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -97.24 130.75 44.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -79.88 129.25 34.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.15 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.83 -155.57 26.31 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -70.55 164.54 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 13' ' ' THR . 47.0 p -67.65 74.6 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.271 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 18.48 -107.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.702 179.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 13' ' ' THR . 58.5 t0 56.47 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.322 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 50.0 tt0 -74.79 139.12 43.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.63 8.16 11.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.474 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 tm-20 -67.45 126.89 30.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.59 118.64 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.376 0.608 . . . . 0.0 111.528 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -114.57 141.84 47.21 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.859 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 151.93 58.42 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.499 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' C ' HD13 ' A' ' 25' ' ' LEU . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.793 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 112' ' ' LEU . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' HB1' ' CE1' ' A' ' 40' ' ' PHE . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE1' ' HB1' ' A' ' 38' ' ' ALA . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 5.0 p-10 -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.769 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HZ2' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.769 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 81' ' ' ASP . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' H ' HG12 ' A' ' 80' ' ' VAL . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.42 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 21' ' ' PRO . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.714 ' C ' HD12 ' A' ' 107' ' ' LEU . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 57.1 tp -101.8 -20.11 15.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.83 121.38 36.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.348 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -131.2 12.72 5.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.816 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -70.51 -23.25 62.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.439 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -88.14 97.14 10.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -95.14 -60.08 1.76 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -66.24 -45.53 80.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.285 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -41.18 97.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.8 47.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.927 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -100.96 3.11 41.35 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.63 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -67.09 -39.76 86.84 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.493 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.37 127.29 23.55 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.666 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.35 145.64 52.79 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 115.441 -0.379 . . . . 0.0 109.999 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.35 130.46 35.05 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.366 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.87 160.01 22.25 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.626 0.579 . . . . 0.0 111.022 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.08 154.02 26.08 Favored Glycine 0 C--O 1.218 -0.846 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.977 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 12' ' ' THR . 5.7 t 41.84 91.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 11' ' ' VAL . 30.1 m -25.68 -66.99 0.05 OUTLIER 'General case' 0 C--N 1.345 0.37 0 O-C-N 124.299 0.999 . . . . 0.0 111.261 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 m 47.98 74.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.087 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -43.79 -86.57 0.0 OUTLIER 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.114 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -143.11 -92.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.59 13.84 9.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.003 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.6 169.74 14.9 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 133.42 56.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.08 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 38.4 tt0 -138.77 174.64 10.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 54.1 mttm -81.06 145.5 56.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.586 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 25' ' ' LEU . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 24' ' ' VAL . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 33' ' ' LEU . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.734 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' ARG . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 19' ' ' GLN . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.7 m-20 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' SER . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' VAL . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.78 ' NE2' HD21 ' A' ' 77' ' ' LEU . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 38' ' ' ALA . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 84' ' ' SER . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.459 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -66.71 130.92 44.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -111.79 -120.03 0.29 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -115.46 127.34 55.26 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.492 0.663 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -66.75 123.39 20.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.066 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -77.56 2.55 16.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.132 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -74.66 118.81 18.03 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 1.1 p-80 -80.66 -27.8 37.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.214 -0.795 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.023 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.83 -41.49 95.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.091 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.54 96.15 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.59 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 37.9 t-80 -85.21 -0.56 55.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.609 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -122.5 146.84 47.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.47 -171.64 6.72 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.15 140.6 49.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.029 0.442 . . . . 0.0 111.107 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.46 129.61 34.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -70.92 136.84 48.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.116 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.48 -84.64 0.13 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' THR . 17.8 t -95.96 -26.43 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 p -59.42 10.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.444 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' VAL . 13.6 p -75.3 164.03 26.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.423 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.55 -38.67 90.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -88.32 78.44 7.99 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -125.39 6.12 7.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.135 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.02 142.4 58.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.99 115.63 15.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.32 169.88 9.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt -84.09 138.29 39.81 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 45' ' ' THR . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 HD12 ' A' ' 25' ' ' LEU . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.66 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 105' ' ' VAL . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 37' ' ' THR . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.646 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.631 HG13 ' CZ2' ' A' ' 54' ' ' TRP . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 93' ' ' THR . 88.6 m-20 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 93.3 m-20 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 102' ' ' GLU . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 101' ' ' ILE . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.716 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt -45.32 148.07 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.3 pt-20 -75.56 108.35 8.32 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.066 0.46 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -85.57 127.06 34.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.143 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -64.22 -166.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.397 . . . . 0.0 110.513 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.49 138.83 45.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -75.98 -2.11 28.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.569 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -66.17 -43.46 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.672 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 C--O 1.217 -0.608 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.113 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.79 -42.32 99.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.777 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.93 145.78 28.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -104.87 121.37 43.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 0.0 111.293 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -91.48 -13.68 31.78 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.047 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.77 165.85 53.54 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.92 147.86 32.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.056 0.455 . . . . 0.0 110.44 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 mt -73.18 133.23 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.243 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -63.13 136.99 58.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.069 0.461 . . . . 0.0 110.968 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -137.05 46.42 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.297 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 11' ' ' VAL . 7.0 p -65.95 129.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.782 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -50.79 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 t -143.39 150.72 39.5 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -166.89 12.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.188 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -154.33 97.7 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 109.923 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -123.9 -31.92 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.005 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.71 161.0 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.943 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.72 139.45 47.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.286 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -115.51 -173.76 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -84.39 118.75 71.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 92' ' ' VAL . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.654 ' HG ' ' CD2' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.459 HG11 ' CE1' ' A' ' 75' ' ' HIS . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.692 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 96.1 m-20 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' TRP . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.741 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.692 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.741 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 38' ' ' ALA . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 81' ' ' ASP . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 80' ' ' VAL . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 109' ' ' ILE . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.82 HG22 ' CD2' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.82 ' CD2' HG22 ' A' ' 92' ' ' VAL . 2.5 p80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 26' ' ' TYR . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.68 ' C ' HD12 ' A' ' 107' ' ' LEU . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.628 HG21 ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 114' ' ' HIS . 52.9 tp -65.28 131.46 46.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' OE1' ' ND1' ' A' ' 115' ' ' HIS . 44.9 tp10 -146.61 102.82 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.319 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' NE2' HD11 ' A' ' 112' ' ' LEU . 89.6 m-70 -93.67 -2.85 53.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.669 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.489 ' ND1' ' OE1' ' A' ' 113' ' ' GLU . 69.5 m80 -56.9 -14.9 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -105.98 41.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.694 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 25.1 t-80 -132.38 -98.85 0.29 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 78.8 t60 -70.1 -8.33 48.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.574 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.31 -40.49 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.648 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.79 137.34 56.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 110.615 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -68.9 81.74 0.3 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.673 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -167.3 50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.55 -1.67 61.95 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.19 136.39 58.05 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.405 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 2.5 mm? -75.17 137.23 41.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.958 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.09 160.43 24.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.813 0.34 . . . . 0.0 110.472 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.29 153.11 46.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.37 130.66 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.058 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p 48.38 -132.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.263 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 29.8 p -60.68 -116.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' N ' ' OG1' ' A' ' 13' ' ' THR . 96.9 m-20 44.92 47.04 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -166.59 95.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.07 8.07 8.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.6 152.08 23.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.647 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -70.11 133.79 47.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.679 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 47.3 tt0 -137.8 168.18 20.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 29.5 mtmm -81.64 116.32 62.35 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.442 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' CG1' ' A' ' 92' ' ' VAL . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' C ' HD12 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.467 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 34.5 t30 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 77' ' ' LEU . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.646 HD21 ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 38' ' ' ALA . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 23' ' ' ILE . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.484 ' C ' HD12 ' A' ' 107' ' ' LEU . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 106' ' ' LYS . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 2.4 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 114' ' ' HIS . 41.7 mt -64.51 144.46 57.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -63.27 5.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.652 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 112' ' ' LEU . 52.4 t-80 -119.41 71.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 115' ' ' HIS . 6.8 p80 -99.82 110.71 23.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.456 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -163.73 -51.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.057 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -81.04 143.81 32.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -143.99 150.75 38.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.41 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.816 179.498 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.61 136.21 53.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.56 59.03 1.26 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -59.95 -43.52 94.95 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.108 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -157.65 -77.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.673 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.08 140.79 18.79 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.642 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.53 154.33 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -71.49 121.24 18.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.852 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.635 ' N ' HD13 ' A' ' 8' ' ' LEU . 4.7 m -67.04 131.34 45.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.645 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.81 176.97 5.47 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' THR . 56.1 t -118.39 132.99 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -64.43 73.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.902 0.382 . . . . 0.0 110.601 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' VAL . 14.2 t -111.72 -9.57 14.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 35.9 p-10 -75.74 59.31 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -63.84 -52.01 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.756 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -126.56 12.31 7.44 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.389 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -69.05 151.65 46.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.341 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -59.5 129.16 40.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' NE2' ' OD2' ' A' ' 14' ' ' ASP . 6.9 mm100 -113.7 -179.4 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 110.013 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -87.57 126.45 61.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.867 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 25' ' ' LEU . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 92' ' ' VAL . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 111' ' ' GLN . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CZ ' HD12 ' A' ' 107' ' ' LEU . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.422 HH12 ' HB3' ' A' ' 43' ' ' ARG . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HB3' HH12 ' A' ' 41' ' ' ARG . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.467 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CE2' HD13 ' A' ' 60' ' ' LEU . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 77' ' ' LEU . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 89.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 55' ' ' TYR . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.724 ' NE2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 80' ' ' VAL . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 80' ' ' VAL . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.742 ' O ' HD12 ' A' ' 109' ' ' ILE . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.626 HG21 HD21 ' A' ' 25' ' ' LEU . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.594 ' C ' HD22 ' A' ' 107' ' ' LEU . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 106' ' ' LYS . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.43 ' O ' HD22 ' A' ' 33' ' ' LEU . 24.6 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -61.18 -46.26 91.25 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -61.33 143.3 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.703 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -86.36 137.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -63.6 -40.9 98.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.774 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 115' ' ' HIS . 96.0 m-70 -158.37 146.4 18.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.818 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -131.02 122.25 26.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -120.95 -81.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.336 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.684 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -86.12 139.4 31.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.824 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.48 151.3 19.42 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -65.35 -38.9 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.349 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -84.14 -13.71 52.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.822 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.14 83.46 0.52 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 136.12 57.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.28 135.87 43.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.022 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -65.18 155.37 35.21 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.004 0.431 . . . . 0.0 111.12 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.72 98.38 0.17 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 13' ' ' THR . 2.1 p -62.64 157.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' VAL . 25.2 p -57.69 86.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.792 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' VAL . 26.8 p -61.24 -83.21 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -74.91 123.93 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -129.42 165.51 21.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.56 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -122.38 13.09 10.22 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -69.19 131.5 45.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -76.65 134.47 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -141.45 154.09 45.37 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -88.57 109.5 29.8 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 44' ' ' VAL . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' ND2' ' O ' ' A' ' 57' ' ' ASN . 0.6 OUTLIER 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.797 ' H ' HD23 ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.799 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 38' ' ' ALA . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' N ' ' A' ' 81' ' ' ASP . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.588 ' N ' HG22 ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.639 HG21 HD12 ' A' ' 107' ' ' LEU . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.426 HD21 ' HE2' ' A' ' 47' ' ' TYR . 0.2 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 102' ' ' GLU . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 101' ' ' ILE . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.639 HD12 HG21 ' A' ' 90' ' ' VAL . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp -84.38 130.95 34.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -149.11 -50.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.589 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -87.15 127.53 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -155.36 166.63 32.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -89.79 133.04 34.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -66.19 -41.48 90.17 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -77.38 130.56 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.489 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.522 -179.762 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.6 mpt? -62.41 -40.23 95.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.13 134.23 56.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.719 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -82.13 -19.44 40.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.7 -70.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.29 170.58 43.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.92 145.33 56.03 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.163 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD22 ' A' ' 8' ' ' LEU . 2.5 mm? -75.26 138.56 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.09 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -69.96 144.87 52.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.91 -129.2 3.32 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.0 t -94.27 128.28 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 13' ' ' THR . 29.4 p -119.56 -77.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.104 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.556 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.4 m 65.42 -133.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 13' ' ' THR . 11.9 t0 -168.56 -169.3 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -76.91 152.65 35.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.307 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -124.72 11.55 8.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.056 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -71.66 177.83 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.185 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -53.86 147.26 12.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 46' ' ' GLY . 84.5 mt-30 -145.28 146.41 31.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 13.0 ptmt -93.3 107.92 29.43 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 101' ' ' ILE . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.787 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 107' ' ' LEU . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 75' ' ' HIS . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.83 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.405 ' CE1' HD13 ' A' ' 60' ' ' LEU . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 54' ' ' TRP . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.742 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.83 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 0.5 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 81' ' ' ASP . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 80' ' ' VAL . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.617 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 107' ' ' LEU . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HG2' HG13 ' A' ' 100' ' ' VAL . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 95' ' ' GLU . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.617 HG21 ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -93.24 118.4 31.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.615 ' N ' HD13 ' A' ' 112' ' ' LEU . 41.9 tp10 -61.22 110.73 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -100.85 98.85 9.3 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.94 -40.68 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.689 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -84.9 147.84 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.702 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -67.22 123.73 21.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.815 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -103.84 133.72 48.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.269 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 ttp -91.02 120.04 31.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.57 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -110.72 147.38 34.51 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.946 0.403 . . . . 0.0 110.836 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.35 157.96 44.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.37 -171.41 28.49 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.9 143.07 52.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.863 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.0 mp -88.79 126.6 35.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.185 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 ' OG1' ' OE2' ' A' ' 17' ' ' GLU . 7.3 p -85.55 160.07 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.174 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.18 -142.79 4.24 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.5 t 54.17 94.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.726 0.298 . . . . 0.0 110.812 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.9 p 44.98 -160.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m 56.33 15.21 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.523 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -89.15 9.87 23.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.242 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -63.37 -44.6 94.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.931 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -122.99 12.65 9.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' OE2' ' OG1' ' A' ' 9' ' ' THR . 76.9 tt0 -76.64 154.53 34.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.079 0.466 . . . . 0.0 110.736 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.25 151.89 46.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.789 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -142.08 169.17 18.1 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -81.72 112.84 37.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 45' ' ' THR . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.52 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 45' ' ' THR . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 60' ' ' LEU . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.909 ' N ' HD23 ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.53 HH12 ' NH1' ' A' ' 68' ' ' ARG . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.774 ' CE1' HD22 ' A' ' 77' ' ' LEU . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' C ' HD23 ' A' ' 77' ' ' LEU . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 80' ' ' VAL . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 107' ' ' LEU . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 45' ' ' THR . 0.3 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 90' ' ' VAL . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp -73.34 122.37 21.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -113.48 124.26 51.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.952 0.406 . . . . 0.0 110.867 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -157.81 161.76 38.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -81.05 -9.31 59.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -75.88 138.39 41.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 110.959 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -96.94 141.39 30.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.699 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.592 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -75.79 -17.29 59.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.271 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 72.4 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.635 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.8 mtp -82.59 147.5 28.55 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.198 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.82 149.21 30.94 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -87.01 169.27 12.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.959 0.409 . . . . 0.0 111.547 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 6' ' ' GLY . 2.8 pp20? -68.08 -35.71 78.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' N ' ' CD ' ' A' ' 5' ' ' GLU . . . -134.13 123.72 3.35 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.38 53.27 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 111.45 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 tp -72.35 133.82 45.16 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 m -72.55 133.27 44.67 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.1 166.21 12.19 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' THR . 26.8 m -102.43 7.89 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.256 0.222 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 12' ' ' THR . 7.8 t -65.62 66.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.356 0.598 . . . . 0.0 111.721 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' VAL . 41.6 p -130.6 -84.27 0.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.921 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 66.3 t0 45.61 30.36 0.77 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.112 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -68.43 -42.21 79.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.265 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -124.46 -32.06 3.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.839 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 81.0 tt0 -65.57 128.55 36.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.34 128.94 34.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -107.33 177.67 4.77 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.011 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -84.46 130.38 53.95 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.448 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 105' ' ' VAL . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.58 ' HB2' HE22 ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 45' ' ' THR . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.5 ' OH ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.69 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.87 HD13 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.69 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 ' CZ ' ' A' ' 62' ' ' ARG . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 38' ' ' ALA . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 81' ' ' ASP . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 80' ' ' VAL . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.619 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.653 HD22 ' HB2' ' A' ' 98' ' ' GLU . 2.5 p-10 -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.653 ' HB2' HD22 ' A' ' 96' ' ' ASN . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 26' ' ' TYR . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.529 ' O ' ' NE2' ' A' ' 110' ' ' GLN . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.58 HE22 ' HB2' ' A' ' 31' ' ' ARG . 4.3 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 114' ' ' HIS . 2.2 pp -63.97 134.41 55.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -41.02 90.27 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 121.082 0.468 . . . . 0.0 110.758 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 42.7 t60 -63.51 -39.91 95.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.93 137.69 58.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 116' ' ' HIS . 2.6 p80 -149.75 -45.72 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -136.74 34.55 2.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 0.0 111.507 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -62.82 140.31 58.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' CD2' ' OXT' ' A' ' 119' ' ' HIS . 22.5 p-80 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 116.92 -1.514 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 119.916 -0.087 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.451 HD12 HD12 ' A' ' 25' ' ' LEU . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.69 ' C ' HD13 ' A' ' 25' ' ' LEU . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 32' ' ' VAL . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.541 ' N ' HG22 ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.491 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.447 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' VAL . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASP . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 107' ' ' LEU . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 90' ' ' VAL . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 84' ' ' SER . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp . . . . . 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 119.584 -0.246 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.598 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.794 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 36' ' ' GLU . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 32' ' ' VAL . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' HG13 ' A' ' 24' ' ' VAL . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 13.7 m120 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.637 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 79' ' ' ILE . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 80' ' ' VAL . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 107' ' ' LEU . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 3.3 m-80 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 21' ' ' PRO . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.704 ' C ' HD12 ' A' ' 107' ' ' LEU . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 106' ' ' LYS . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.409 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.495 HG23 HD12 ' A' ' 101' ' ' ILE . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' C ' HD13 ' A' ' 25' ' ' LEU . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 36' ' ' GLU . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB2' HG22 ' A' ' 32' ' ' VAL . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 107' ' ' LEU . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 ' C ' HD22 ' A' ' 53' ' ' ASN . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 52' ' ' VAL . 7.2 m120 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.775 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.775 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 80' ' ' VAL . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.574 ' N ' HG22 ' A' ' 79' ' ' ILE . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.606 HG22 ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 23' ' ' ILE . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.728 ' C ' HD12 ' A' ' 107' ' ' LEU . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 51.0 tp . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.506 HG22 HG22 ' A' ' 44' ' ' VAL . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.531 ' C ' HD13 ' A' ' 25' ' ' LEU . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 44' ' ' VAL . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 23' ' ' ILE . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CE2' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CE2' ' ND2' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.749 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.779 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 69' ' ' VAL . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.779 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.749 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.45 HG21 HE22 ' A' ' 110' ' ' GLN . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 107' ' ' LEU . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' LEU . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.654 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.639 ' N ' HD12 ' A' ' 109' ' ' ILE . 96.0 mm-40 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp . . . . . 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.462 HD12 HD12 ' A' ' 25' ' ' LEU . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 ' C ' HD13 ' A' ' 25' ' ' LEU . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.805 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 47' ' ' TYR . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.506 ' ND2' ' OH ' ' A' ' 55' ' ' TYR . 63.1 t-20 -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.503 ' CD2' ' N ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.506 ' OH ' ' ND2' ' A' ' 53' ' ' ASN . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.713 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.713 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD13 HD11 ' A' ' 56' ' ' LEU . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 38' ' ' ALA . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 107' ' ' LEU . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 102' ' ' GLU . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 101' ' ' ILE . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.641 ' C ' HD12 ' A' ' 107' ' ' LEU . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' SER . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp . . . . . 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 25' ' ' LEU . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.741 ' O ' HG21 ' A' ' 105' ' ' VAL . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.616 ' N ' HG22 ' A' ' 44' ' ' VAL . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 75' ' ' HIS . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.784 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' H ' HG12 ' A' ' 90' ' ' VAL . 8.6 m120 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.483 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.784 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.6 ' O ' HG21 ' A' ' 109' ' ' ILE . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 107' ' ' LEU . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 6.2 m-80 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 26' ' ' TYR . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.772 ' C ' HD12 ' A' ' 107' ' ' LEU . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 2.6 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' C ' ' HG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 25' ' ' LEU . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HD12 ' A' ' 25' ' ' LEU . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.674 ' CE1' HD21 ' A' ' 107' ' ' LEU . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' N ' HG13 ' A' ' 32' ' ' VAL . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 109' ' ' ILE . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 32' ' ' VAL . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 25' ' ' LEU . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 44' ' ' VAL . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.616 ' N ' ' NE2' ' A' ' 49' ' ' GLN . 0.1 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 60' ' ' LEU . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.608 ' CZ ' HD13 ' A' ' 60' ' ' LEU . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.58 HH11 ' N ' ' A' ' 78' ' ' ASP . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.58 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG22 ' A' ' 80' ' ' VAL . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 107' ' ' LEU . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' VAL . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.71 ' C ' HD12 ' A' ' 107' ' ' LEU . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.588 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.471 ' N ' HD12 ' A' ' 109' ' ' ILE . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt . . . . . 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.779 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 36' ' ' GLU . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' CB ' HD12 ' A' ' 79' ' ' ILE . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 45' ' ' THR . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.773 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.804 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.804 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.773 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.598 HG22 ' NE2' ' A' ' 103' ' ' HIS . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.598 ' NE2' HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.732 ' C ' HD12 ' A' ' 107' ' ' LEU . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' SER . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.483 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.586 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 75.2 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp . . . . . 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt . . . . . 0 CA--C 1.545 0.766 0 CA-C-O 119.702 -0.19 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 92' ' ' VAL . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' C ' HD13 ' A' ' 25' ' ' LEU . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.613 ' N ' HG12 ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 75' ' ' HIS . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.522 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 38' ' ' ALA . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 23' ' ' ILE . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HB2' HD11 ' A' ' 101' ' ' ILE . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 25' ' ' LEU . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.701 ' C ' HD13 ' A' ' 25' ' ' LEU . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 40' ' ' PHE . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' C ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.438 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE2' HG11 ' A' ' 30' ' ' VAL . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.476 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.77 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 11.4 t-20 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 54' ' ' TRP . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.698 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.476 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 107' ' ' LEU . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 21' ' ' PRO . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.709 ' C ' HD12 ' A' ' 107' ' ' LEU . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.534 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.477 ' N ' HD12 ' A' ' 109' ' ' ILE . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.456 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp . . . . . 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.499 -0.185 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.575 ' C ' HD13 ' A' ' 25' ' ' LEU . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.793 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 112' ' ' LEU . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.449 ' HB1' ' CE1' ' A' ' 40' ' ' PHE . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE1' ' HB1' ' A' ' 38' ' ' ALA . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.769 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HZ2' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.769 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 81' ' ' ASP . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.514 ' H ' HG12 ' A' ' 80' ' ' VAL . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.42 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 21' ' ' PRO . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.714 ' C ' HD12 ' A' ' 107' ' ' LEU . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.427 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 57.1 tp . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.531 0.238 0 N-CA-C 110.586 -0.153 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 25' ' ' LEU . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 24' ' ' VAL . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 33' ' ' LEU . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.734 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' ARG . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.9 m120 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' SER . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' VAL . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.78 ' NE2' HD21 ' A' ' 77' ' ' LEU . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 38' ' ' ALA . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 84' ' ' SER . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.459 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 119.623 -0.227 . . . . 0.0 110.806 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 45' ' ' THR . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 HD12 ' A' ' 25' ' ' LEU . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.66 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 105' ' ' VAL . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 37' ' ' THR . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.646 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.631 HG13 ' CZ2' ' A' ' 54' ' ' TRP . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 13.8 m120 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.4 m120 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.659 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.446 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 102' ' ' GLU . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 101' ' ' ILE . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.716 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt . . . . . 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 92' ' ' VAL . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.568 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.593 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.459 HG11 ' CE1' ' A' ' 75' ' ' HIS . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.692 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 11.4 m120 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' TRP . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.741 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.692 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.741 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 38' ' ' ALA . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 81' ' ' ASP . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 80' ' ' VAL . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 109' ' ' ILE . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.621 HG22 ' ND1' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.621 ' ND1' HG22 ' A' ' 92' ' ' VAL . 2.6 p-80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 26' ' ' TYR . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.68 ' C ' HD12 ' A' ' 107' ' ' LEU . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.628 HG21 ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.9 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.5 mtmm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' CG1' ' A' ' 92' ' ' VAL . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.402 ' C ' HD12 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.61 HD22 ' H ' ' A' ' 89' ' ' GLU . 2.3 t-20 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 77' ' ' LEU . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.646 HD21 ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 38' ' ' ALA . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.61 ' H ' HD22 ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 23' ' ' ILE . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.484 ' C ' HD12 ' A' ' 107' ' ' LEU . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 106' ' ' LYS . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.416 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 22.0 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 25' ' ' LEU . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 92' ' ' VAL . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 111' ' ' GLN . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CZ ' HD12 ' A' ' 107' ' ' LEU . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.422 HH12 ' HB3' ' A' ' 43' ' ' ARG . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HB3' HH12 ' A' ' 41' ' ' ARG . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.467 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CE2' HD13 ' A' ' 60' ' ' LEU . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 77' ' ' LEU . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 26.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 55' ' ' TYR . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.724 ' NE2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 80' ' ' VAL . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 80' ' ' VAL . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.742 ' O ' HD12 ' A' ' 109' ' ' ILE . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.626 HG21 HD21 ' A' ' 25' ' ' LEU . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.594 ' C ' HD22 ' A' ' 107' ' ' LEU . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 106' ' ' LYS . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.719 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.43 ' O ' HD22 ' A' ' 33' ' ' LEU . 1.7 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt . . . . . 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 44' ' ' VAL . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.494 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.421 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 15.1 t-20 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.797 ' H ' HD23 ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.799 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 38' ' ' ALA . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' N ' ' A' ' 81' ' ' ASP . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.588 ' N ' HG22 ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.639 HG21 HD12 ' A' ' 107' ' ' LEU . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 102' ' ' GLU . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 101' ' ' ILE . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.639 HD12 HG21 ' A' ' 90' ' ' VAL . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 ptmt . . . . . 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 101' ' ' ILE . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.787 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 107' ' ' LEU . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' C ' ' A' ' 41' ' ' ARG . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.633 ' CZ2' ' CD2' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.405 ' CE1' HD13 ' A' ' 60' ' ' LEU . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 54' ' ' TRP . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.742 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.633 ' CD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 81' ' ' ASP . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 80' ' ' VAL . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.617 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 107' ' ' LEU . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HG2' HG13 ' A' ' 100' ' ' VAL . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 95' ' ' GLU . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.617 HG21 ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD13 ' C ' ' A' ' 112' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.422 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 45' ' ' THR . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.52 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 45' ' ' THR . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 60' ' ' LEU . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.909 ' N ' HD23 ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.53 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.53 HH12 ' NH1' ' A' ' 68' ' ' ARG . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.774 ' CE1' HD22 ' A' ' 77' ' ' LEU . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.586 ' C ' HD23 ' A' ' 77' ' ' LEU . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 80' ' ' VAL . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 107' ' ' LEU . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.636 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 90' ' ' VAL . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm . . . . . 0 CA--C 1.551 0.981 0 CA-C-O 119.391 -0.338 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 105' ' ' VAL . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.657 ' HE ' ' NE2' ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 45' ' ' THR . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.69 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.87 HD13 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.69 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 ' CZ ' ' A' ' 62' ' ' ARG . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 38' ' ' ALA . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 81' ' ' ASP . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 80' ' ' VAL . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.619 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.695 HD21 ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.695 ' N ' HD21 ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 26' ' ' TYR . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.657 ' NE2' ' HE ' ' A' ' 31' ' ' ARG . 1.7 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 112' ' ' LEU . 2.2 pp . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 77.7 mtm -103.24 107.93 18.94 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.82 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.65 78.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.536 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.514 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 9.8 p80 -83.59 124.86 31.22 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.532 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -157.15 -17.43 0.09 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.117 0.484 . . . . 0.0 110.29 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.24 156.11 26.54 Favored Glycine 0 CA--C 1.53 1.013 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.75 140.88 58.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.63 0.252 . . . . 0.0 111.291 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.0 tp -85.71 125.3 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.712 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -69.6 134.25 48.55 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.14 156.58 33.41 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 13' ' ' THR . 61.7 t -106.32 -37.86 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.19 0.519 . . . . 0.0 110.046 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -57.56 9.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.0 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.554 ' H ' ' C ' ' A' ' 11' ' ' VAL . 69.2 p -49.92 -37.46 31.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.298 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 14' ' ' ASP . 24.8 p-10 -173.14 -54.49 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.061 0.458 . . . . 0.0 110.886 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -117.48 175.26 5.71 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -111.72 -39.24 4.64 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.871 0.367 . . . . 0.0 110.147 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -117.13 119.99 36.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.704 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -84.47 111.66 19.68 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.731 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -105.29 162.57 13.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.479 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -84.24 139.52 39.17 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.904 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -53.31 158.53 7.2 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.022 1.815 . . . . 0.0 111.821 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.535 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 7.4 p-10 173.05 106.42 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.451 HD12 HD12 ' A' ' 25' ' ' LEU . 23.9 pt -80.32 156.73 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.69 ' C ' HD13 ' A' ' 25' ' ' LEU . 53.1 t -114.97 133.21 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.617 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.54 -157.12 0.75 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.46 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 1.3 m-85 -114.67 89.58 19.18 Favored Pre-proline 0 N--CA 1.47 0.571 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -67.56 -23.04 43.65 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 120.981 1.12 . . . . 0.0 110.316 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.62 116.37 65.33 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.304 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -57.94 149.23 71.63 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 119.577 0.885 . . . . 0.0 111.191 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.3 t -131.47 139.13 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 CA-C-O 121.074 0.464 . . . . 0.0 110.784 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.543 ' NH2' ' OE1' ' A' ' 110' ' ' GLN . 70.4 ttt180 -125.45 134.27 52.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.995 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG22 ' HB2' ' A' ' 36' ' ' GLU . 3.4 p -136.46 150.53 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.56 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.4 mp -91.47 138.85 31.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 112' ' ' LEU . 72.0 tt0 -48.96 138.85 11.02 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.53 -0.28 42.98 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HB2' HG22 ' A' ' 32' ' ' VAL . 75.9 mm-40 -119.08 138.62 52.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.049 -0.576 . . . . 0.0 109.977 178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -82.48 138.07 34.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.758 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -108.02 147.26 31.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.148 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -134.37 120.87 20.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.289 0.566 . . . . 0.0 110.83 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.11 152.77 51.99 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.385 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -117.72 140.29 49.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.038 0.447 . . . . 0.0 110.553 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 49.0 t -144.56 102.75 3.86 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.297 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.439 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 54.5 ttp180 -131.8 174.84 9.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.541 HG22 ' N ' ' A' ' 45' ' ' THR . 2.6 p -126.93 169.44 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.541 ' N ' HG22 ' A' ' 44' ' ' VAL . 5.0 t -163.9 176.86 9.04 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.588 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.59 -20.37 27.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.93 142.07 26.55 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 122.547 -0.384 . . . . 0.0 110.163 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.8 Cg_exo -54.56 152.4 27.26 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 121.283 1.322 . . . . 0.0 112.097 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 48' ' ' PRO . 10.5 pt20 -13.22 82.34 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.07 -175.53 2.71 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 123.116 2.544 . . . . 0.0 110.691 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -116.24 93.39 4.22 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 ' CG2' ' NE2' ' A' ' 75' ' ' HIS . 2.8 m -115.34 162.97 13.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-O 121.309 0.576 . . . . 0.0 111.067 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -140.24 172.78 12.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.984 -1.007 . . . . 0.0 108.538 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.491 ' O ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -148.72 168.58 22.51 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.08 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -126.69 117.61 23.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.111 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.8 mp -90.05 132.18 35.53 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 49.55 10.51 0.04 OUTLIER 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.342 0.519 . . . . 0.0 110.229 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 98.15 23.99 12.2 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.8 mt-30 -123.06 118.38 27.61 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.021 0.439 . . . . 0.0 111.025 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.522 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.4 tp -73.95 150.5 40.75 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.742 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.3 tp 61.21 112.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 O-C-N 124.025 0.828 . . . . 0.0 113.097 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.447 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 14.3 tpt180 -111.18 153.59 25.57 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.468 178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' A' ' 62' ' ' ARG . 20.9 mmtp -58.28 146.71 33.27 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -178.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.6 p -73.26 -137.0 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.526 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' OG ' ' A' ' 64' ' ' SER . 64.6 mttp -16.85 -30.98 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.1 ttt85 -61.21 -38.85 88.07 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.442 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 78' ' ' ASP . 58.9 m-85 -126.64 150.88 48.69 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.816 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -69.52 110.5 4.81 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.566 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 p -152.96 135.63 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.641 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' ' O ' ' A' ' 74' ' ' ILE . 59.3 ttp180 -143.04 113.38 7.3 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.405 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 28.9 m-85 -78.22 88.75 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.751 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.405 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 52.0 m-20 -168.59 26.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.03 -18.89 42.0 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.675 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.3 mp -105.36 117.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.456 ' NE2' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -143.48 109.71 5.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -106.65 135.24 48.52 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.2 mt -100.66 102.15 13.2 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.166 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 67' ' ' PHE . 59.5 t0 -114.53 106.34 14.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.793 0.27 . . . . 0.0 110.523 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.513 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 1.5 pt -107.55 108.53 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.792 0.33 . . . . 0.0 110.886 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 80' ' ' VAL . 3.0 p -138.71 7.25 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.482 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 18.2 p30 -63.15 -1.6 1.06 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.168 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' ASP . 2.3 t 86.05 -7.31 0.78 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.265 177.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.35 98.48 8.38 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -131.16 -33.78 1.49 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.909 -178.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 8.7 t80 -51.82 62.55 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.601 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.8 t0 -159.72 114.87 2.39 Favored 'General case' 0 C--N 1.321 -0.674 0 O-C-N 121.426 -0.796 . . . . 0.0 109.445 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.429 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 24.4 p -82.68 130.17 35.08 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.247 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.12 -155.96 6.61 Favored Glycine 0 C--N 1.339 0.735 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 58' ' ' GLY . 85.5 tt0 -141.33 142.73 33.79 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.265 0.555 . . . . 0.0 110.896 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 107' ' ' LEU . 74.3 t -114.69 136.45 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.125 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -141.77 126.08 17.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 m -115.46 137.86 47.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.253 0.549 . . . . 0.0 111.136 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -129.54 163.79 25.19 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -144.46 155.33 43.67 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.961 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -126.92 148.03 50.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -155.41 143.18 14.12 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.72 -22.99 47.26 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 CA-C-N 119.65 0.911 . . . . 0.0 111.453 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.16 0.69 11.27 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -160.31 159.55 30.92 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.046 -1.073 . . . . 0.0 112.582 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 98.4 t -143.35 135.26 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 113.566 -1.317 . . . . 0.0 108.284 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 46.4 mt -134.65 163.21 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.214 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 21.9 pt-20 -157.45 138.92 13.81 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.277 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -145.54 136.86 24.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.229 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -112.57 134.45 54.09 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.283 0.563 . . . . 0.0 111.844 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.48 158.06 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.215 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -117.96 126.42 52.3 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD12 HG21 ' A' ' 90' ' ' VAL . 79.2 mt -121.93 124.75 44.81 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 177.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -124.43 125.95 45.11 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' O ' ' A' ' 84' ' ' SER . 74.6 mt -108.86 113.24 43.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.124 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.543 ' OE1' ' NH2' ' A' ' 31' ' ' ARG . 43.8 tp60 -78.1 -134.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.379 0.424 . . . . 0.0 110.955 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.489 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 55.0 tt0 -156.94 157.81 35.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.976 0.417 . . . . 0.0 111.788 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 tp 88.58 -143.89 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.54 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' OE1' ' CE1' ' A' ' 114' ' ' HIS . 16.8 pt-20 -170.83 -28.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.831 0.348 . . . . 0.0 110.589 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.429 ' CE1' ' OE1' ' A' ' 113' ' ' GLU . 72.7 m80 -86.98 135.83 33.14 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.629 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.42 ' CD2' ' H ' ' A' ' 115' ' ' HIS . 5.1 p80 -86.31 158.72 19.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.664 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -66.78 154.87 39.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.237 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -147.51 155.42 41.87 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -151.64 -172.2 4.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.456 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.7 m80 . . . . . 0 C--O 1.219 -0.528 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.831 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -90.61 126.87 36.09 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.008 0.432 . . . . 0.0 110.729 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.22 -60.16 1.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.507 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 5' ' ' GLU . 19.5 p-80 -152.46 -124.56 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.346 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 79.8 mm-40 -59.5 129.55 42.54 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.25 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.93 -42.97 96.63 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.22 136.6 55.24 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 122.693 -0.298 . . . . 0.0 110.528 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 tp -97.96 128.77 44.74 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 111.74 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.2 m -97.35 124.15 41.4 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.06 -4.96 0.04 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.76 129.06 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.4 t -147.34 23.92 1.14 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.676 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.6 t -77.9 152.18 33.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.486 ' OD2' ' N ' ' A' ' 14' ' ' ASP . 11.4 p-10 -158.56 -53.61 0.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.896 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -112.16 154.61 25.24 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.809 0.338 . . . . 0.0 110.201 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -126.14 7.54 7.22 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.094 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -71.76 130.45 41.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.353 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -67.19 135.95 54.28 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.95 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -134.49 -175.5 3.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.745 0.307 . . . . 0.0 110.542 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -82.77 124.04 77.56 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.604 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.2 Cg_exo -59.04 165.31 8.82 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 121.309 1.339 . . . . 0.0 111.448 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 4.2 p-10 167.65 104.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.259 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.5 pt -79.56 161.08 4.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.181 0.515 . . . . 0.0 111.392 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.598 ' C ' HD13 ' A' ' 25' ' ' LEU . 3.3 p -116.49 136.01 54.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.794 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.81 -156.57 0.72 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.284 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -111.15 94.33 20.92 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 122.144 0.177 . . . . 0.0 110.569 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -67.3 -22.67 45.79 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.724 1.616 . . . . 0.0 112.226 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -91.36 124.49 61.08 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.053 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -59.92 149.48 83.66 Favored 'Trans proline' 0 N--CA 1.488 1.197 0 CA-C-N 119.923 1.008 . . . . 0.0 110.521 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.23 136.93 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.247 0.546 . . . . 0.0 110.64 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -126.77 135.72 51.45 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.578 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 36' ' ' GLU . 2.0 p -133.79 153.05 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.0 mt -96.38 136.19 37.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.007 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 12.4 tm-20 -40.72 128.71 2.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.655 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.08 1.37 48.33 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.429 ' HB2' HG22 ' A' ' 32' ' ' VAL . 71.8 mm-40 -119.15 132.92 56.03 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.522 0.677 . . . . 0.0 110.342 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 p -85.88 151.68 23.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.421 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.9 156.52 30.59 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.655 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -134.12 113.77 12.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.178 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -126.94 146.95 50.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.581 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.09 145.7 51.58 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.595 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -156.15 138.8 15.09 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.585 179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' H ' HG13 ' A' ' 24' ' ' VAL . 92.0 mtm-85 -142.94 -178.58 5.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.996 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -115.63 163.14 13.15 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.473 ' OG1' ' OD2' ' A' ' 22' ' ' ASP . 6.2 p -146.72 149.72 33.96 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.693 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.01 -4.97 85.45 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.055 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -141.5 130.67 12.5 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 117.253 0.526 . . . . 0.0 111.753 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.5 Cg_endo -62.24 161.92 25.2 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.447 1.431 . . . . 0.0 111.133 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.466 ' C ' ' O ' ' A' ' 48' ' ' PRO . 2.2 pt20 -3.96 77.27 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.44 162.16 28.01 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.781 2.321 . . . . 0.0 110.631 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -104.6 103.4 13.06 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 95' ' ' GLU . 32.6 m -129.73 165.06 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 22.4 t-20 -140.41 176.48 8.74 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.658 ' CE2' ' CE1' ' A' ' 75' ' ' HIS . 7.1 m95 -144.21 166.51 24.84 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.575 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -123.94 108.66 12.66 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.523 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' A' ' 58' ' ' GLY . 10.7 mp -87.98 136.89 32.76 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 13.7 m120 47.44 8.76 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.45 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.65 23.06 9.03 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -125.14 118.74 26.77 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.728 0.264 . . . . 0.0 111.6 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.9 pt? -65.97 143.03 57.64 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.14 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 122.021 0.915 . . . . 0.0 112.646 177.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.637 HH21 ' H ' ' A' ' 78' ' ' ASP . 57.1 ttt85 -88.12 150.78 23.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.564 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.8 mmmt -65.77 139.28 58.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.398 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.671 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.4 m -75.74 -140.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.833 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -15.47 -37.01 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.671 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.3 mmm180 -62.96 -39.66 95.33 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.155 0.502 . . . . 0.0 109.984 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' N ' ' O ' ' A' ' 64' ' ' SER . 52.4 m-85 -122.71 146.91 47.07 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -71.19 116.68 11.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.541 0.686 . . . . 0.0 111.921 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 69' ' ' VAL . 11.6 p -153.4 131.92 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.537 178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.5 ttm-85 -128.36 103.79 7.35 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -73.9 89.84 1.89 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.615 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -171.19 28.78 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.87 -18.43 40.25 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.633 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.4 mt -111.06 124.3 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.658 ' CE1' ' CE2' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -141.51 112.86 7.52 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -97.39 123.05 41.09 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -106.2 102.62 12.02 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.637 ' H ' HH21 ' A' ' 62' ' ' ARG . 47.3 p-10 -124.22 132.15 53.58 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 80' ' ' VAL . 96.0 mt -86.09 161.27 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.32 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 79' ' ' ILE . 31.9 t -128.16 165.06 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.536 ' N ' HG12 ' A' ' 80' ' ' VAL . 68.0 t0 -64.96 59.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.475 0.485 . . . . 0.0 110.226 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.538 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER 167.74 134.88 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.0 tptp 71.44 64.71 0.15 Allowed 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.427 0.455 . . . . 0.0 110.389 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.596 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.7 OUTLIER -138.36 -38.81 0.54 Allowed 'General case' 0 C--O 1.215 -0.762 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.929 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.602 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 2.3 p90 -53.1 59.19 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 50.2 t0 -159.59 117.04 2.67 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.131 0.491 . . . . 0.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 16.1 p -83.03 126.4 32.51 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.804 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -138.36 -158.05 7.63 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 98.1 mt-10 -137.38 133.99 35.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.342 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 107' ' ' LEU . 62.4 t -103.96 142.29 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -148.23 116.71 6.59 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.8 m -91.31 131.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.591 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 53' ' ' ASN . 32.5 m -119.53 156.24 30.65 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.863 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.56 150.48 31.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 110.776 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 82.9 tt0 -131.34 148.26 52.65 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 3.3 m-80 -153.06 150.79 24.82 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.999 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.78 -22.61 62.63 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 121.474 1.449 . . . . 0.0 111.519 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -120.47 7.63 10.65 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.27 172.68 45.33 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.891 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 m -149.47 133.01 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 21' ' ' PRO . 74.6 mt -134.91 139.72 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.34 0.591 . . . . 0.0 112.395 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -138.87 152.55 47.89 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.436 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -144.61 144.85 31.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -112.99 127.04 56.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.157 0.504 . . . . 0.0 111.855 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.34 156.44 30.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.193 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.704 ' C ' HD12 ' A' ' 107' ' ' LEU . 88.4 tttt -113.25 122.6 47.93 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.197 0.522 . . . . 0.0 111.804 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.704 HD12 ' C ' ' A' ' 106' ' ' LYS . 8.7 mp -124.25 118.92 27.9 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -120.27 131.36 54.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.857 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 84' ' ' SER . 66.9 mt -109.91 112.49 40.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -86.04 -127.92 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.611 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.409 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 75.2 mt-30 -149.5 154.3 38.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.747 0.308 . . . . 0.0 110.654 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.7 tp -101.39 -32.11 10.61 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -76.35 145.61 39.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.048 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -69.59 -174.69 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.774 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -63.75 -40.46 96.77 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.479 ' H ' ' CD2' ' A' ' 116' ' ' HIS . 8.5 p80 -84.88 159.63 20.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.146 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -140.45 163.13 33.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.159 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.3 m170 -62.13 131.35 49.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.774 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.4 m80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.817 -1.087 . . . . 0.0 110.493 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 66.8 mtt -83.23 143.57 30.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.689 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -155.76 156.91 35.64 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.992 0.425 . . . . 0.0 111.137 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 81.2 t60 -157.8 47.1 0.37 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.22 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -93.72 90.8 6.72 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.582 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.39 -55.03 2.55 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.15 149.4 50.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.894 0.378 . . . . 0.0 111.307 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 49.7 tp -87.41 129.22 35.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.347 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 t -89.14 160.26 17.1 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.481 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.74 163.52 23.72 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 13' ' ' THR . 3.5 m -83.34 133.76 28.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 t -67.51 66.71 0.08 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.695 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.61 HG22 ' N ' ' A' ' 14' ' ' ASP . 58.1 m -81.44 -115.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.118 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.61 ' N ' HG22 ' A' ' 13' ' ' THR . 52.0 t0 -151.41 140.58 21.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.022 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -93.57 117.57 30.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.965 0.412 . . . . 0.0 110.759 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -125.86 5.97 7.35 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.157 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -100.04 122.27 42.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.437 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -85.16 133.16 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.028 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -107.16 172.06 7.03 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -85.27 140.76 36.65 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -53.67 141.18 65.02 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.067 1.178 . . . . 0.0 110.981 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -178.95 105.65 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.866 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.495 HG23 HD12 ' A' ' 101' ' ' ILE . 2.3 pp -84.9 151.69 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.342 0.591 . . . . 0.0 112.266 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' C ' HD13 ' A' ' 25' ' ' LEU . 13.9 p -123.44 144.81 31.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-N 115.087 -0.961 . . . . 0.0 108.8 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.584 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.04 -152.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.405 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -94.57 107.88 33.18 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.53 -26.32 80.59 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.14 1.226 . . . . 0.0 112.872 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -118.91 148.84 45.47 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 111.375 0.139 . . . . 0.0 111.375 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.53 154.46 36.06 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.815 1.677 . . . . 0.0 111.232 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.04 136.62 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -132.44 137.26 47.2 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.311 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' HB2' ' A' ' 36' ' ' GLU . 1.4 p -132.5 161.17 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mt -101.13 135.26 42.88 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.906 0.384 . . . . 0.0 111.675 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 35.0 tp10 -42.12 125.37 3.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.19 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.84 3.7 52.05 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB2' HG22 ' A' ' 32' ' ' VAL . 88.5 mt-10 -114.25 128.68 56.48 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.695 0.283 . . . . 0.0 110.316 179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -79.38 145.25 33.49 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.423 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -124.76 161.59 26.1 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.854 0.359 . . . . 0.0 111.156 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -138.57 128.78 25.71 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.97 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.418 ' CE2' HD21 ' A' ' 107' ' ' LEU . 69.1 m-85 -128.04 131.66 49.14 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.143 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -104.97 127.8 52.97 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 44.5 t -147.78 125.53 11.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.065 0.459 . . . . 0.0 109.896 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 72.5 ttt180 -135.86 176.88 8.28 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 45' ' ' THR . 3.2 p -134.54 173.48 14.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.607 ' N ' HG22 ' A' ' 44' ' ' VAL . 3.1 t -145.93 158.55 43.86 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.179 0.899 . . . . 0.0 110.166 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.36 -84.2 0.19 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.214 -0.517 . . . . 0.0 111.94 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -137.36 140.29 30.23 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -53.2 134.98 58.61 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.353 1.369 . . . . 0.0 112.185 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 71.87 67.58 0.34 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.001 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -89.06 -178.34 1.81 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 123.736 2.957 . . . . 0.0 111.455 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -103.68 133.19 49.1 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 ' C ' HD22 ' A' ' 53' ' ' ASN . 21.4 t -142.58 138.92 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 121.209 0.528 . . . . 0.0 112.317 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.45 HD22 ' C ' ' A' ' 52' ' ' VAL . 7.2 m120 -129.7 128.94 43.54 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.775 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 42.0 m95 -110.92 137.49 48.49 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -124.17 101.13 7.05 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.818 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.0 mp -90.13 136.91 32.76 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 19.1 m120 47.75 9.5 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.125 0 O-C-N 122.221 -0.299 . . . . 0.0 111.29 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.32 23.27 12.94 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 110.119 -1.193 . . . . 0.0 110.119 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 56' ' ' LEU . 51.7 tt0 -123.81 126.0 45.67 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -72.59 150.97 42.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.206 -179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 64.98 110.32 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 124.432 1.082 . . . . 0.0 113.048 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.57 ' NH2' ' CD1' ' A' ' 54' ' ' TRP . 30.4 ptt-85 -95.5 139.02 32.37 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -57.34 146.32 29.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.764 0.792 . . . . 0.0 112.931 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.707 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 t -75.6 -136.76 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.861 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -11.64 -37.71 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.707 ' N ' ' O ' ' A' ' 64' ' ' SER . 41.7 ttm180 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.747 0.703 . . . . 0.0 109.449 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -121.17 155.45 34.52 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -69.04 110.9 4.7 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.4 t -135.26 132.7 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.521 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.4 ttt85 -147.34 98.62 3.03 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.516 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 33.7 m-85 -74.27 87.67 1.98 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.434 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 67.1 m-20 -164.99 24.78 0.06 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 102.32 -15.31 56.36 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.912 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.5 mp -102.36 115.13 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 122.425 0.29 . . . . 0.0 111.103 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.775 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.04 109.52 5.92 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.156 0.503 . . . . 0.0 111.908 -179.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -108.44 125.41 51.73 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.211 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 11.8 mt -105.74 107.55 18.61 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -120.19 115.28 23.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.994 0.426 . . . . 0.0 112.072 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 80' ' ' VAL . 69.2 mt -78.65 162.14 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.574 ' N ' HG22 ' A' ' 79' ' ' ILE . 3.0 m -135.42 165.26 30.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 177.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -67.12 64.13 0.06 Allowed 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.496 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' O ' ' A' ' 80' ' ' VAL . 52.1 m -133.97 -75.01 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.348 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.03 105.37 8.84 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.468 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.593 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.0 OUTLIER -142.91 -36.13 0.39 Allowed 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.652 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.3 p90 -52.87 59.01 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 84' ' ' SER . 67.2 t0 -163.06 123.27 2.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.275 0.559 . . . . 0.0 110.707 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 22.6 p -88.05 130.86 34.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.289 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.13 -155.81 6.56 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.58 140.08 36.97 Favored 'General case' 0 N--CA 1.471 0.617 0 O-C-N 122.524 -0.398 . . . . 0.0 111.21 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.2 136.75 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -135.41 122.42 21.34 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.606 HG22 ' CZ3' ' A' ' 54' ' ' TRP . 29.2 t -113.59 133.22 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.9 t -145.74 156.69 43.77 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.384 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -144.41 154.69 43.24 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -117.34 159.57 22.52 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -155.18 159.69 31.53 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -42.93 -58.51 1.3 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 121.67 1.58 . . . . 0.0 111.292 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -120.57 23.6 10.73 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.836 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.54 129.51 5.38 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.99 128.03 70.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.495 HD12 HG23 ' A' ' 23' ' ' ILE . 4.5 pt -143.97 152.65 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.561 0.695 . . . . 0.0 112.68 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -153.99 149.59 27.39 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.348 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -144.66 134.07 23.16 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -107.48 127.47 53.63 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.091 0.472 . . . . 0.0 111.308 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.1 p -143.71 142.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.163 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.728 ' C ' HD12 ' A' ' 107' ' ' LEU . 54.2 mtpt -110.54 133.66 53.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.705 0.764 . . . . 0.0 112.531 -178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.728 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.3 mp -123.73 126.59 46.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.749 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 0.7 OUTLIER -124.18 124.15 41.84 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.927 0.394 . . . . 0.0 110.383 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.587 HG21 ' O ' ' A' ' 84' ' ' SER . 69.5 mt -105.31 116.02 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -92.54 -125.59 0.09 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.485 ' NE2' ' O ' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -149.22 151.06 33.63 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.646 -0.421 . . . . 0.0 111.968 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 51.0 tp -40.65 108.41 0.09 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.465 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.4 159.08 24.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.539 ' O ' ' N ' ' A' ' 116' ' ' HIS . 91.7 m-70 -75.1 139.79 43.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.743 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -49.66 87.01 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.601 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 114' ' ' HIS . 86.3 t60 -64.98 -43.31 93.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.118 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -84.05 128.29 34.46 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.081 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -124.62 128.76 49.37 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.382 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.613 -179.804 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 5.9 ptp -82.33 -0.67 46.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.698 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -53.42 149.15 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.056 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -60.61 136.52 58.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.21 0.529 . . . . 0.0 110.62 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 5' ' ' GLU . 56.7 mp0 -80.43 39.99 0.48 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.325 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.75 -39.06 96.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.28 129.15 42.52 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 97.5 mt -73.76 137.1 43.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.005 0.431 . . . . 0.0 110.591 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -84.05 162.0 20.5 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.203 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.11 -53.57 0.4 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 13' ' ' THR . 14.8 p -68.46 144.82 13.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 14' ' ' ASP . 4.4 m -75.68 45.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.454 ' O ' ' C ' ' A' ' 14' ' ' ASP . 98.5 m 48.91 -90.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.105 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 12' ' ' THR . 16.6 p30 25.59 -120.9 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.635 0.584 . . . . 0.0 111.878 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.59 111.84 18.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.941 0.401 . . . . 0.0 110.624 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -126.73 12.49 7.37 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.425 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -97.56 124.95 42.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.17 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.1 mmtt -97.12 130.99 44.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.193 0.521 . . . . 0.0 110.77 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -144.78 155.38 43.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.932 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.38 109.72 23.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.088 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.12 151.95 55.99 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.416 1.411 . . . . 0.0 112.04 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -168.18 168.66 11.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.76 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.506 HG22 HG22 ' A' ' 44' ' ' VAL . 9.2 pt -146.77 138.46 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.155 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.531 ' C ' HD13 ' A' ' 25' ' ' LEU . 95.9 t -100.68 128.92 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.832 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.73 -164.75 2.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.795 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.72 93.58 24.63 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.4 -18.11 44.02 Favored 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 121.761 1.641 . . . . 0.0 111.42 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -97.64 127.48 37.5 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.39 144.61 98.4 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 120.924 1.083 . . . . 0.0 110.808 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.2 t -127.24 132.54 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 120.972 0.415 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -123.57 128.07 49.2 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.14 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -124.32 178.79 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.41 ' H ' HG22 ' A' ' 32' ' ' VAL . 49.3 mt -124.82 135.3 52.81 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.122 0.419 . . . . 0.0 111.18 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 52.4 tp10 -40.09 126.1 2.07 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.64 2.4 46.7 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 8.3 mp0 -121.08 127.99 52.18 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -82.48 156.67 23.94 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.509 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -137.15 169.83 17.12 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.383 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.3 mtt85 -142.05 129.29 21.05 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.171 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -132.91 145.8 51.24 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.951 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -123.98 139.53 53.87 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.453 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 43.1 t -147.89 127.21 13.06 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.08 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' HG23 ' A' ' 44' ' ' VAL . 96.1 mtt-85 -123.62 169.1 11.81 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 23' ' ' ILE . 71.1 t -158.94 97.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 35.4 p -131.44 132.97 44.73 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.55 -45.64 0.03 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.642 ' N ' ' CD2' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -136.87 173.46 5.51 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.43 132.52 41.3 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.11 1.207 . . . . 0.0 112.366 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 28.77 73.93 0.4 Allowed Pre-proline 0 N--CA 1.465 0.324 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.347 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.58 156.58 49.42 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.422 2.082 . . . . 0.0 109.203 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -71.58 130.29 40.84 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.837 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.9 t -129.03 134.79 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' ND2' ' CE2' ' A' ' 55' ' ' TYR . 0.7 OUTLIER -145.84 132.03 19.44 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.61 179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.89 140.75 37.26 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.578 ' CE2' ' ND2' ' A' ' 53' ' ' ASN . 41.0 m-85 -119.42 98.71 6.27 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.557 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.2 mp -91.5 136.3 33.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 51.16 8.84 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.467 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 100.76 9.57 45.83 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -113.91 129.89 56.55 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -80.82 150.9 28.98 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 71.98 112.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 178.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.749 HH22 ' H ' ' A' ' 78' ' ' ASP . 66.5 ttt180 -99.18 149.63 22.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.142 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -60.99 149.02 38.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.338 0.59 . . . . 0.0 111.538 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.7 t -72.86 -136.51 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.127 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' OG ' ' A' ' 64' ' ' SER . 87.4 mttt -20.05 -33.65 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.658 ' N ' ' O ' ' A' ' 64' ' ' SER . 80.1 mtp180 -62.05 -38.55 89.19 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.685 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.499 ' CD1' ' NH2' ' A' ' 62' ' ' ARG . 42.0 m-85 -122.96 151.24 42.01 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.779 ' HE ' HH22 ' A' ' 70' ' ' ARG . 20.3 tpt180 -72.01 111.74 7.51 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.472 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 69' ' ' VAL . 23.3 m -149.71 126.48 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.843 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.779 HH22 ' HE ' ' A' ' 68' ' ' ARG . 91.4 mtm-85 -119.49 99.97 7.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -73.85 100.52 3.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.39 0.614 . . . . 0.0 110.854 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.418 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 42.8 t0 -177.95 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.395 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 166.53 -22.76 0.12 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.6 mt -106.49 121.51 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 111.514 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -140.76 109.72 6.09 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -98.76 125.34 44.07 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.485 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.9 mt -104.06 96.24 6.53 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.749 ' H ' HH22 ' A' ' 62' ' ' ARG . 84.4 m-20 -113.43 148.63 35.51 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.509 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 11.2 pt -124.38 163.74 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.269 178.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 82' ' ' CYS . 30.6 m -131.97 169.42 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.617 0.246 . . . . 0.0 110.543 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 82' ' ' CYS . 98.6 m-20 -64.2 67.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.296 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.521 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER 159.32 142.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.816 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 64.94 56.66 1.05 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.14 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.8 p -136.41 -34.54 0.77 Allowed 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.0 t80 -49.1 62.71 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.0 t0 -154.06 108.39 3.04 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.866 -0.521 . . . . 0.0 111.397 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.45 HG21 HE22 ' A' ' 110' ' ' GLN . 49.4 p -75.84 126.14 30.43 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 120.912 -1.118 . . . . 0.0 109.455 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.11 -151.58 5.45 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -142.11 142.0 32.74 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.525 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.491 HG21 HD22 ' A' ' 107' ' ' LEU . 48.2 t -111.49 133.87 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -142.6 134.82 27.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.348 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 49.4 t -111.13 125.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 p -129.17 128.63 43.78 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.109 0.48 . . . . 0.0 111.202 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.5 139.47 53.98 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -138.35 105.83 5.56 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.589 0.709 . . . . 0.0 112.27 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.632 ' ND2' ' CG ' ' A' ' 47' ' ' TYR . 8.1 t-20 -104.7 143.44 26.7 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -50.56 -12.11 0.49 Allowed 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.687 1.591 . . . . 0.0 113.963 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -112.27 -18.34 12.54 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.6 169.51 37.1 Favored Glycine 0 C--O 1.223 -0.532 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -144.35 136.49 22.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 101' ' ' ILE . 2.5 pt -145.39 130.16 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.349 0.595 . . . . 0.0 111.529 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 17.2 pt-20 -145.96 166.43 26.04 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.163 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 35.4 m170 -147.25 141.56 26.28 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.22 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.23 133.1 36.79 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' LEU . 39.2 t -139.05 140.23 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.654 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.9 tptp -111.91 120.9 43.49 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 111.948 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.654 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.37 126.36 49.22 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -122.33 121.25 36.27 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.639 HD12 ' N ' ' A' ' 110' ' ' GLN . 0.1 OUTLIER -109.26 115.65 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.639 ' N ' HD12 ' A' ' 109' ' ' ILE . 96.0 mm-40 -86.67 -129.01 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.244 -1.344 . . . . 0.0 111.837 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' O ' ' C ' ' A' ' 112' ' ' LEU . 56.9 tt0 -151.03 154.26 36.7 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.849 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.474 ' C ' ' O ' ' A' ' 111' ' ' GLN . 56.5 tp -17.7 -91.04 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.663 0.602 . . . . 0.0 112.574 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.36 83.97 1.74 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.848 0.356 . . . . 0.0 110.783 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -102.61 -15.5 16.36 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.82 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -117.03 128.81 55.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -94.62 24.12 4.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.694 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.52 -41.27 94.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.817 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -57.69 96.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.043 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.3 m170 . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.934 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 1' ' ' ARG . 49.0 ptt85 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.171 0.51 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.403 ' O ' ' N ' ' A' ' 4' ' ' HIS . 54.6 mtt -64.6 -39.31 93.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.728 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -40.38 94.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.726 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 6' ' ' GLY . 73.0 t60 -74.48 -44.07 53.13 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.949 0.404 . . . . 0.0 110.512 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -73.72 34.5 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.466 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -82.95 -133.28 1.98 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.0 145.77 51.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.739 0.304 . . . . 0.0 110.402 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 8' ' ' LEU . 8.6 mp -75.61 136.66 40.47 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 t -65.38 155.91 33.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.471 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.64 -160.06 11.8 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.601 ' C ' ' H ' ' A' ' 13' ' ' THR . 18.4 m -86.41 134.15 28.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.9 p -59.0 10.87 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.509 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 11' ' ' VAL . 44.3 m 52.09 93.38 0.02 OUTLIER 'General case' 0 C--O 1.228 -0.072 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.448 ' CB ' ' O ' ' A' ' 13' ' ' THR . 9.5 t0 83.73 121.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.752 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.433 ' CD ' ' N ' ' A' ' 15' ' ' GLN . 15.4 mp0 -90.02 14.32 12.58 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.097 -178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 11.81 7.72 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.68 0.276 . . . . 0.0 110.326 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -80.95 148.49 29.79 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.759 0.314 . . . . 0.0 110.485 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -95.59 116.84 29.41 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.071 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -107.98 179.64 4.16 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -83.18 139.72 42.27 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -58.0 138.91 88.41 Favored 'Trans proline' 0 N--CA 1.487 1.128 0 CA-C-N 119.527 0.867 . . . . 0.0 110.653 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.1 t0 177.95 103.44 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.504 0.502 . . . . 0.0 111.637 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.462 HD12 HD12 ' A' ' 25' ' ' LEU . 10.5 pt -79.89 152.69 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.339 -0.544 . . . . 0.0 111.262 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 ' C ' HD13 ' A' ' 25' ' ' LEU . 76.1 t -111.08 132.86 58.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.923 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.805 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.07 -165.24 2.05 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.521 179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -70.86 116.19 43.68 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.8 -25.67 79.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.212 1.275 . . . . 0.0 111.845 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -141.31 171.2 7.85 Favored Pre-proline 0 N--CA 1.465 0.308 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.54 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -75.59 157.84 40.13 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.374 2.05 . . . . 0.0 111.613 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.6 148.81 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.324 0.583 . . . . 0.0 111.441 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 -131.6 136.51 47.83 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.158 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.05 155.67 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.5 mt -99.04 136.18 39.38 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 4.2 tm-20 -47.55 135.5 11.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.822 0.344 . . . . 0.0 111.377 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 102.87 -1.08 48.26 Favored Glycine 0 N--CA 1.462 0.414 0 N-CA-C 109.869 -1.293 . . . . 0.0 109.869 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -112.73 124.38 52.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.271 -0.465 . . . . 0.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -79.34 148.67 31.97 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.652 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -132.17 176.22 8.58 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.151 0.501 . . . . 0.0 111.213 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -151.13 141.21 22.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.228 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -136.42 145.17 44.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.253 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -133.85 148.84 51.33 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 10.1 m -156.87 134.84 11.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.195 0.522 . . . . 0.0 110.225 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 70.9 ttt-85 -131.24 175.3 9.23 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 43' ' ' ARG . 31.8 m -121.34 170.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -145.58 155.32 42.98 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.85 -66.9 0.29 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.739 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 1.6 t80 -138.62 147.65 55.6 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 119.688 -0.196 . . . . 0.0 111.519 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.44 ' HD2' ' CG ' ' A' ' 47' ' ' TYR . 2.7 Cg_endo -46.87 166.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.578 1.519 . . . . 0.0 111.738 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.427 ' C ' ' O ' ' A' ' 48' ' ' PRO . 19.8 mt-30 -5.1 80.04 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.56 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.485 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -79.48 -153.48 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.823 2.348 . . . . 0.0 109.422 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -92.64 126.64 37.82 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -126.22 132.68 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.951 0.405 . . . . 0.0 111.319 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.506 ' ND2' ' OH ' ' A' ' 55' ' ' TYR . 63.1 t-20 -145.33 130.08 18.11 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.503 ' CD2' ' N ' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -118.28 144.67 45.64 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.904 0.383 . . . . 0.0 110.68 -178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.506 ' OH ' ' ND2' ' A' ' 53' ' ' ASN . 76.3 m-85 -122.73 102.24 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.713 ' CD2' ' HE ' ' A' ' 62' ' ' ARG . 8.2 mp -88.9 134.75 33.85 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.5 t30 51.51 9.27 0.07 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.349 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 95.39 19.27 30.64 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 56' ' ' LEU . 99.5 mm-40 -123.25 133.27 54.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.936 -0.632 . . . . 0.0 110.29 -179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' O ' HG22 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -86.52 151.45 23.48 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.297 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 60' ' ' LEU . 6.4 tp 61.24 113.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.713 ' HE ' ' CD2' ' A' ' 56' ' ' LEU . 42.4 ttm-85 -97.7 157.67 15.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.474 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 62' ' ' ARG . 12.2 mmtp -61.85 143.75 55.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.316 0.579 . . . . 0.0 110.456 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 66' ' ' ARG . 38.7 t -74.78 -138.44 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.877 -178.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.2 mttm -7.12 -44.53 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.5 ttm180 -59.89 -32.52 70.82 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.443 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.22 150.16 42.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.593 ' NH2' ' CD2' ' A' ' 76' ' ' TYR . 65.6 ttp85 -77.42 116.86 18.36 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.405 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.7 m -146.22 129.25 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.396 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.509 ' O ' ' O ' ' A' ' 74' ' ' ILE . 70.1 mmt-85 -125.8 101.32 6.8 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 72' ' ' ASP . 2.9 t80 -73.55 88.2 1.64 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.288 -178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 35.7 m-20 -168.98 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.315 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.74 -15.2 45.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.509 ' O ' ' O ' ' A' ' 70' ' ' ARG . 78.1 mt -114.76 128.05 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.954 0.407 . . . . 0.0 112.09 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.55 109.08 6.2 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.869 0.366 . . . . 0.0 111.308 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.593 ' CD2' ' NH2' ' A' ' 68' ' ' ARG . 3.8 m-85 -101.65 115.62 30.93 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD13 HD11 ' A' ' 56' ' ' LEU . 12.0 mt -105.97 108.21 19.61 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.504 ' OD2' ' N ' ' A' ' 78' ' ' ASP . 11.3 p-10 -120.1 150.36 40.73 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 38' ' ' ALA . 6.0 pt -123.44 165.43 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.054 177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.6 m -132.78 169.6 21.66 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 110.458 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' C ' ' SG ' ' A' ' 82' ' ' CYS . 63.0 t0 -55.79 70.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.43 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.591 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.7 p 158.02 144.45 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.138 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.41 61.3 0.88 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.091 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -131.63 -39.18 1.13 Allowed 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.748 -0.206 . . . . 0.0 111.239 -179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.613 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 3.8 t80 -54.13 66.33 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 84' ' ' SER . 28.0 t70 -153.13 109.07 3.32 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.3 p -81.47 121.59 26.47 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.294 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.14 -151.66 5.49 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.5 pt-20 -144.67 146.92 32.49 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.66 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.453 ' HB ' HD13 ' A' ' 107' ' ' LEU . 70.6 t -118.84 145.17 25.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.891 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -144.6 128.54 17.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.1 t -114.67 134.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -147.16 155.84 42.47 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.776 0.322 . . . . 0.0 110.497 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.74 147.9 26.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -135.71 108.09 7.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.335 0.588 . . . . 0.0 112.17 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -84.62 172.16 9.57 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -72.29 -17.13 27.73 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 121.219 1.279 . . . . 0.0 112.399 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -107.38 -0.19 22.54 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.14 176.01 44.6 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 119.75 -1.214 . . . . 0.0 112.717 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -139.96 135.96 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-N 114.449 -0.875 . . . . 0.0 110.085 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 102' ' ' GLU . 47.8 mt -138.0 152.06 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.149 0.5 . . . . 0.0 110.794 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 101' ' ' ILE . 11.2 pt-20 -158.79 145.74 17.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.133 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -139.17 131.98 29.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -106.84 128.71 54.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.227 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 31.6 m -133.59 157.45 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.641 ' C ' HD12 ' A' ' 107' ' ' LEU . 53.6 mtpt -115.22 123.49 48.99 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.488 0.661 . . . . 0.0 110.967 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.641 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.6 mp -123.32 120.75 33.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -126.45 126.74 44.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.188 0.518 . . . . 0.0 110.414 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' SER . 54.3 mt -103.05 112.0 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.984 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -87.37 -129.83 0.06 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.821 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.58 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 87.1 mt-30 -148.07 154.61 40.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.752 0.31 . . . . 0.0 110.386 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.6 tp -80.31 99.29 7.82 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.121 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 115' ' ' HIS . 44.3 tp10 -121.06 126.05 48.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.203 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -70.88 33.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.9 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.559 ' H ' ' C ' ' A' ' 113' ' ' GLU . 11.6 t-160 -58.72 -43.83 90.24 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.11 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.44 ' O ' ' ND1' ' A' ' 116' ' ' HIS . 42.9 t-80 -114.74 28.36 8.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.605 0.241 . . . . 0.0 111.334 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -65.26 -43.45 91.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.884 0.374 . . . . 0.0 111.035 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -122.87 131.56 53.8 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 57.9 m80 . . . . . 0 C--O 1.22 -0.499 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.283 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -98.86 120.0 38.57 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.91 -20.52 0.08 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -67.77 -49.38 62.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.84 0.353 . . . . 0.0 111.228 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -172.21 178.25 2.92 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.23 34.69 2.41 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.79 149.33 40.3 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 120.799 -0.361 . . . . 0.0 110.357 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.4 mp -80.24 127.78 32.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.037 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 m -83.91 152.0 24.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.356 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 47.55 4.9 Favored Glycine 0 C--N 1.333 0.378 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 74.1 t -117.32 120.06 63.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.335 0.588 . . . . 0.0 111.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.3 m -70.95 66.43 0.38 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.519 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 13' ' ' THR . 5.2 t -98.19 102.07 13.72 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.133 0.492 . . . . 0.0 112.277 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.1 t0 38.94 83.22 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.52 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -60.41 -94.53 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.132 0.491 . . . . 0.0 110.863 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -124.49 5.45 8.31 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.347 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -63.94 135.89 56.88 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.587 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -58.02 128.48 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.254 0.55 . . . . 0.0 112.215 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -82.12 140.12 33.99 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.056 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 53.7 tttp -85.81 135.67 37.58 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.53 141.9 90.25 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.933 1.012 . . . . 0.0 111.18 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD2' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER 164.16 112.28 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.211 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 25' ' ' LEU . 15.3 pt -81.03 159.73 4.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.006 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.9 m -116.98 135.44 57.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.82 -153.55 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.264 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.741 ' O ' HG21 ' A' ' 105' ' ' VAL . 8.4 m-85 -111.04 94.65 21.42 Favored Pre-proline 0 N--CA 1.47 0.557 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.37 -20.27 42.52 Favored 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 121.245 1.297 . . . . 0.0 111.418 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -92.1 126.21 53.92 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.386 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -55.92 146.62 67.21 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 121.0 1.133 . . . . 0.0 111.05 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.27 139.23 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -124.08 132.33 53.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.876 0.369 . . . . 0.0 110.738 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 33' ' ' LEU . 12.9 t -115.22 161.63 13.85 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 CA-C-O 121.558 0.694 . . . . 0.0 110.371 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 52.7 mt -111.72 128.78 56.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.788 -1.097 . . . . 0.0 108.188 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.5 tt0 -40.06 119.18 0.99 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.679 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.87 -1.34 61.25 Favored Glycine 0 N--CA 1.468 0.804 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.83 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -101.58 119.83 39.37 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 p -72.27 139.33 48.0 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 121.328 0.585 . . . . 0.0 110.879 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.94 162.05 21.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.823 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -137.85 120.01 15.64 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.094 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -121.02 133.09 55.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -107.32 141.34 38.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.461 ' O ' ' ND1' ' A' ' 75' ' ' HIS . 19.8 t -147.95 110.52 4.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.432 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 65.6 ttp85 -126.45 174.29 8.74 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG22 ' N ' ' A' ' 45' ' ' THR . 3.1 p -129.49 170.03 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 119.419 1.009 . . . . 0.0 108.347 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.616 ' N ' HG22 ' A' ' 44' ' ' VAL . 7.1 p -142.22 157.52 44.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.81 -74.99 0.39 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -136.1 140.98 34.66 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.4 118.51 4.71 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.0 1.133 . . . . 0.0 112.992 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 66.24 71.33 0.48 Allowed Pre-proline 0 N--CA 1.468 0.44 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -86.23 -159.99 0.1 Allowed 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 123.133 2.555 . . . . 0.0 110.395 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -103.13 139.36 38.73 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 75' ' ' HIS . 67.6 t -146.49 141.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.34 0.59 . . . . 0.0 112.297 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -139.95 141.83 36.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.234 178.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.784 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -121.79 148.73 44.3 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.029 0.442 . . . . 0.0 111.846 -178.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -121.58 108.38 13.52 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.717 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -90.28 131.01 36.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' H ' HG12 ' A' ' 90' ' ' VAL . 8.6 m120 50.16 9.83 0.05 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 101.96 24.26 8.69 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' LEU . 86.5 mt-30 -121.83 118.02 27.94 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.238 0.542 . . . . 0.0 111.654 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.648 ' O ' HG22 ' A' ' 61' ' ' ILE . 42.4 tp -66.54 152.57 44.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.525 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 60' ' ' LEU 0.26 5.4 tp 68.54 108.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 124.819 1.324 . . . . 0.0 113.572 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.483 HH21 ' H ' ' A' ' 78' ' ' ASP . 9.2 ttt-85 -85.64 158.53 20.06 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 114.574 -1.193 . . . . 0.0 108.736 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -76.07 141.83 41.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.439 0.637 . . . . 0.0 111.048 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.601 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.0 p -74.5 -138.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.339 -1.3 . . . . 0.0 113.519 -177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.533 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.8 mttm -17.02 -36.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' A' ' 64' ' ' SER . 81.6 mtp180 -61.51 -37.88 85.32 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.176 0.898 . . . . 0.0 110.15 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.422 ' CG ' ' NH1' ' A' ' 62' ' ' ARG . 96.6 m-85 -123.19 151.63 42.02 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -71.47 115.27 10.45 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.33 -0.548 . . . . 0.0 110.619 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -150.39 130.4 3.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.64 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.6 mtt180 -132.15 101.29 5.33 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.435 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -71.54 85.55 0.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.334 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 70.3 m-20 -163.97 24.09 0.07 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.727 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' O ' ' CE1' ' A' ' 75' ' ' HIS . . . 108.04 -19.26 32.82 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 74' ' ' ILE . 3.7 mp -107.47 115.32 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 122.44 0.296 . . . . 0.0 110.716 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.784 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.13 110.95 6.51 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.905 -179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.76 118.83 36.38 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.47 ' HA ' ' HE ' ' A' ' 62' ' ' ARG . 39.4 mt -103.48 106.29 16.76 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 79' ' ' ILE . 65.7 t0 -122.7 141.8 51.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.776 0.322 . . . . 0.0 111.483 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.528 ' N ' ' OD2' ' A' ' 78' ' ' ASP . 1.3 pt -132.78 110.12 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.184 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 81' ' ' ASP . 0.4 OUTLIER -87.76 -156.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 51.8 t0 -74.67 52.33 0.51 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 81' ' ' ASP . 71.1 m -156.42 106.98 2.38 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.132 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt 72.13 80.33 0.15 Allowed 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.278 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.6 ' O ' HG21 ' A' ' 109' ' ' ILE . 17.7 p -143.51 -41.61 0.29 Allowed 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.489 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.636 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -57.05 57.21 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 84' ' ' SER . 39.3 m-20 -157.74 117.62 3.35 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.305 -0.872 . . . . 0.0 111.377 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.447 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 18.2 p -83.25 115.94 22.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.613 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -136.42 -151.59 6.1 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 58' ' ' GLY . 97.3 mt-10 -145.44 143.09 29.85 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.222 -0.576 . . . . 0.0 111.202 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 107' ' ' LEU . 3.8 m -117.56 136.34 55.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.889 0.376 . . . . 0.0 110.753 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -133.14 131.9 41.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.779 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 51.5 t -117.05 132.8 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.5 t -136.41 150.16 48.64 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.34 159.92 39.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.239 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 96' ' ' ASN . 85.0 tt0 -132.26 155.75 47.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 95' ' ' GLU . 6.2 m-80 -155.37 152.82 25.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.81 -27.46 62.38 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 120.983 1.122 . . . . 0.0 112.324 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -122.2 6.89 9.68 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.1 157.26 28.12 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 119.365 -1.397 . . . . 0.0 112.45 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 73.4 t -141.42 136.33 32.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 114.225 -0.987 . . . . 0.0 108.972 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 mt -132.04 154.78 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-O 121.052 0.453 . . . . 0.0 111.302 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.29 134.9 12.62 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.417 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -137.56 132.32 32.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.035 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -110.91 131.41 55.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.134 0.492 . . . . 0.0 111.026 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.741 HG21 ' O ' ' A' ' 26' ' ' TYR . 12.1 p -144.38 142.97 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.772 ' C ' HD12 ' A' ' 107' ' ' LEU . 50.2 mtmt -104.28 135.01 46.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.772 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -127.83 122.62 33.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.847 -1.07 . . . . 0.0 108.992 178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -119.43 121.73 40.14 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.6 HG21 ' O ' ' A' ' 84' ' ' SER . 48.3 mt -105.18 107.35 22.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.544 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -72.07 -133.4 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.776 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 2.6 pt20 -153.67 154.29 33.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.146 0.498 . . . . 0.0 112.251 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' H ' ' HB3' ' A' ' 34' ' ' GLU . 34.9 tp -112.94 120.99 43.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.465 178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -86.4 119.48 26.71 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.221 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -84.2 134.02 34.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.491 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 116' ' ' HIS . 0.5 OUTLIER -80.54 -126.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.835 179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -154.01 162.96 40.82 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.11 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.2 142.79 52.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.664 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -76.87 136.78 38.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.878 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 45.9 t-80 . . . . . 0 C--O 1.219 -0.546 0 CA-C-O 118.167 -0.92 . . . . 0.0 110.773 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.404 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 76.7 ttt-85 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.2 ttp -98.43 76.04 2.25 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.404 ' HB2' ' NH2' ' A' ' 1' ' ' ARG . . . -168.74 131.58 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.225 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.0 p-80 -154.58 149.15 26.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.885 0.374 . . . . 0.0 110.886 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' OE1' ' NH2' ' A' ' 68' ' ' ARG . 16.5 pt-20 -68.39 -39.31 81.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.156 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.4 138.24 4.88 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.02 140.29 57.68 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.844 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.716 ' N ' HD22 ' A' ' 8' ' ' LEU . 2.7 mm? -76.31 140.5 41.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 m -72.15 137.05 46.71 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.507 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.14 133.1 1.51 Allowed Glycine 0 CA--C 1.527 0.782 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -89.29 125.63 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' O ' ' CB ' ' A' ' 13' ' ' THR . 42.7 p -56.85 -84.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.144 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.413 ' CB ' ' O ' ' A' ' 12' ' ' THR . 0.3 OUTLIER 77.6 96.86 0.06 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.665 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 14' ' ' ASP . 55.5 p-10 -82.99 147.5 28.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.581 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -141.02 156.28 46.05 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.006 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -124.92 12.46 8.42 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -115.26 130.88 57.03 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.271 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -63.09 130.77 46.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -90.67 163.77 14.4 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.103 0.477 . . . . 0.0 111.293 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm -85.61 139.13 35.56 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -57.82 143.07 96.32 Favored 'Trans proline' 0 N--CA 1.489 1.247 0 C-N-CA 120.778 0.985 . . . . 0.0 111.81 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' C ' ' HG1' ' A' ' 45' ' ' THR . 22.1 t0 -171.05 101.93 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.468 0.651 . . . . 0.0 109.912 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD11 HD13 ' A' ' 25' ' ' LEU . 3.2 tt -81.97 134.55 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.665 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 ' O ' HD12 ' A' ' 25' ' ' LEU . 4.0 p -119.92 138.94 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 HD13 HD11 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -161.66 -155.08 0.37 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.935 0.397 . . . . 0.0 110.732 -179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.674 ' CE1' HD21 ' A' ' 107' ' ' LEU . 33.9 m-85 -43.18 115.11 1.74 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.15 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.23 -19.83 66.28 Favored 'Trans proline' 0 N--CA 1.487 1.107 0 C-N-CA 120.741 0.961 . . . . 0.0 110.407 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -170.07 151.6 4.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.946 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -50.57 148.74 14.77 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.511 1.474 . . . . 0.0 110.217 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -135.29 141.31 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-O 121.229 0.537 . . . . 0.0 110.89 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -133.83 139.82 46.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.261 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -125.27 -174.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' N ' HG13 ' A' ' 32' ' ' VAL . 77.8 mt -123.69 146.66 48.08 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' N ' HD11 ' A' ' 109' ' ' ILE . 78.6 tt0 -52.98 129.58 30.99 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.761 -0.776 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.09 -9.53 54.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HB2' HG22 ' A' ' 32' ' ' VAL . 95.7 mt-10 -110.42 121.78 46.13 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 t -77.49 146.5 36.39 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.382 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -118.14 168.58 10.44 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.455 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -146.9 127.71 14.38 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -139.9 152.96 46.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.09 0.471 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -133.48 156.94 46.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.454 ' SG ' HD21 ' A' ' 25' ' ' LEU . 2.2 t -153.15 122.45 6.65 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.723 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.4 mtp85 -125.08 174.14 8.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 45' ' ' THR . 1.5 p -139.19 172.5 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.543 ' N ' HG22 ' A' ' 44' ' ' VAL . 40.9 p -138.19 153.05 49.18 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 119.743 1.156 . . . . 0.0 110.343 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 150.12 -85.62 0.16 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -133.95 139.78 34.37 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.39 144.14 84.23 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.085 1.19 . . . . 0.0 111.545 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.616 ' N ' ' NE2' ' A' ' 49' ' ' GLN . 0.1 OUTLIER 62.42 68.76 1.0 Allowed Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.649 -179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.76 -164.81 0.28 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.268 2.645 . . . . 0.0 110.773 177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -139.56 90.05 2.37 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 2.9 m -126.87 166.82 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 121.047 0.451 . . . . 0.0 111.438 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' HB3' HD11 ' A' ' 60' ' ' LEU . 78.2 m-20 -140.9 167.81 21.3 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.718 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.619 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -125.94 153.06 44.81 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.086 0.47 . . . . 0.0 111.387 -179.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.608 ' CZ ' HD13 ' A' ' 60' ' ' LEU . 25.9 m-85 -124.06 102.56 7.81 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.574 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 10.0 mp -85.83 136.56 33.26 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.1 m120 45.75 9.51 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.344 -0.223 . . . . 0.0 111.314 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.17 25.96 8.6 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.532 ' N ' ' O ' ' A' ' 56' ' ' LEU . 98.7 mt-30 -124.71 120.37 31.62 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.608 HD13 ' CZ ' ' A' ' 55' ' ' TYR . 50.8 tp -71.83 137.41 47.53 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 80.01 109.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-O 122.026 0.917 . . . . 0.0 113.257 177.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.58 HH11 ' N ' ' A' ' 78' ' ' ASP . 55.3 ttt85 -91.68 143.92 26.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.144 175.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.03 146.94 53.25 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.514 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 14.7 m -75.55 -137.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.435 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -8.47 -41.9 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.5 ttm-85 -60.42 -39.39 87.22 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.528 ' CB ' ' HE ' ' A' ' 62' ' ' ARG . 84.7 m-85 -122.63 155.17 36.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OE1' ' A' ' 5' ' ' GLU . 99.9 mtt180 -78.48 122.07 25.37 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.048 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' O ' HG23 ' A' ' 69' ' ' VAL . 2.3 m -148.48 120.78 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.555 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 mmm180 -115.6 99.2 7.17 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 3.3 t80 -72.8 88.08 1.31 Allowed 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.562 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 -175.82 25.88 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.229 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.1 -21.78 11.86 Favored Glycine 0 CA--C 1.531 1.077 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.9 mt -114.08 129.87 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.619 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.57 111.74 6.84 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 121.089 -0.244 . . . . 0.0 111.289 179.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -92.6 122.65 35.23 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.4 mt -109.89 95.3 5.51 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.58 ' N ' HH11 ' A' ' 62' ' ' ARG . 94.7 m-20 -120.59 144.65 47.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 9.0 pt -121.63 165.97 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 82' ' ' CYS . 9.8 p -138.25 172.17 14.41 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 118.733 0.697 . . . . 0.0 109.477 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.55 ' H ' HG22 ' A' ' 80' ' ' VAL . 59.8 t0 -59.68 70.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 O-C-N 123.122 0.264 . . . . 0.0 110.624 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.563 ' N ' ' O ' ' A' ' 80' ' ' VAL . 14.5 p 176.63 133.33 0.05 Allowed 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.665 0.603 . . . . 0.0 110.27 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 pttt 46.63 68.39 0.63 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.565 0.697 . . . . 0.0 112.013 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.587 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.2 t -127.42 -34.37 2.27 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.632 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.4 p90 -50.51 60.32 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.587 ' N ' ' O ' ' A' ' 84' ' ' SER . 25.7 t0 -153.35 110.9 3.52 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.71 0.767 . . . . 0.0 111.203 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 44.1 p -79.97 127.04 31.79 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.727 -0.608 . . . . 0.0 110.73 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.64 -152.62 5.68 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 145.18 34.15 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 122.398 -0.472 . . . . 0.0 111.081 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG21 HD22 ' A' ' 107' ' ' LEU . 70.6 t -117.73 134.53 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.721 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -139.92 130.45 25.59 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.84 131.28 73.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.411 . . . . 0.0 110.079 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.07 133.22 54.33 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.081 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -116.12 148.73 39.98 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' O ' ' OD1' ' A' ' 96' ' ' ASN . 80.3 tt0 -135.15 152.97 52.1 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.913 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 95' ' ' GLU . 6.5 m120 -154.38 153.19 27.71 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -56.59 -28.8 76.37 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.482 1.455 . . . . 0.0 112.818 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -120.0 15.05 12.44 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -163.57 156.68 28.6 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.819 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 70.2 t -135.46 133.07 52.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.465 HD12 ' HB ' ' A' ' 23' ' ' ILE . 0.6 OUTLIER -149.54 157.95 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 120.835 0.35 . . . . 0.0 110.79 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -169.45 159.93 8.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.775 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -154.08 150.17 27.91 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 0.0 110.758 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -119.58 134.77 55.08 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.129 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' VAL . 27.3 m -136.46 164.13 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.126 -179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.71 ' C ' HD12 ' A' ' 107' ' ' LEU . 98.4 mttt -121.68 123.66 42.42 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.43 0.633 . . . . 0.0 111.91 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -125.03 125.84 44.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.366 -0.834 . . . . 0.0 108.869 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -133.82 125.18 27.9 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.712 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.588 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -109.57 110.31 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.471 ' N ' HD12 ' A' ' 109' ' ' ILE . 76.5 mt-30 -83.12 -124.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.335 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 83.5 mt-30 -148.5 156.54 42.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.67 0.272 . . . . 0.0 111.018 -178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.29 -41.78 98.8 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -94.92 121.95 37.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.31 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -155.11 80.85 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.138 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -157.71 22.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -88.33 51.7 2.26 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.108 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.432 ' O ' ' ND1' ' A' ' 119' ' ' HIS . 73.1 m80 -119.14 141.09 49.12 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.389 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.489 ' O ' ' CG ' ' A' ' 119' ' ' HIS . 79.8 t60 -66.93 -45.75 76.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.443 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.489 ' CG ' ' O ' ' A' ' 118' ' ' HIS . 57.1 p-80 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.781 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 17.7 tpp85 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 3' ' ' ALA . 3.5 ppp? -60.26 -40.64 91.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.942 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.444 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -74.68 152.38 39.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 111.036 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -76.78 147.32 37.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.62 125.68 24.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.021 0.438 . . . . 0.0 110.643 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.04 165.16 38.32 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.73 140.72 49.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.0 mt -73.91 140.1 45.4 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.215 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.4 p -81.91 159.67 23.59 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.853 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 11' ' ' VAL . . . -98.19 13.08 63.52 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 10' ' ' GLY . 16.6 m 46.18 175.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.776 0.322 . . . . 0.0 111.083 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.0 m 37.61 80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.747 0.308 . . . . 0.0 111.301 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 92.2 m -87.96 124.01 33.27 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.172 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -173.7 99.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.671 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -144.89 66.68 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.682 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.58 12.81 8.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.785 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.91 173.83 11.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.841 0.353 . . . . 0.0 110.35 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -69.38 137.75 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.574 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -139.1 159.79 41.31 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -83.47 111.08 28.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 119.182 -0.437 . . . . 0.0 110.403 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -72.82 161.54 43.5 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 CA-C-N 120.407 1.181 . . . . 0.0 111.433 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.588 ' N ' ' OG1' ' A' ' 45' ' ' THR . 0.1 OUTLIER -178.73 112.83 0.06 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.518 0.675 . . . . 0.0 111.304 179.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.55 ' CG2' ' NE2' ' A' ' 103' ' ' HIS . 0.9 OUTLIER -89.97 141.97 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.851 -178.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 12.4 m -114.53 139.88 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.452 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.779 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -153.51 -161.21 1.22 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.179 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -95.91 101.02 7.31 Favored Pre-proline 0 CA--C 1.55 0.975 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 2.8 Cg_endo -71.3 -23.42 24.15 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.35 1.367 . . . . 0.0 112.501 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -98.35 134.07 22.26 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.975 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.02 146.84 95.05 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.094 1.196 . . . . 0.0 110.461 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.9 t -127.78 135.0 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 121.008 0.432 . . . . 0.0 110.638 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' NH2' HE22 ' A' ' 110' ' ' GLN . 83.0 mtp180 -126.34 132.87 51.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.827 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB2' ' A' ' 36' ' ' GLU . 5.0 p -129.96 151.97 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.6 mp -93.95 137.74 32.83 Favored 'General case' 0 C--O 1.223 -0.308 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.82 132.54 8.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.928 0.394 . . . . 0.0 111.869 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.41 5.13 52.5 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' N ' ' OE1' ' A' ' 36' ' ' GLU . 25.2 mp0 -118.89 123.42 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.439 ' H ' HG22 ' A' ' 37' ' ' THR . 0.1 OUTLIER -74.47 154.16 38.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' CB ' HD12 ' A' ' 79' ' ' ILE . . . -119.93 157.82 27.97 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.984 0.421 . . . . 0.0 110.956 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.439 ' HG2' HH21 ' A' ' 39' ' ' ARG . 79.2 mtp85 -131.26 104.49 7.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.071 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -121.63 147.72 45.48 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.282 0.563 . . . . 0.0 109.83 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -132.5 149.14 52.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.431 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 94.6 m -151.99 127.12 9.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -128.47 175.47 8.5 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 45' ' ' THR . 20.3 t -137.22 170.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 22' ' ' ASP . 41.2 p -141.39 153.3 44.98 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.876 0.762 . . . . 0.0 110.72 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 138.15 -95.82 0.23 Allowed Glycine 0 CA--C 1.529 0.965 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.22 165.82 32.66 Favored Pre-proline 0 N--CA 1.474 0.754 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -64.82 143.28 79.46 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.544 1.496 . . . . 0.0 112.519 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 64.67 70.72 0.6 Allowed Pre-proline 0 N--CA 1.464 0.225 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.465 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -87.24 176.63 4.22 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 123.079 2.52 . . . . 0.0 110.291 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -105.86 107.24 18.14 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 m -147.93 165.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-O 121.439 0.638 . . . . 0.0 111.68 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 26.8 p30 -156.66 150.69 25.03 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.773 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -116.09 152.07 34.34 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.411 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -123.62 100.68 6.91 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -87.91 139.21 30.75 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 46.92 11.4 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.122 0 O-C-N 121.934 -0.479 . . . . 0.0 110.662 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 93.96 23.76 21.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 56' ' ' LEU . 65.1 tt0 -124.57 131.06 53.49 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.582 0.353 . . . . 0.0 110.141 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -82.71 152.31 25.84 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.6 tp 61.53 110.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 124.233 0.958 . . . . 0.0 112.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.804 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.6 tpm_? -100.91 151.51 21.66 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 114.596 -1.183 . . . . 0.0 108.775 177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.804 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 4.6 tptt -55.54 139.17 44.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.559 0.695 . . . . 0.0 111.58 -178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.721 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.3 t -74.96 -136.93 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.846 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 98.6 mttt -15.62 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.1 tpm_? -60.31 -39.91 88.68 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -120.56 164.94 15.7 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -70.07 110.93 5.39 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.248 -0.581 . . . . 0.0 110.866 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.1 t -142.53 135.14 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.594 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.487 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.1 tpt180 -142.91 101.07 3.77 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -72.87 89.52 1.4 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.116 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -174.41 26.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.057 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.23 -22.25 27.43 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 70' ' ' ARG . 95.8 mt -104.67 118.04 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.328 0.585 . . . . 0.0 112.115 -178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.773 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -139.7 104.7 4.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.103 178.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -99.71 126.57 45.78 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -108.82 105.38 14.92 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -115.29 139.76 49.69 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 80' ' ' VAL . 89.4 mt -100.78 160.73 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 82' ' ' CYS . 58.6 t -128.97 161.43 38.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.527 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 90.8 m-20 -58.04 70.12 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 O-C-N 123.374 0.421 . . . . 0.0 110.358 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.625 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 157.97 149.48 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.86 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 66.1 mttm 62.44 58.9 1.61 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.02 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.582 ' O ' ' N ' ' A' ' 86' ' ' ASP . 1.1 p -137.63 -37.18 0.61 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.958 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CZ ' ' NE2' ' A' ' 111' ' ' GLN . 11.2 t80 -53.74 66.75 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 84' ' ' SER . 10.9 p-10 -161.27 119.04 2.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.9 p -82.21 120.16 25.0 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.108 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -134.88 -154.16 7.03 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' N ' ' CD ' ' A' ' 89' ' ' GLU . 1.8 pm0 -145.79 146.66 31.27 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.873 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 46.0 t -113.02 140.55 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -146.68 129.4 16.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.48 132.52 65.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.176 0.513 . . . . 0.0 109.831 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.47 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 63.0 p -124.94 120.74 32.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.647 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.53 131.07 52.85 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -150.28 137.11 19.21 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.732 0.777 . . . . 0.0 112.167 -179.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.38 172.05 4.13 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -66.51 -18.26 54.19 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 121.066 1.177 . . . . 0.0 113.015 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' A' ' 98' ' ' GLU . 56.0 mp0 -102.36 -0.55 32.49 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.59 173.36 44.43 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 119.766 -1.206 . . . . 0.0 112.13 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.3 155.85 32.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 114.871 -0.665 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.598 HG22 ' NE2' ' A' ' 103' ' ' HIS . 5.8 mt -147.21 147.05 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.5 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -154.13 134.48 13.38 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.682 -0.236 . . . . 0.0 110.723 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.598 ' NE2' HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -133.76 133.08 41.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.772 -0.195 . . . . 0.0 110.784 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.4 137.48 37.04 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.224 0.535 . . . . 0.0 110.438 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.79 143.95 24.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.986 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.732 ' C ' HD12 ' A' ' 107' ' ' LEU . 87.3 tttt -116.19 121.31 41.71 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.124 0.488 . . . . 0.0 111.32 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.4 mp -124.07 125.2 44.11 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.4 125.85 46.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG21 ' O ' ' A' ' 84' ' ' SER . 46.7 mt -106.88 113.9 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.112 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.483 HE22 ' NH2' ' A' ' 31' ' ' ARG . 86.9 mt-30 -93.38 -130.97 0.13 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.105 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.586 ' NE2' ' CZ ' ' A' ' 85' ' ' TYR . 75.2 mt-30 -146.96 152.96 39.49 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.653 0.263 . . . . 0.0 110.804 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 58.4 tp -66.05 131.44 46.21 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -58.03 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.237 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -91.57 127.38 37.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.019 0.438 . . . . 0.0 110.724 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -85.8 -55.8 3.79 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.571 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.34 166.4 33.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.853 0.358 . . . . 0.0 110.797 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -69.41 137.93 53.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.381 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -74.34 135.26 42.5 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.4 m80 . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.638 -179.501 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -72.25 -21.71 61.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.039 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.417 ' N ' ' SD ' ' A' ' 2' ' ' MET . . . -59.13 -36.18 74.77 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -95.92 127.58 42.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.443 ' OE2' ' N ' ' A' ' 6' ' ' GLY . 0.3 OUTLIER -65.92 -40.92 91.88 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.16 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.443 ' N ' ' OE2' ' A' ' 5' ' ' GLU . . . -101.73 65.43 0.47 Allowed Glycine 0 N--CA 1.464 0.531 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.27 139.98 57.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.077 0.465 . . . . 0.0 110.585 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 8' ' ' LEU . 11.2 mp -84.0 137.47 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.355 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -86.88 124.57 33.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.959 179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.64 -136.59 51.0 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.0 123.02 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.7 p -125.04 -60.41 1.36 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.541 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 64.6 p -93.12 134.89 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.461 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' OD2' ' OE2' ' A' ' 17' ' ' GLU . 24.7 t70 -100.3 105.1 16.61 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.821 0.343 . . . . 0.0 110.389 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -105.1 49.27 0.81 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.298 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -125.22 13.86 8.33 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.065 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 17' ' ' GLU . 57.2 mp0 -86.99 145.6 26.44 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.173 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -68.47 125.17 25.63 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.824 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -119.31 172.04 7.89 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.912 0.387 . . . . 0.0 110.714 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.8 ptpt -84.21 139.5 39.25 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -58.55 153.93 45.43 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.846 1.697 . . . . 0.0 112.1 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -172.83 101.49 0.14 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.2 0.524 . . . . 0.0 110.536 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD11 HG11 ' A' ' 92' ' ' VAL . 3.5 tt -82.55 144.94 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.678 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' C ' HD13 ' A' ' 25' ' ' LEU . 48.7 t -114.38 134.78 56.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.446 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.8 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -152.04 -161.3 1.28 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.554 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -101.37 100.72 14.42 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -69.48 -21.96 34.06 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.449 1.433 . . . . 0.0 111.957 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 28' ' ' GLU . 7.1 pt-20 -94.53 125.42 51.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.69 148.74 90.68 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.081 1.187 . . . . 0.0 110.953 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -132.71 136.18 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.216 0.532 . . . . 0.0 111.272 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -125.37 136.05 53.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.042 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 33' ' ' LEU . 6.3 p -128.28 160.67 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' N ' HG22 ' A' ' 32' ' ' VAL . 62.6 mt -103.72 133.72 48.25 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 120.645 0.259 . . . . 0.0 110.643 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 35' ' ' GLY . 3.4 tm-20 -45.57 132.72 8.19 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' N ' ' CD ' ' A' ' 34' ' ' GLU . . . 98.63 -2.99 59.01 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -115.12 124.63 52.0 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.56 ' N ' ' OD1' ' A' ' 81' ' ' ASP . 1.7 t -77.52 149.35 34.94 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.243 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.673 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -130.86 165.85 22.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -141.11 124.07 16.28 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.421 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.61 147.77 50.74 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.43 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 -126.55 143.77 51.1 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.996 0.427 . . . . 0.0 110.588 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 t -142.35 114.26 8.1 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 70.9 ttt180 -129.21 173.2 10.71 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 45' ' ' THR . 79.7 t -128.95 170.79 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.613 ' N ' HG12 ' A' ' 44' ' ' VAL . 29.9 p -141.57 154.19 45.29 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.607 0.639 . . . . 0.0 110.032 178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.88 -99.26 0.39 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -114.94 161.27 30.05 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.303 -0.449 . . . . 0.0 110.343 -179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.4 Cg_exo -45.05 162.59 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.74 2.294 . . . . 0.0 112.701 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 1.8 pm0 -3.78 82.95 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.81 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.03 -156.79 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.777 2.318 . . . . 0.0 110.527 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -105.96 131.57 53.11 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' A' ' 75' ' ' HIS . 4.4 t -146.9 153.87 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 112.669 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -152.92 139.78 19.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.237 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 1.9 p-90 -140.81 158.0 44.58 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.237 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.423 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 0.6 OUTLIER -131.91 124.69 29.99 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.48 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.0 mp -88.95 136.76 32.84 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 92.2 m-20 47.01 8.94 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.412 0.551 . . . . 0.0 111.335 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 100.97 20.77 13.14 Favored Glycine 0 CA--C 1.538 1.528 0 N-CA-C 110.799 -0.921 . . . . 0.0 110.799 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.467 ' N ' ' O ' ' A' ' 56' ' ' LEU . 68.2 tp60 -121.98 125.01 45.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.637 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.7 OUTLIER -84.28 152.98 23.83 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.1 tp 58.8 112.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-O 121.78 0.8 . . . . 0.0 112.829 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.522 HH22 ' H ' ' A' ' 78' ' ' ASP . 20.8 ttm180 -107.18 152.3 24.25 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.32 176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.405 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 18.6 mmtp -60.12 150.07 30.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.549 0.69 . . . . 0.0 111.713 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.713 ' O ' ' N ' ' A' ' 66' ' ' ARG . 12.2 m -74.29 -138.19 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.707 -1.133 . . . . 0.0 112.167 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -8.35 -40.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.713 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.1 mtp85 -61.75 -36.86 82.22 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.481 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.71 144.04 47.43 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -71.05 111.31 6.31 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.239 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -152.27 135.29 7.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.139 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.523 ' O ' ' O ' ' A' ' 74' ' ' ILE . 55.6 ttp180 -133.64 106.41 7.38 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.457 ' O ' ' OD2' ' A' ' 72' ' ' ASP . 12.6 m-85 -73.47 90.11 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.845 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 71' ' ' TYR . 55.8 m-20 -169.89 24.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.413 -0.812 . . . . 0.0 108.868 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.08 -17.23 19.83 Favored Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.523 ' O ' ' O ' ' A' ' 70' ' ' ARG . 94.1 mt -115.52 126.24 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -141.79 111.82 6.82 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.477 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 89.8 m-85 -95.83 125.36 40.34 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.042 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -92.18 80.56 5.04 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.522 ' H ' HH22 ' A' ' 62' ' ' ARG . 95.8 m-20 -102.66 135.75 43.73 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.673 HD11 ' HB3' ' A' ' 38' ' ' ALA . 22.9 pt -127.27 164.39 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.875 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.576 ' O ' ' N ' ' A' ' 82' ' ' CYS . 33.6 m -133.2 171.03 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 37' ' ' THR . 96.4 m-20 -60.05 71.14 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 O-C-N 123.148 0.28 . . . . 0.0 110.324 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.576 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.3 m 158.97 143.04 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 59.9 mttp 64.84 63.45 0.7 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.136 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -143.38 -34.78 0.4 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.864 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 35.6 t80 -48.42 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' N ' ' O ' ' A' ' 84' ' ' SER . 1.0 OUTLIER -164.67 119.47 1.39 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 68.2 p -82.83 128.86 34.81 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.679 -0.638 . . . . 0.0 110.746 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -141.5 -158.77 7.66 Favored Glycine 0 C--N 1.343 0.941 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.566 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 99.0 mt-10 -141.96 144.65 33.83 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 p -119.81 133.37 66.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.223 0.535 . . . . 0.0 109.977 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -137.46 133.85 35.13 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG11 HD11 ' A' ' 23' ' ' ILE . 56.7 t -114.31 126.84 71.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.182 0.515 . . . . 0.0 111.051 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.2 p -121.3 124.8 45.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.543 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.02 153.06 36.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.989 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -128.18 154.47 45.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -156.0 150.27 19.88 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -24.42 61.72 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 120.984 1.123 . . . . 0.0 112.836 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -115.09 3.06 14.32 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.39 174.59 46.09 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 119.779 -1.2 . . . . 0.0 112.125 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -144.54 139.85 23.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 102' ' ' GLU . 86.3 mt -134.6 161.01 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-O 121.007 0.432 . . . . 0.0 111.771 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.569 ' N ' HG22 ' A' ' 101' ' ' ILE . 3.0 pp20? -162.22 144.26 11.02 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.611 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -140.72 138.98 34.61 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.826 0.346 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -103.87 122.72 45.73 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.332 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 106' ' ' LYS . 39.8 t -132.16 162.37 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 105' ' ' VAL . 54.9 mtpt -132.45 124.79 29.29 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.254 0.549 . . . . 0.0 112.151 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 88' ' ' GLY . 75.5 mt -120.51 121.2 37.92 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.05 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -126.84 124.44 39.64 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.92 123.63 72.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.977 0.894 . . . . 0.0 111.203 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -87.96 -124.87 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.317 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.514 ' N ' ' CD ' ' A' ' 111' ' ' GLN . 3.5 pm0 -155.56 159.06 39.39 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.946 0.403 . . . . 0.0 110.851 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.9 tp -108.97 -77.4 0.6 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.067 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -85.68 124.72 32.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.283 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -61.9 -46.85 87.57 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.885 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -142.6 138.46 30.77 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 110.419 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -83.16 128.06 34.16 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.001 0.429 . . . . 0.0 110.122 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 77.5 t60 -160.59 -13.32 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.477 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -111.43 144.41 40.69 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.102 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 40.2 m170 . . . . . 0 C--O 1.221 -0.409 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.79 179.61 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' ALA . 39.0 ttm180 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.9 mtt -72.63 21.84 0.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 110.629 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 1' ' ' ARG . . . -60.89 -38.6 86.23 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.624 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CD2' ' N ' ' A' ' 4' ' ' HIS . 0.4 OUTLIER -69.46 59.38 0.13 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.786 0.327 . . . . 0.0 110.63 -179.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.08 -58.67 4.12 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.906 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.02 -113.2 0.29 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.8 148.86 32.99 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.857 0.361 . . . . 0.0 110.591 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 9' ' ' THR . 0.5 OUTLIER -86.79 123.65 32.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.659 ' N ' HD13 ' A' ' 8' ' ' LEU . 16.3 p -103.03 146.63 28.07 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.927 0.394 . . . . 0.0 110.639 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -92.58 8.75 76.73 Favored Glycine 0 N--CA 1.465 0.607 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.1 m -122.08 130.26 74.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.183 0.516 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.36 60.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.131 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.5 p -112.83 -140.56 0.38 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.642 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 t0 49.4 25.27 1.26 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -67.03 -124.44 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.653 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -125.42 8.75 7.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -63.08 148.34 48.14 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.096 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 44.5 mmtt -73.44 140.89 46.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.008 0.432 . . . . 0.0 110.846 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.6 tp60 -135.45 170.41 15.99 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.58 116.05 59.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 119.615 -0.231 . . . . 0.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.498 ' HB2' HD11 ' A' ' 101' ' ' ILE . 6.0 Cg_exo -61.91 156.09 51.11 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.624 1.549 . . . . 0.0 112.132 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 22' ' ' ASP . 6.1 p-10 175.67 103.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.967 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 25' ' ' LEU . 18.3 pt -80.68 153.68 4.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.077 0.465 . . . . 0.0 111.753 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.701 ' C ' HD13 ' A' ' 25' ' ' LEU . 2.9 p -115.2 135.23 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.705 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -156.23 -159.01 0.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -85.38 111.45 36.82 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' O ' ' OE2' ' A' ' 28' ' ' GLU . 2.3 Cg_endo -62.6 -23.29 74.68 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.268 1.312 . . . . 0.0 112.599 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' A' ' 27' ' ' PRO . 16.3 mm-40 -128.92 168.93 14.26 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 119.408 -0.33 . . . . 0.0 110.452 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.39 155.15 32.24 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.0 1.8 . . . . 0.0 110.535 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 40' ' ' PHE . 3.3 p -137.81 142.28 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.691 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -139.85 149.64 43.69 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.706 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' C ' HD22 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -128.92 -173.83 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.776 HD22 ' N ' ' A' ' 33' ' ' LEU . 1.3 mm? -118.87 140.89 49.22 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' A' ' 85' ' ' TYR . 43.1 tp10 -51.05 130.26 25.48 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.32 -3.19 47.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -118.17 129.67 55.65 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -78.76 157.55 28.45 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.438 ' H ' ' HB ' ' A' ' 79' ' ' ILE . . . -122.29 153.63 38.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.983 0.42 . . . . 0.0 111.31 -178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.3 108.62 9.33 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.284 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE2' HG11 ' A' ' 30' ' ' VAL . 39.4 m-85 -124.38 148.5 47.5 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -135.9 150.79 49.47 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' HB3' ' HD1' ' A' ' 75' ' ' HIS . 11.8 t -152.78 131.37 12.26 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.73 176.2 8.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.6 m -129.53 171.62 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.86 146.72 39.69 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.112 0.414 . . . . 0.0 110.604 179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.7 -95.01 0.15 Allowed Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 159.28 71.08 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.74 141.34 95.6 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.738 1.625 . . . . 0.0 112.543 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.81 71.02 0.29 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.176 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.71 163.03 12.29 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 123.289 2.66 . . . . 0.0 111.478 177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -124.29 87.13 2.67 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' CZ ' ' A' ' 71' ' ' TYR . 15.2 m -124.92 162.74 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 111.789 -178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' OG1' ' A' ' 93' ' ' THR . 51.3 p30 -138.18 163.51 31.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.009 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.77 ' O ' HD12 ' A' ' 60' ' ' LEU . 1.1 p-90 -149.57 168.03 24.67 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.027 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 7.8 m-85 -130.59 116.98 18.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.682 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 56' ' ' LEU . 9.5 mp -85.04 137.34 33.12 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 11.4 t-20 49.62 8.97 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 O-C-N 122.12 -0.363 . . . . 0.0 110.987 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.73 24.26 12.35 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.528 ' N ' ' O ' ' A' ' 56' ' ' LEU . 90.1 mt-30 -125.91 120.82 31.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.745 0.307 . . . . 0.0 110.7 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 54' ' ' TRP . 33.8 tp -74.52 149.39 40.25 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.4 tp 62.77 110.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 124.231 0.957 . . . . 0.0 112.704 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 63' ' ' LYS . 8.3 tpm_? -110.52 146.53 35.86 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.206 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.698 ' H ' ' HE ' ' A' ' 62' ' ' ARG . 64.2 mmtt -61.02 151.95 29.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.519 0.676 . . . . 0.0 111.809 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.651 ' O ' ' N ' ' A' ' 66' ' ' ARG . 18.2 m -75.2 -140.07 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.461 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -7.84 -41.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.651 ' N ' ' O ' ' A' ' 64' ' ' SER . 55.5 ttt85 -60.74 -40.07 91.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 119.436 1.016 . . . . 0.0 109.233 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -120.11 139.13 53.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -67.42 115.92 7.59 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.49 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.07 134.12 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.885 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.2 mtp180 -137.27 101.29 4.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.17 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 52' ' ' VAL . 10.5 t80 -71.73 88.65 1.0 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.799 -178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -175.84 28.95 0.0 OUTLIER 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.64 -22.27 17.32 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.485 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.5 mt -110.61 123.55 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.266 0.555 . . . . 0.0 112.316 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.476 ' HD1' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -137.49 106.66 6.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.285 179.559 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -99.64 123.45 43.92 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.9 mt -102.89 96.95 7.17 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.402 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -111.65 141.4 45.3 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 80' ' ' VAL . 85.0 mt -109.36 160.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 82' ' ' CYS . 34.7 m -132.45 168.99 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' O ' ' SG ' ' A' ' 82' ' ' CYS . 92.8 m-20 -62.53 67.44 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 110.244 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.571 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.2 m 164.05 132.4 0.01 OUTLIER 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.014 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.9 mttt 67.49 60.0 0.48 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.082 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -126.82 -38.73 2.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -51.65 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' N ' ' O ' ' A' ' 84' ' ' SER . 34.3 p-10 -157.04 113.22 2.95 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.649 0.737 . . . . 0.0 110.713 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -80.32 129.25 34.38 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.164 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -146.95 -151.11 5.34 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.601 -0.999 . . . . 0.0 110.601 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' GLY . 22.3 pt-20 -146.01 143.67 29.6 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 119.726 -0.79 . . . . 0.0 112.657 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG21 HD22 ' A' ' 107' ' ' LEU . 68.8 t -118.34 137.21 53.03 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.087 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.053 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.79 126.72 20.84 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.4 t -106.65 117.86 53.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.796 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 77.1 p -117.17 127.79 54.47 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.576 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.0 154.74 28.26 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.172 0.51 . . . . 0.0 110.965 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -136.53 149.21 48.0 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.409 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -154.48 154.14 28.99 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -59.89 -28.75 87.88 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 120.83 1.02 . . . . 0.0 112.097 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -117.86 3.07 12.23 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.11 152.56 23.98 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 119.823 -1.179 . . . . 0.0 112.346 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 65.9 t -139.87 138.42 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' A' ' 21' ' ' PRO . 4.7 mt -142.22 154.94 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.039 0.447 . . . . 0.0 111.287 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -143.71 128.53 18.34 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.558 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -131.45 127.89 38.34 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.518 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -114.63 132.42 56.38 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.103 0.478 . . . . 0.0 110.244 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.2 m -134.16 159.12 42.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.446 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.709 ' C ' HD12 ' A' ' 107' ' ' LEU . 58.3 mttp -114.95 122.22 45.59 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.652 0.739 . . . . 0.0 110.744 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.7 mp -122.77 124.45 43.37 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.924 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -136.95 135.5 37.77 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.321 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.534 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -115.54 112.32 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 CA-C-O 121.394 0.616 . . . . 0.0 109.36 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.477 ' N ' HD12 ' A' ' 109' ' ' ILE . 91.9 mm-40 -78.22 -130.79 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.008 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.456 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 12.5 pt20 -149.01 155.38 40.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.77 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.7 tp -54.61 125.14 18.6 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.59 144.1 54.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.049 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -95.35 140.64 29.95 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.529 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -59.68 139.83 56.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.532 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.467 ' CG ' ' N ' ' A' ' 117' ' ' HIS . 53.5 p-80 -148.98 -45.67 0.14 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.305 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.467 ' N ' ' CG ' ' A' ' 116' ' ' HIS . 58.9 t-80 -154.56 -57.34 0.11 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.801 0.334 . . . . 0.0 110.366 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -86.83 125.23 33.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.359 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.455 ' CG ' ' OXT' ' A' ' 119' ' ' HIS . 58.5 t-80 . . . . . 0 C--O 1.219 -0.52 0 CA-C-O 117.829 -1.081 . . . . 0.0 110.27 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 67.3 mtt -82.01 141.84 32.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 0.0 110.698 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.54 162.28 39.97 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.166 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.19 142.36 43.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.994 0.426 . . . . 0.0 110.544 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' OE2' ' N ' ' A' ' 5' ' ' GLU . 56.4 mp0 -65.38 -41.27 93.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.298 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -169.56 -21.22 0.02 OUTLIER Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 139.68 58.34 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.848 -0.341 . . . . 0.0 110.375 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.6 mt -97.24 130.75 44.42 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.91 0.386 . . . . 0.0 110.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -79.88 129.25 34.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.15 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.83 -155.57 26.31 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -70.55 164.54 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 13' ' ' THR . 47.0 p -67.65 74.6 0.17 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.895 0.379 . . . . 0.0 111.271 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER 18.48 -107.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.702 179.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' N ' ' OG1' ' A' ' 13' ' ' THR . 58.5 t0 56.47 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.067 0.46 . . . . 0.0 111.322 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.431 ' HG2' ' H ' ' A' ' 17' ' ' GLU . 50.0 tt0 -74.79 139.12 43.09 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -119.63 8.16 11.2 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.474 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' A' ' 15' ' ' GLN . 2.8 tm-20 -67.45 126.89 30.74 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.59 118.64 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.376 0.608 . . . . 0.0 111.528 -178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -114.57 141.84 47.21 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.859 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.91 151.93 58.42 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.499 -179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB2' HD11 ' A' ' 101' ' ' ILE . 3.0 Cg_exo -51.56 157.63 4.91 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.251 1.967 . . . . 0.0 112.429 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' O ' HG22 ' A' ' 45' ' ' THR . 38.9 t0 -174.68 102.61 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.11 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.17 145.57 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.515 0.674 . . . . 0.0 112.755 -178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.575 ' C ' HD13 ' A' ' 25' ' ' LEU . 7.4 p -110.99 135.41 50.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.793 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -154.91 -155.81 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.548 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -112.32 92.89 20.31 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -68.28 -22.49 39.96 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.596 1.53 . . . . 0.0 110.484 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -86.1 118.26 70.12 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -59.31 146.25 95.31 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 CA-C-N 119.858 0.985 . . . . 0.0 110.252 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.1 t -134.83 137.37 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.867 0.365 . . . . 0.0 110.379 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -127.66 137.82 52.63 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.331 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.05 155.51 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.887 0.375 . . . . 0.0 110.616 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.2 mt -88.86 131.09 35.25 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' A' ' 112' ' ' LEU . 4.1 pt-20 -47.9 142.68 4.71 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.071 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.27 3.09 58.89 Favored Glycine 0 N--CA 1.463 0.469 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.18 145.88 43.58 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.221 -0.49 . . . . 0.0 110.126 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.9 p -86.52 140.65 29.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.818 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' HB1' ' CE1' ' A' ' 40' ' ' PHE . . . -111.92 146.13 38.31 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -131.33 112.14 12.48 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.314 0.578 . . . . 0.0 111.544 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.449 ' CE1' ' HB1' ' A' ' 38' ' ' ALA . 45.5 m-85 -133.81 156.82 47.34 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.454 ' NH1' ' CZ ' ' A' ' 76' ' ' TYR . 62.5 ttm-85 -121.99 146.83 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.474 ' SG ' ' ND1' ' A' ' 75' ' ' HIS . 44.5 t -141.61 104.46 4.56 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG2' ' H ' ' A' ' 44' ' ' VAL . 64.2 ttt180 -129.6 174.6 9.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 45' ' ' THR . 2.4 p -135.26 172.28 16.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.576 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.8 t -161.83 177.44 9.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.82 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.55 -28.21 11.81 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.02 117.31 8.26 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -63.45 117.18 4.15 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 120.208 1.11 . . . . 0.0 112.875 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 66.29 68.99 0.59 Allowed Pre-proline 0 N--CA 1.467 0.402 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.81 -163.21 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.985 2.456 . . . . 0.0 109.62 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -130.42 88.62 2.66 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.74 166.51 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.545 0.688 . . . . 0.0 111.866 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -141.71 158.34 43.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.632 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.769 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 0.6 OUTLIER -146.15 167.69 22.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.913 -179.37 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.531 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 4.6 m-85 -137.79 119.44 15.04 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 56' ' ' LEU . 8.8 mp -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 45.8 11.41 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.533 0.606 . . . . 0.0 110.99 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.5 26.45 9.97 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.526 ' N ' ' O ' ' A' ' 56' ' ' LEU . 56.0 tt0 -125.08 120.73 32.3 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.775 0.321 . . . . 0.0 111.114 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 64.8 tp -78.68 151.35 32.25 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.157 0.583 . . . . 0.0 112.392 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 5.0 tp 61.78 110.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 O-C-N 124.329 1.018 . . . . 0.0 112.802 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 tpt180 -102.44 152.6 20.93 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.469 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.603 ' HZ2' ' H ' ' A' ' 64' ' ' SER . 1.6 tptp -60.04 146.77 41.59 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.806 -0.757 . . . . 0.0 111.832 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.67 ' O ' ' N ' ' A' ' 66' ' ' ARG . 3.2 m -74.3 -137.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.528 -1.215 . . . . 0.0 112.319 -178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -20.67 -30.17 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 -178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.67 ' N ' ' O ' ' A' ' 64' ' ' SER . 43.2 ttm180 -60.94 -40.43 93.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.166 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -123.79 155.96 36.98 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 178.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -69.56 104.42 2.35 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.084 0.469 . . . . 0.0 110.954 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 69' ' ' VAL . 9.9 p -155.76 127.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.21 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.535 ' O ' ' O ' ' A' ' 74' ' ' ILE . 22.5 tpt180 -136.05 119.21 16.56 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -77.69 90.29 3.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.704 0.764 . . . . 0.0 110.705 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -162.96 26.41 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.348 -1.296 . . . . 0.0 107.674 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.4 -14.85 56.57 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.556 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.535 ' O ' ' O ' ' A' ' 70' ' ' ARG . 6.4 pt -111.88 124.25 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.812 0.815 . . . . 0.0 112.799 -178.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.769 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -139.16 105.07 5.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.029 179.346 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.454 ' CZ ' ' NH1' ' A' ' 41' ' ' ARG . 3.3 m-30 -86.57 124.81 33.28 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.636 0.732 . . . . 0.0 109.574 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -94.03 79.43 4.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.012 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -117.43 106.44 13.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.291 0.496 . . . . 0.0 111.421 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 2.3 pt -108.2 114.81 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.273 -0.421 . . . . 0.0 109.95 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 81' ' ' ASP . 1.4 t -82.77 -148.78 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.514 ' H ' HG12 ' A' ' 80' ' ' VAL . 36.6 p30 -84.97 58.03 4.78 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 86.5 m -104.72 -82.8 0.51 Allowed 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -132.89 122.56 24.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.802 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.581 ' O ' HG21 ' A' ' 109' ' ' ILE . 0.8 OUTLIER -143.53 -39.77 0.31 Allowed 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.9 -178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 1.2 p90 -53.14 59.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 84' ' ' SER . 64.3 m-20 -159.47 117.18 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.418 0.627 . . . . 0.0 110.616 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.42 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 44.0 p -81.08 119.69 23.87 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.564 -179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.21 -148.96 5.34 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.55 148.79 32.52 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.058 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 75.1 t -116.28 134.12 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.007 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -134.58 129.01 34.33 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.871 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -119.81 133.73 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.995 0.426 . . . . 0.0 109.894 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -143.38 151.36 40.32 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.33 146.86 48.56 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.642 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -135.71 91.06 2.66 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -93.8 173.78 4.43 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.41 -18.84 43.86 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 121.233 1.289 . . . . 0.0 112.492 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -115.79 3.14 13.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.91 172.26 44.24 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 118.726 -1.702 . . . . 0.0 112.714 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.6 m -145.12 147.41 18.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.508 -0.846 . . . . 0.0 109.619 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.549 HD11 ' HB2' ' A' ' 21' ' ' PRO . 9.5 mt -143.66 154.48 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.655 0.265 . . . . 0.0 110.325 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -151.1 136.35 17.62 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.083 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -136.68 131.28 33.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.541 -0.299 . . . . 0.0 110.533 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -94.13 134.14 36.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.089 0.471 . . . . 0.0 110.525 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.56 144.33 21.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.463 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.714 ' C ' HD12 ' A' ' 107' ' ' LEU . 64.5 mttp -119.52 127.71 53.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.486 0.66 . . . . 0.0 112.379 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.714 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -124.25 120.5 32.4 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -113.11 118.84 35.86 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' SER . 64.7 mt -103.74 113.24 40.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.931 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -86.92 -130.72 0.06 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.022 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -151.49 152.98 33.73 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.96 0.41 . . . . 0.0 111.032 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' H ' ' HG2' ' A' ' 34' ' ' GLU . 57.1 tp -101.8 -20.11 15.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.317 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -94.83 121.38 36.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.348 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.402 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 4.1 p80 -131.2 12.72 5.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.816 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -70.51 -23.25 62.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.439 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -88.14 97.14 10.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.617 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.402 ' CE1' ' O ' ' A' ' 114' ' ' HIS . 73.7 m80 -95.14 -60.08 1.76 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.784 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -66.24 -45.53 80.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.959 0.409 . . . . 0.0 110.429 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.285 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -41.18 97.85 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.5 148.8 47.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.927 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -100.96 3.11 41.35 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.63 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -67.09 -39.76 86.84 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.493 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.37 127.29 23.55 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 120.046 -1.073 . . . . 0.0 111.666 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.35 145.64 52.79 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 115.441 -0.379 . . . . 0.0 109.999 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.35 130.46 35.05 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.554 -0.293 . . . . 0.0 110.366 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.7 p -82.87 160.01 22.25 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.626 0.579 . . . . 0.0 111.022 -178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.08 154.02 26.08 Favored Glycine 0 C--O 1.218 -0.846 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.977 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' C ' ' A' ' 12' ' ' THR . 5.7 t 41.84 91.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.459 ' C ' ' O ' ' A' ' 11' ' ' VAL . 30.1 m -25.68 -66.99 0.05 OUTLIER 'General case' 0 C--N 1.345 0.37 0 O-C-N 124.299 0.999 . . . . 0.0 111.261 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.4 m 47.98 74.72 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.087 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -43.79 -86.57 0.0 OUTLIER 'General case' 0 C--O 1.244 0.812 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.114 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -143.11 -92.59 0.12 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.458 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -123.59 13.84 9.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.003 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -71.6 169.74 14.9 Favored 'General case' 0 C--O 1.25 1.113 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.015 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.62 133.42 56.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.08 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.526 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 38.4 tt0 -138.77 174.64 10.32 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 54.1 mttm -81.06 145.5 56.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.586 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -51.5 136.35 48.5 Favored 'Trans proline' 0 N--CA 1.483 0.859 0 C-N-CA 121.903 1.735 . . . . 0.0 112.62 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -131.93 130.26 41.33 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.9 tt -125.19 118.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' C ' HD12 ' A' ' 25' ' ' LEU . 35.7 m -112.51 126.1 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 24' ' ' VAL . 2.7 mp -159.61 -153.53 0.36 Allowed 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -113.76 93.02 26.84 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 122.794 0.438 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.59 -18.21 53.75 Favored 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.007 1.804 . . . . 0.0 112.081 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -96.48 133.64 24.48 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.419 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.38 145.53 97.63 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 C-N-CA 121.133 1.222 . . . . 0.0 111.671 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 54.8 t -130.52 132.98 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-O 121.235 0.541 . . . . 0.0 110.348 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -138.66 140.36 38.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.368 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' C ' HD12 ' A' ' 33' ' ' LEU . 2.5 p -134.99 160.24 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 O-C-N 122.146 -0.346 . . . . 0.0 110.102 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.596 HD12 ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -97.49 131.06 44.47 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.872 0.368 . . . . 0.0 110.329 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 84.5 tt0 -39.25 129.41 1.73 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.25 -179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.91 5.65 27.0 Favored Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -125.28 140.46 52.81 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.024 0.44 . . . . 0.0 111.386 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 30.6 p -89.86 138.81 31.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.708 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.734 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -121.33 163.82 18.03 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 120.95 0.405 . . . . 0.0 111.291 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -136.86 133.29 35.67 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.775 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -137.93 143.68 40.89 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -134.15 146.32 50.1 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.985 0.421 . . . . 0.0 110.565 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 43.7 t -146.18 121.14 10.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.369 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 44' ' ' VAL . 67.8 mtp180 -130.99 172.13 12.43 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 43' ' ' ARG . 78.7 t -158.25 100.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.9 m -124.71 128.66 49.14 Favored 'General case' 0 CA--C 1.505 -0.763 0 O-C-N 121.691 -0.631 . . . . 0.0 111.343 -177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 19' ' ' GLN . . . 174.95 -27.84 0.08 OUTLIER Glycine 0 CA--C 1.52 0.384 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -136.91 139.01 27.52 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -53.06 142.84 52.9 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 CA-C-N 119.683 0.922 . . . . 0.0 112.309 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 37.34 72.35 0.86 Allowed Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.74 153.47 38.36 Favored 'Trans proline' 0 C--N 1.293 -2.343 0 C-N-CA 122.73 2.287 . . . . 0.0 111.341 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -98.18 136.4 38.46 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.7 m -147.3 167.02 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.425 0.631 . . . . 0.0 111.869 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -146.07 136.14 23.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.479 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.588 ' CD1' ' CG ' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -107.01 137.67 44.63 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.63 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -122.05 100.24 6.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.4 mp -93.05 137.62 32.24 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.503 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.9 m120 52.12 7.64 0.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.781 0.324 . . . . 0.0 111.014 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.6 21.67 18.57 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -125.48 128.8 48.61 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.204 -0.586 . . . . 0.0 110.505 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.477 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 50.1 tp -76.39 154.29 35.02 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.0 tp 60.52 112.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 CA-C-O 121.921 0.867 . . . . 0.0 112.6 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.432 ' HG3' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -104.85 139.82 39.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.539 -1.21 . . . . 0.0 107.846 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.426 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 46.9 mmtt -50.31 152.94 1.65 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.175 0.512 . . . . 0.0 112.004 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.747 ' O ' ' N ' ' A' ' 66' ' ' ARG . 20.2 m -72.88 -137.06 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.784 -178.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -13.45 -35.23 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.747 ' N ' ' O ' ' A' ' 64' ' ' SER . 94.8 mtt-85 -62.09 -37.23 84.26 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 121.475 -0.766 . . . . 0.0 109.51 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 64' ' ' SER . 78.1 m-85 -122.69 149.8 43.57 Favored 'General case' 0 C--O 1.239 0.552 0 O-C-N 123.845 0.716 . . . . 0.0 109.143 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 76' ' ' TYR . 95.8 mtt-85 -75.8 110.58 10.36 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.003 0.43 . . . . 0.0 110.917 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 69' ' ' VAL . 35.1 m -147.59 136.01 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.593 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.505 ' O ' ' O ' ' A' ' 74' ' ' ILE . 99.7 mtt180 -133.89 104.18 6.17 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.418 ' CD2' ' N ' ' A' ' 71' ' ' TYR . 0.1 OUTLIER -72.37 85.74 1.11 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.263 -179.037 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -169.06 26.94 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.71 -17.8 55.96 Favored Glycine 0 CA--C 1.536 1.368 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.1 mt -102.69 116.05 45.7 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 O-C-N 123.9 0.412 . . . . 0.0 111.593 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.78 ' NE2' HD21 ' A' ' 77' ' ' LEU . 3.7 t-80 -141.5 104.56 4.6 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.568 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 68' ' ' ARG . 56.8 m-85 -105.37 126.53 52.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.409 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.78 HD21 ' NE2' ' A' ' 75' ' ' HIS . 79.2 mt -109.62 105.41 14.69 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.651 0.262 . . . . 0.0 110.788 177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 78' ' ' ASP . 55.4 p-10 -116.71 142.81 46.42 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.608 0.718 . . . . 0.0 111.475 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 38' ' ' ALA . 20.1 pt -128.53 164.12 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.8 -167.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 O-C-N 123.222 0.326 . . . . 0.0 110.247 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -82.13 52.8 2.07 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.636 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.5 t -109.76 -73.4 0.69 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -134.67 129.03 34.18 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -147.25 -37.77 0.21 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.727 -177.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.655 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -52.63 63.08 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -178.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 66.3 t0 -155.61 113.4 3.35 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 121.472 -0.768 . . . . 0.0 110.164 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 16.7 p -84.49 131.37 34.66 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.064 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.56 -157.94 7.56 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 121.846 0.692 . . . . 0.0 111.938 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.503 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 12.7 pt-20 -139.1 136.21 34.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 O-C-N 122.252 -0.558 . . . . 0.0 111.078 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.0 t -114.81 134.27 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -146.54 141.85 27.43 Favored 'General case' 0 C--O 1.215 -0.724 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.86 136.3 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-O 121.181 0.515 . . . . 0.0 110.153 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.9 p -122.91 115.04 21.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.043 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -128.02 151.29 49.34 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.6 136.66 4.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.057 0.932 . . . . 0.0 112.36 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.14 174.36 2.57 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.351 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -70.53 -14.79 33.98 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 121.25 1.3 . . . . 0.0 113.629 -178.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -105.05 -9.74 17.64 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.08 179.43 41.78 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 120.037 -1.077 . . . . 0.0 111.93 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.28 134.83 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.043 0.449 . . . . 0.0 110.33 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 101' ' ' ILE . 1.6 pp -143.12 150.61 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.217 0.532 . . . . 0.0 110.862 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.444 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 3.0 pm0 -166.94 162.78 15.91 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 26.7 m170 -146.99 138.13 23.98 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -102.78 134.86 45.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.803 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.37 159.71 35.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.408 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 33.6 ttmt -119.89 118.43 30.73 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.302 0.572 . . . . 0.0 110.521 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 9.5 mp -121.48 122.4 39.65 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -128.79 128.87 44.82 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 84' ' ' SER . 78.6 mt -110.13 116.6 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.698 -179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -86.96 -125.52 0.04 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.569 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.459 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 24.3 pt20 -160.71 162.92 32.7 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.247 -178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 43.5 tp -66.71 130.92 44.77 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.706 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -111.79 -120.03 0.29 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.715 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -115.46 127.34 55.26 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 121.492 0.663 . . . . 0.0 109.848 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.604 ' CD2' ' H ' ' A' ' 115' ' ' HIS . 4.7 p80 -66.75 123.39 20.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.066 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -77.56 2.55 16.1 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.132 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -74.66 118.81 18.03 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 1.1 p-80 -80.66 -27.8 37.03 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.038 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.214 -0.795 0 CA-C-O 117.6 -1.191 . . . . 0.0 111.023 -178.284 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.83 -41.49 95.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.091 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.54 96.15 2.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.59 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 4' ' ' HIS . 37.9 t-80 -85.21 -0.56 55.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.609 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -122.5 146.84 47.02 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.47 -171.64 6.72 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.15 140.6 49.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.029 0.442 . . . . 0.0 111.107 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.6 mt -81.46 129.61 34.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.0 m -70.92 136.84 48.79 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.116 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.48 -84.64 0.13 Allowed Glycine 0 CA--C 1.519 0.3 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 13' ' ' THR . 17.8 t -95.96 -26.43 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.6 p -59.42 10.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.444 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 11' ' ' VAL . 13.6 p -75.3 164.03 26.86 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.423 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -65.55 -38.67 90.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.896 0.379 . . . . 0.0 110.692 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -88.32 78.44 7.99 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.385 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -125.39 6.12 7.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.135 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.02 142.4 58.4 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.99 115.63 15.89 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.32 169.88 9.62 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.847 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.53 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 42.5 mttt -84.09 138.29 39.81 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.806 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -58.53 148.03 83.4 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.332 1.354 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 45' ' ' THR . 4.8 p-10 173.73 108.66 0.01 OUTLIER 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.019 177.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HD12 HD12 ' A' ' 25' ' ' LEU . 19.9 pt -82.16 152.91 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.142 -178.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.66 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.3 t -116.14 134.94 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.642 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -151.88 -156.19 0.69 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 105' ' ' VAL . 7.9 m-85 -106.12 96.83 13.99 Favored Pre-proline 0 N--CA 1.477 0.919 0 CA-C-N 117.632 0.196 . . . . 0.0 110.87 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -67.87 -21.71 43.69 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 C-N-CA 121.202 1.268 . . . . 0.0 111.138 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.32 122.4 68.56 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.266 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.98 146.26 94.65 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.19 1.26 . . . . 0.0 110.73 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 76.8 t -129.84 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 120.962 0.41 . . . . 0.0 111.351 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -128.99 137.12 51.16 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.835 179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.03 159.03 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 110.267 -0.271 . . . . 0.0 110.267 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 33' ' ' LEU . 8.0 mp -93.5 128.87 39.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.449 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 15.2 tm-20 -45.66 140.77 3.2 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.508 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.11 67.17 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -113.71 128.25 56.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.247 -0.477 . . . . 0.0 109.855 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 37' ' ' THR . 1.3 t -76.73 139.7 40.56 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.659 ' HB3' ' CG2' ' A' ' 79' ' ' ILE . . . -124.39 166.04 16.67 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.467 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -137.76 124.84 21.49 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.978 0.418 . . . . 0.0 110.731 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -132.25 142.49 49.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -134.79 151.0 50.6 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 75' ' ' HIS . 49.3 t -159.92 134.81 7.87 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.172 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -133.64 178.38 6.98 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.85 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.646 HG22 ' N ' ' A' ' 45' ' ' THR . 7.3 p -130.48 173.92 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.646 ' N ' HG22 ' A' ' 44' ' ' VAL . 1.1 t -152.18 170.22 20.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.969 0.804 . . . . 0.0 109.726 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.44 -99.92 0.51 Allowed Glycine 0 N--CA 1.474 1.22 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.951 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.405 ' CD2' ' C ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -125.51 175.49 3.07 Favored Pre-proline 0 N--CA 1.475 0.789 0 CA-C-N 115.588 -0.306 . . . . 0.0 110.529 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -72.98 167.34 27.61 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.341 2.028 . . . . 0.0 113.99 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 34.9 69.4 1.06 Allowed Pre-proline 0 N--CA 1.474 0.758 0 CA-C-N 114.549 -1.205 . . . . 0.0 113.716 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.33 161.19 8.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 123.191 2.594 . . . . 0.0 110.526 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.4 126.89 32.71 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.631 HG13 ' CZ2' ' A' ' 54' ' ' TRP . 63.3 t -129.68 133.34 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -176.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 52' ' ' VAL . 13.8 m120 -156.79 135.17 11.37 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CZ2' ' CE1' ' A' ' 75' ' ' HIS . 35.9 m95 -122.11 158.16 29.89 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.255 0.48 . . . . 0.0 111.14 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -124.32 101.66 7.29 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.294 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 6.5 mp -90.75 137.61 32.22 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 14.4 m120 49.36 8.24 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 122.366 -0.209 . . . . 0.0 111.285 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 99.1 22.92 12.04 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 56' ' ' LEU . 95.9 mt-30 -124.54 128.4 48.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.665 0.386 . . . . 0.0 110.379 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -77.64 148.88 34.83 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 81.01 111.41 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 177.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' O ' ' OH ' ' A' ' 71' ' ' TYR . 29.5 tpt180 -83.87 143.36 29.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 177.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -61.94 134.37 56.58 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.527 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.633 ' O ' ' N ' ' A' ' 66' ' ' ARG . 4.7 p -74.08 -140.96 0.01 OUTLIER 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' N ' ' OG ' ' A' ' 64' ' ' SER . 68.3 mttm -20.85 -33.46 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.633 ' N ' ' O ' ' A' ' 64' ' ' SER . 99.8 mtt180 -63.09 -40.25 97.1 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.346 -0.942 . . . . 0.0 108.99 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' N ' ' O ' ' A' ' 64' ' ' SER . 61.3 m-85 -120.44 149.16 42.82 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.85 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 76' ' ' TYR . 78.4 ttt180 -70.62 116.19 10.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.162 0.506 . . . . 0.0 111.23 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 p -154.83 140.43 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.999 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 74' ' ' ILE . 27.1 mmt180 -130.76 100.35 5.25 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 62' ' ' ARG . 87.0 m-85 -72.98 97.94 2.41 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.544 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 68.0 t0 -176.14 -27.41 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.315 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.27 -25.4 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.4 mp -110.3 124.4 67.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' CE1' ' CZ2' ' A' ' 54' ' ' TRP . 3.0 p-80 -134.48 110.3 9.3 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.097 0.475 . . . . 0.0 110.508 177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 68' ' ' ARG . 2.7 m-85 -97.17 112.82 24.44 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.816 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.6 mt -95.85 95.54 8.33 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -110.59 143.14 41.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.659 ' CG2' ' HB3' ' A' ' 38' ' ' ALA . 2.5 tt -126.45 162.15 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' N ' ' CG1' ' A' ' 79' ' ' ILE . 42.7 t -137.92 -104.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -136.24 56.52 1.81 Allowed 'General case' 0 CA--C 1.523 -0.089 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 97.2 m -104.91 -86.42 0.46 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -130.55 123.82 30.44 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.57 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.5 OUTLIER -140.39 -39.01 0.44 Allowed 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.2 t80 -53.51 63.73 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.57 ' N ' ' O ' ' A' ' 84' ' ' SER . 52.8 t0 -160.79 117.01 2.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.259 0.552 . . . . 0.0 110.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 43.1 p -79.39 114.24 18.16 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.453 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.45 -161.63 11.15 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.446 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 96.0 mt-10 -138.15 135.47 35.73 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.298 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 105' ' ' VAL . 55.9 t -107.33 135.79 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -145.16 131.54 19.66 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -112.97 140.39 33.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 53' ' ' ASN . 50.1 p -138.56 130.44 28.05 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.61 160.47 28.37 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -153.69 96.93 2.06 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.731 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 96' ' ' ASN . 0.9 OUTLIER -81.79 171.06 12.93 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -71.45 -20.49 27.34 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.438 1.425 . . . . 0.0 112.614 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.5 mp0 -105.46 -1.26 25.15 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.26 175.57 43.54 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 119.909 -1.139 . . . . 0.0 111.984 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.72 139.15 28.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 114.653 -0.773 . . . . 0.0 109.578 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 102' ' ' GLU . 62.0 mt -136.03 151.75 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 111.814 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.434 ' N ' HG22 ' A' ' 101' ' ' ILE . 19.1 pt-20 -154.64 139.74 17.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.951 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -131.05 132.3 44.83 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -108.88 123.18 48.66 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.777 0.799 . . . . 0.0 112.059 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 26' ' ' TYR . 11.7 p -143.07 137.58 26.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.716 ' C ' HD12 ' A' ' 107' ' ' LEU . 0.3 OUTLIER -103.76 135.71 44.8 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.787 0.803 . . . . 0.0 112.674 -177.326 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.716 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.0 mp -122.36 125.69 46.45 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -119.91 119.28 33.03 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.519 HG21 ' O ' ' A' ' 84' ' ' SER . 68.3 mt -103.68 119.62 52.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -93.79 -132.47 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.692 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -154.0 158.42 40.58 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.577 0.227 . . . . 0.0 110.685 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' A' ' 34' ' ' GLU . 68.0 mt -45.32 148.07 0.69 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.255 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 113' ' ' GLU . 6.3 pt-20 -75.56 108.35 8.32 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.066 0.46 . . . . 0.0 110.723 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -85.57 127.06 34.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.143 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -64.22 -166.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.397 . . . . 0.0 110.513 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -73.49 138.83 45.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.077 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -75.98 -2.11 28.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.569 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -66.17 -43.46 86.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.672 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 47.4 m80 . . . . . 0 C--O 1.217 -0.608 0 CA-C-O 117.929 -1.034 . . . . 0.0 110.113 -179.168 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 95.3 mmm -62.79 -42.32 99.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.777 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.93 145.78 28.39 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -104.87 121.37 43.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 0.0 111.293 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -91.48 -13.68 31.78 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.047 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.77 165.85 53.54 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.92 147.86 32.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.056 0.455 . . . . 0.0 110.44 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 61.3 mt -73.18 133.23 43.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.243 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 m -63.13 136.99 58.09 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.069 0.461 . . . . 0.0 110.968 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.81 -137.05 46.42 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.297 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 11' ' ' VAL . 7.0 p -65.95 129.13 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.869 0.366 . . . . 0.0 110.782 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.7 p -50.79 -85.82 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.796 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.1 t -143.39 150.72 39.5 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.574 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.3 p-10 -166.89 12.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.188 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -154.33 97.7 2.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 109.923 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.3 tttp -123.9 -31.92 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.005 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -77.71 161.0 28.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.007 0.432 . . . . 0.0 110.943 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.72 139.45 47.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.286 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -115.51 -173.76 2.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 ptpt -84.39 118.75 71.9 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.03 141.26 95.96 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 120.723 0.949 . . . . 0.0 111.291 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -170.13 171.27 6.99 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.391 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 92' ' ' VAL . 10.6 tt -140.25 131.52 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.992 0.425 . . . . 0.0 111.272 179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -103.9 132.46 50.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.568 HD22 ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -146.98 -167.39 2.76 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.448 0.467 . . . . 0.0 111.675 -179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' O ' HG11 ' A' ' 105' ' ' VAL . 1.1 m-85 -110.5 94.23 18.53 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.421 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -70.25 -23.49 28.49 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.456 1.437 . . . . 0.0 111.0 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -86.3 121.03 72.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.254 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.27 146.12 95.67 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 CA-C-N 119.98 1.028 . . . . 0.0 109.731 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.9 t -127.65 132.15 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 120.82 0.343 . . . . 0.0 111.507 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -114.97 122.97 47.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.074 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.0 t -111.33 143.4 21.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-O 121.05 0.453 . . . . 0.0 109.92 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.9 mp -98.53 123.91 42.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.166 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -35.02 116.17 0.33 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.118 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 10.52 16.42 Favored Glycine 0 N--CA 1.469 0.842 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.075 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.7 131.9 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.223 0.535 . . . . 0.0 110.743 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -74.32 140.58 44.97 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.903 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -121.72 158.16 29.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.165 0.507 . . . . 0.0 110.449 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -140.71 121.68 14.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.157 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -131.98 147.64 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -119.24 138.02 53.26 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.977 0.418 . . . . 0.0 110.819 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 91.1 m -141.59 111.02 6.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.317 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 72.4 ttt180 -124.15 168.78 12.44 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.455 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 74.5 t -153.41 96.0 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 50.4 p -85.12 -171.29 3.56 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.22 -88.84 0.36 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.807 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -137.18 162.61 54.44 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -50.24 157.02 3.33 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 122.548 2.166 . . . . 0.0 112.798 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 35.44 70.25 1.01 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -83.16 170.24 12.27 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.19 2.593 . . . . 0.0 110.391 175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -96.24 117.4 30.7 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.459 HG11 ' CE1' ' A' ' 75' ' ' HIS . 58.4 t -139.27 137.03 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -144.86 143.9 30.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.692 ' HE1' ' CG ' ' A' ' 75' ' ' HIS . 1.0 OUTLIER -139.68 164.68 29.28 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 120.509 -0.476 . . . . 0.0 109.993 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.576 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.2 m-85 -137.4 118.41 14.34 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.55 -0.46 . . . . 0.0 112.057 -178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 58' ' ' GLY . 9.8 mp -85.49 139.19 31.69 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 11.4 m120 46.56 9.54 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.771 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 99.98 21.14 14.35 Favored Glycine 0 CA--C 1.536 1.369 0 N-CA-C 111.261 -0.735 . . . . 0.0 111.261 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -127.07 125.49 41.39 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 122.706 -0.29 . . . . 0.0 111.618 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' TRP . 63.8 tp -77.85 152.4 33.41 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.375 0.67 . . . . 0.0 112.33 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 4.7 tp 61.27 112.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 124.184 0.928 . . . . 0.0 113.079 178.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.741 HH12 ' N ' ' A' ' 78' ' ' ASP . 78.2 ttt180 -102.14 147.85 26.12 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 114.096 -1.411 . . . . 0.0 108.554 177.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -52.62 146.31 10.35 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.088 0.471 . . . . 0.0 111.073 -178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.733 ' O ' ' N ' ' A' ' 66' ' ' ARG . 48.8 p -71.52 -137.12 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.697 -177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' N ' ' OG ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -21.86 -26.42 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -178.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.733 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.2 ttt180 -60.99 -39.39 89.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -122.69 158.49 29.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -69.42 105.51 2.62 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -140.26 136.92 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.965 0.412 . . . . 0.0 111.237 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' O ' ' O ' ' A' ' 74' ' ' ILE . 61.1 ttm-85 -140.22 102.77 4.44 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -73.69 90.09 1.81 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.812 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -169.77 28.01 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.804 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.08 -16.83 45.59 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.93 126.68 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.385 0.612 . . . . 0.0 112.019 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.692 ' CG ' ' HE1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -138.7 104.88 5.22 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.72 179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -100.89 124.84 47.18 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.039 0.447 . . . . 0.0 110.631 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -93.61 83.83 4.55 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.741 ' N ' HH12 ' A' ' 62' ' ' ARG . 44.0 t0 -101.39 116.0 31.79 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -178.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 38' ' ' ALA . 24.6 mt -97.64 153.42 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 81' ' ' ASP . 92.5 t -130.78 -89.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.413 ' N ' HG12 ' A' ' 80' ' ' VAL . 66.1 t0 -151.72 50.61 0.81 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.169 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 78.2 m -107.94 -82.78 0.55 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.216 0.531 . . . . 0.0 109.571 179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -129.27 130.86 46.74 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.628 ' O ' HG21 ' A' ' 109' ' ' ILE . 4.0 m -135.7 -47.3 0.68 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.78 0.324 . . . . 0.0 111.074 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.546 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 11.6 t80 -53.31 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 84' ' ' SER . 36.1 t70 -154.17 111.99 3.5 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 121.94 -0.475 . . . . 0.0 110.772 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 p -85.26 131.56 34.4 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.726 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.79 -155.46 6.5 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.41 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 94.0 mt-10 -137.98 143.28 40.59 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.0 t -111.97 136.99 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 104' ' ' LYS . 88.2 tttt -152.9 142.7 22.05 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.621 HG22 ' ND1' ' A' ' 103' ' ' HIS . 9.8 m -126.76 131.45 71.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.378 0.609 . . . . 0.0 111.167 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.5 p -114.27 109.23 18.05 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.66 139.14 52.0 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -143.79 112.11 6.36 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 122.293 1.044 . . . . 0.0 112.504 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.584 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -98.17 157.38 34.58 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -56.6 -19.9 31.94 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 C-N-CA 121.504 1.469 . . . . 0.0 113.008 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -104.87 -10.28 17.44 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.25 44.94 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 119.818 -1.182 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 77.0 t -137.21 132.52 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.613 0.244 . . . . 0.0 110.353 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.6 mt -132.01 129.23 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.26 150.54 42.74 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.621 ' ND1' HG22 ' A' ' 92' ' ' VAL . 2.6 p-80 -138.68 141.98 38.99 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.676 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.429 ' NZ ' ' NZ ' ' A' ' 91' ' ' LYS . 68.3 mttm -104.43 116.6 32.41 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.687 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 26' ' ' TYR . 27.8 m -135.69 163.57 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.68 ' C ' HD12 ' A' ' 107' ' ' LEU . 63.2 pttt -131.8 132.19 43.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.958 0.885 . . . . 0.0 111.637 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.68 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.1 mp -125.64 123.93 40.06 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -119.89 123.76 44.37 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.628 HG21 ' O ' ' A' ' 84' ' ' SER . 58.9 mt -102.49 107.54 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.306 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -85.13 -127.93 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.338 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -148.78 156.1 41.88 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-O 120.924 0.392 . . . . 0.0 111.07 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 114' ' ' HIS . 52.9 tp -65.28 131.46 46.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.792 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.489 ' OE1' ' ND1' ' A' ' 115' ' ' HIS . 44.9 tp10 -146.61 102.82 3.6 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.319 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.482 ' NE2' HD11 ' A' ' 112' ' ' LEU . 89.6 m-70 -93.67 -2.85 53.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.669 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.489 ' ND1' ' OE1' ' A' ' 113' ' ' GLU . 69.5 m80 -56.9 -14.9 3.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.599 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -105.98 41.52 1.39 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.694 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.426 ' CG ' ' N ' ' A' ' 118' ' ' HIS . 25.1 t-80 -132.38 -98.85 0.29 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.426 ' N ' ' CG ' ' A' ' 117' ' ' HIS . 78.8 t60 -70.1 -8.33 48.61 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.014 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.574 -179.688 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.9 ttp -64.31 -40.49 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.648 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.79 137.34 56.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.931 0.396 . . . . 0.0 110.615 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -68.9 81.74 0.3 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.673 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -167.3 50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.372 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.55 -1.67 61.95 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.19 136.39 58.05 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.405 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 8' ' ' LEU . 2.5 mm? -75.17 137.23 41.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.958 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -81.09 160.43 24.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.813 0.34 . . . . 0.0 110.472 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.29 153.11 46.0 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.3 m -81.37 130.66 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.058 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 p 48.38 -132.79 1.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.929 0.395 . . . . 0.0 110.263 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.495 ' OG1' ' N ' ' A' ' 14' ' ' ASP . 29.8 p -60.68 -116.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.54 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.495 ' N ' ' OG1' ' A' ' 13' ' ' THR . 96.9 m-20 44.92 47.04 9.26 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.838 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -166.59 95.04 0.53 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.977 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -124.07 8.07 8.6 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.002 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -85.6 152.08 23.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.647 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -70.11 133.79 47.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.679 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' A' ' 20' ' ' LYS . 47.3 tt0 -137.8 168.18 20.22 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' N ' ' CG ' ' A' ' 19' ' ' GLN . 29.5 mtmm -81.64 116.32 62.35 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.442 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -61.0 155.8 48.1 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.46 1.44 . . . . 0.0 111.929 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.448 ' OD1' ' O ' ' A' ' 45' ' ' THR . 8.8 p-10 -158.35 101.98 1.73 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.785 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' CG1' ' A' ' 92' ' ' VAL . 9.7 tt -85.88 136.86 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.52 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 p -112.12 128.65 68.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.495 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.756 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -155.01 -174.14 4.86 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.723 -179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.15 109.15 8.29 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.387 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -71.89 -22.08 23.79 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.109 1.206 . . . . 0.0 113.275 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -125.14 141.83 39.66 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.61 151.28 55.76 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.843 1.695 . . . . 0.0 111.227 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.78 148.11 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.861 0.362 . . . . 0.0 110.397 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -128.47 143.1 50.93 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.406 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.402 ' C ' HD12 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -121.58 153.69 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.09 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.5 mp -101.09 133.73 45.17 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.059 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 81.7 tt0 -40.37 119.78 1.12 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.349 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 7.11 26.28 Favored Glycine 0 N--CA 1.467 0.732 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.684 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.435 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 9.6 mp0 -121.05 122.04 39.23 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.1 p -74.63 157.89 34.59 Favored 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -137.8 170.07 16.7 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.631 -178.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 91.0 mtm180 -138.63 111.66 7.88 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.737 -1.119 . . . . 0.0 111.192 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -123.16 149.23 44.85 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.1 ptt-85 -138.38 155.22 48.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.096 0.474 . . . . 0.0 111.049 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.3 m -146.91 111.84 5.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.921 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -121.43 168.35 11.79 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -156.07 95.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.448 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -105.73 118.33 36.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.908 0.777 . . . . 0.0 112.922 -177.566 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -156.86 -73.15 0.02 OUTLIER Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 48' ' ' PRO . 74.7 t80 -125.46 133.09 24.55 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 5.2 Cg_exo -55.92 141.19 86.15 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 120.934 1.089 . . . . 0.0 111.909 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 70.29 68.15 0.4 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.869 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.59 159.01 9.28 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 123.296 2.664 . . . . 0.0 111.722 178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.46 118.87 37.65 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 3.9 m -148.18 164.49 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 121.695 0.76 . . . . 0.0 112.204 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -151.97 141.11 21.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.662 ' CD1' ' ND1' ' A' ' 75' ' ' HIS . 19.3 m95 -117.29 148.13 41.95 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -113.69 103.91 11.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.565 0.221 . . . . 0.0 110.945 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 58' ' ' GLY . 11.0 mp -84.15 132.21 34.7 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.61 HD22 ' H ' ' A' ' 89' ' ' GLU . 2.3 t-20 50.31 6.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.127 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 106.24 16.35 15.11 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.77 124.76 46.96 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 60' ' ' LEU . 1.5 pt? -69.74 151.63 45.59 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.476 ' CG2' ' O ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER 85.4 108.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-O 121.872 0.844 . . . . 0.0 112.458 177.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.455 HH11 ' HA ' ' A' ' 77' ' ' LEU . 27.7 tpt180 -80.32 144.68 32.59 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -71.12 140.5 50.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.801 0.334 . . . . 0.0 110.548 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 33.8 t -74.64 -139.72 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.7 mttt -20.93 -36.69 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' A' ' 64' ' ' SER . 92.9 mtm-85 -63.64 -39.38 94.21 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.1 m-85 -121.61 148.62 44.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.787 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' O ' ' O ' ' A' ' 76' ' ' TYR . 10.4 tpt180 -72.58 119.66 17.11 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.279 -178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -155.28 140.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.774 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' O ' ' O ' ' A' ' 74' ' ' ILE . 44.4 ttm180 -136.54 105.24 5.83 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -70.96 88.19 0.75 Allowed 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.827 -177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -173.24 30.38 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.79 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.83 -20.48 50.15 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.8 mp -104.61 108.68 25.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.042 -177.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.662 ' ND1' ' CD1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -135.26 106.32 6.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.273 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 68' ' ' ARG . 74.1 m-85 -96.08 125.84 40.89 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.334 0.587 . . . . 0.0 112.32 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.646 HD21 ' NE2' ' A' ' 75' ' ' HIS . 95.5 mt -94.39 81.69 3.99 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.487 177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -107.36 129.11 54.95 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.414 -0.804 . . . . 0.0 112.796 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 38' ' ' ALA . 10.2 pt -110.01 162.88 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.55 176.89 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-O 120.676 0.274 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -69.25 58.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.549 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 1.8 m -111.51 -88.27 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -128.11 129.88 47.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.9 OUTLIER -142.49 -36.41 0.4 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.588 -177.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -51.74 63.79 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -177.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 53.1 t0 -159.32 117.25 2.78 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.147 0.499 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.2 p -84.9 131.51 34.49 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.094 -0.379 . . . . 0.0 110.279 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.71 -161.36 8.67 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.63 -0.588 . . . . 0.0 111.63 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.61 ' H ' HD22 ' A' ' 57' ' ' ASN . 95.0 mt-10 -134.56 129.67 35.39 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.811 -0.229 . . . . 0.0 110.774 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 105' ' ' VAL . 27.0 m -118.65 134.85 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 110.338 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -130.28 119.01 22.18 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 23' ' ' ILE . 70.6 t -86.12 120.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.5 m -126.88 125.85 42.29 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.505 0.669 . . . . 0.0 112.52 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.28 41.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.796 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -149.08 90.66 1.77 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.658 0.266 . . . . 0.0 111.072 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -79.92 170.87 14.09 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -73.36 -21.25 20.09 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.307 1.338 . . . . 0.0 112.181 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -103.9 -3.83 24.25 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.78 179.18 45.33 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.105 -1.045 . . . . 0.0 111.605 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.2 p -142.07 138.74 30.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.421 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 53.9 mt -130.86 146.41 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -154.37 138.34 16.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.884 0.373 . . . . 0.0 110.808 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -136.12 131.03 34.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.733 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -92.24 118.19 30.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.073 0.464 . . . . 0.0 109.846 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 90' ' ' VAL . 47.2 t -131.69 136.28 57.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.938 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.484 ' C ' HD12 ' A' ' 107' ' ' LEU . 42.3 tttp -111.87 129.39 56.17 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.875 0.369 . . . . 0.0 111.774 -178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 106' ' ' LYS . 7.7 mp -117.15 124.31 48.85 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -117.35 117.57 29.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 84' ' ' SER . 7.3 mm -104.44 114.9 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.141 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.416 ' C ' ' NE2' ' A' ' 111' ' ' GLN . 42.1 tt0 -98.49 -125.67 0.15 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.198 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.474 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 22.0 mp0 -151.51 162.21 41.36 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.794 -0.185 . . . . 0.0 110.587 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' ' H ' ' A' ' 114' ' ' HIS . 41.7 mt -64.51 144.46 57.17 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.264 -0.574 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -63.27 5.2 0.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.652 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 112' ' ' LEU . 84.4 t60 -119.41 71.23 0.86 Allowed 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 115' ' ' HIS . 6.8 p80 -99.82 110.71 23.07 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.998 0.428 . . . . 0.0 110.456 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -163.73 -51.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.057 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -81.04 143.81 32.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.698 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -143.99 150.75 38.76 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.217 0.532 . . . . 0.0 111.41 -178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.816 179.498 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 59.7 mtt -113.61 136.21 53.07 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.217 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.56 59.03 1.26 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -59.95 -43.52 94.95 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.108 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -157.65 -77.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.673 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.08 140.79 18.79 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.061 -0.59 . . . . 0.0 111.642 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.53 154.33 28.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.635 HD13 ' N ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -71.49 121.24 18.3 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.852 -178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.635 ' N ' HD13 ' A' ' 8' ' ' LEU . 4.7 m -67.04 131.34 45.65 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.645 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.81 176.97 5.47 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' THR . 56.1 t -118.39 132.99 66.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -64.43 73.89 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.902 0.382 . . . . 0.0 110.601 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 11' ' ' VAL . 14.2 t -111.72 -9.57 14.11 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.099 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.444 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 35.9 p-10 -75.74 59.31 1.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.299 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -63.84 -52.01 62.03 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.506 -0.478 . . . . 0.0 109.756 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -126.56 12.31 7.44 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.389 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -69.05 151.65 46.2 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.341 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -59.5 129.16 40.64 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.463 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.444 ' NE2' ' OD2' ' A' ' 14' ' ' ASP . 6.9 mm100 -113.7 -179.4 3.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.03 0.443 . . . . 0.0 110.013 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -87.57 126.45 61.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.867 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 5.0 Cg_exo -57.02 151.56 49.31 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.158 1.092 . . . . 0.0 110.906 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 21' ' ' PRO . 58.6 m-20 -164.42 103.01 0.83 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.35 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.478 HD13 ' CD1' ' A' ' 25' ' ' LEU . 2.0 pp -77.93 139.25 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.6 0.714 . . . . 0.0 112.519 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.36 129.4 64.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-N 114.675 -1.148 . . . . 0.0 111.097 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.626 HD21 HG21 ' A' ' 92' ' ' VAL . 4.0 mp -147.69 -165.0 2.14 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -88.56 116.74 67.12 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 177.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.49 -25.89 70.28 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.141 1.227 . . . . 0.0 113.014 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -125.42 159.67 59.08 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.821 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -67.54 152.98 77.68 Favored 'Trans proline' 0 N--CA 1.501 1.957 0 C-N-CA 121.768 1.645 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.9 t -132.35 137.27 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.299 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtm-85 -127.73 137.84 52.58 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.552 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 36' ' ' GLU . 0.3 OUTLIER -123.46 173.36 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 111' ' ' GLN . 5.5 mt -115.02 139.64 49.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.773 0.321 . . . . 0.0 111.507 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -43.78 121.89 2.56 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 120.654 -0.419 . . . . 0.0 109.921 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.77 2.68 43.02 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HB2' HG22 ' A' ' 32' ' ' VAL . 92.1 mt-10 -121.0 128.27 52.54 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.7 151.01 34.4 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HB3' HD12 ' A' ' 79' ' ' ILE . . . -118.48 150.1 40.16 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.989 0.423 . . . . 0.0 110.517 -179.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -117.99 103.5 9.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.913 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.49 ' CZ ' HD12 ' A' ' 107' ' ' LEU . 31.4 m-85 -128.1 150.28 50.04 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.422 HH12 ' HB3' ' A' ' 43' ' ' ARG . 9.5 ptm180 -140.31 154.65 46.87 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.47 ' SG ' ' CE1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -141.17 108.53 5.54 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HB3' HH12 ' A' ' 41' ' ' ARG . 69.2 ttt-85 -132.5 172.29 12.68 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' ' OG1' ' A' ' 45' ' ' THR . 17.8 t -127.65 167.43 22.62 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 44' ' ' VAL . 18.3 m -166.36 106.6 0.67 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 117.784 -1.566 . . . . 0.0 114.341 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.06 -27.61 1.42 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 111.694 -0.562 . . . . 0.0 111.694 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -116.87 134.04 23.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 49' ' ' GLN . 3.5 Cg_exo -58.21 146.85 87.0 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.798 1.665 . . . . 0.0 112.133 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.442 ' C ' ' O ' ' A' ' 48' ' ' PRO . 4.3 mp0 14.11 74.33 0.11 Allowed Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 114.992 -1.004 . . . . 0.0 113.634 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.43 159.44 39.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.074 2.516 . . . . 0.0 110.365 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -115.18 94.8 4.89 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.068 0.394 . . . . 0.0 110.282 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -118.49 165.95 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 121.217 0.532 . . . . 0.0 111.277 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.467 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.2 m120 -140.79 172.51 12.6 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 177.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.641 ' CD2' ' ND1' ' A' ' 75' ' ' HIS . 0.0 OUTLIER -145.73 166.21 26.53 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.933 -179.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.556 ' CE2' HD13 ' A' ' 60' ' ' LEU . 7.1 m-85 -122.23 110.41 15.69 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.991 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.699 HD21 HD22 ' A' ' 77' ' ' LEU . 7.0 mp -83.24 135.87 34.61 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 89' ' ' GLU . 70.7 m-80 44.33 10.26 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 118.354 0.524 . . . . 0.0 111.528 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 102.44 24.97 8.0 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 56' ' ' LEU . 26.1 mt-30 -126.75 122.22 34.21 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 122.488 -0.419 . . . . 0.0 110.037 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.556 HD13 ' CE2' ' A' ' 55' ' ' TYR . 65.1 tp -78.52 154.22 30.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.382 0.673 . . . . 0.0 112.049 -179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 2.7 tp 61.37 109.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.1 tpt180 -105.06 138.3 41.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 113.749 -1.569 . . . . 0.0 108.783 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -54.09 150.55 8.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.682 0.753 . . . . 0.0 111.959 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.693 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.2 p -75.46 -137.1 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.166 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 64' ' ' SER . 97.8 mttt -11.54 -40.17 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 -178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.693 ' N ' ' O ' ' A' ' 64' ' ' SER . 76.2 ttt180 -60.96 -40.95 95.32 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 119.568 -0.853 . . . . 0.0 109.437 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' A' ' 64' ' ' SER . 62.2 m-85 -120.76 144.43 48.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -70.88 118.62 13.9 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.168 -178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.7 p -153.8 136.09 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.511 ' O ' ' O ' ' A' ' 74' ' ' ILE . 92.6 mtm180 -136.64 104.74 5.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 0.9 OUTLIER -72.96 89.37 1.41 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.458 -177.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -172.32 31.03 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.43 -19.94 38.46 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.127 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 74' ' ' ILE . 4.8 mp -112.88 114.33 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.724 ' NE2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -141.9 113.46 7.77 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.46 144.26 26.73 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.724 HD21 ' NE2' ' A' ' 75' ' ' HIS . 86.4 mt -127.22 88.99 2.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.548 -1.205 . . . . 0.0 110.989 179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -114.54 138.01 51.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.263 0.554 . . . . 0.0 111.618 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 80' ' ' VAL . 87.2 mt -97.99 160.4 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 82' ' ' CYS . 3.4 p -125.28 164.79 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.54 ' N ' HG22 ' A' ' 80' ' ' VAL . 62.9 t0 -61.7 70.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.267 0.355 . . . . 0.0 110.913 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.552 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER 151.41 149.62 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.013 0.821 . . . . 0.0 109.025 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.54 ' NZ ' ' NH1' ' A' ' 66' ' ' ARG . 76.1 tttt 66.54 59.16 0.63 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.742 ' O ' HD12 ' A' ' 109' ' ' ILE . 16.4 p -142.92 -32.6 0.47 Allowed 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.134 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.618 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -50.66 62.69 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 84' ' ' SER . 51.5 p-10 -163.07 121.68 2.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.334 0.587 . . . . 0.0 111.013 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 69.5 p -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.673 -0.642 . . . . 0.0 110.239 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -145.26 -158.56 7.72 Favored Glycine 0 C--N 1.349 1.305 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.247 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASN . 82.9 tt0 -142.29 145.38 33.94 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.226 0.536 . . . . 0.0 111.034 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.8 t -116.57 128.29 73.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.757 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -124.6 122.57 37.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.626 HG21 HD21 ' A' ' 25' ' ' LEU . 60.1 t -106.9 132.98 52.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.122 0.487 . . . . 0.0 111.098 -177.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.43 118.75 20.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.21 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -109.93 154.24 23.37 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.208 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -161.27 111.16 1.65 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.064 0.935 . . . . 0.0 112.525 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -109.92 170.65 5.12 Favored Pre-proline 0 N--CA 1.451 -0.377 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -67.9 -20.29 45.38 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.203 1.269 . . . . 0.0 113.362 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -95.8 -7.94 35.66 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 177.81 -167.73 38.77 Favored Glycine 0 N--CA 1.454 -0.149 0 C-N-CA 119.689 -1.244 . . . . 0.0 111.241 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 19.4 m -148.37 154.99 9.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.216 -0.492 . . . . 0.0 109.921 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.3 mt -142.14 158.13 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 120.957 0.408 . . . . 0.0 110.304 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -148.1 121.93 9.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.94 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.466 ' CD2' HD11 ' A' ' 23' ' ' ILE . 2.6 m-70 -132.81 128.1 36.0 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.857 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -109.82 136.18 49.54 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.215 0.531 . . . . 0.0 111.239 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 10.6 p -143.13 137.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.594 ' C ' HD22 ' A' ' 107' ' ' LEU . 25.4 mtpp -97.94 128.71 44.69 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 ' C ' ' A' ' 106' ' ' LYS . 3.8 mm? -120.03 121.92 39.97 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -133.54 127.56 33.43 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.368 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.742 HD12 ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -117.9 122.9 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-O 121.511 0.672 . . . . 0.0 109.747 -179.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.719 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -95.1 -117.5 0.1 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.615 -177.171 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.43 ' O ' HD22 ' A' ' 33' ' ' LEU . 1.7 mp0 -153.21 151.99 30.72 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.888 -0.507 . . . . 0.0 111.271 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -61.18 -46.26 91.25 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.629 179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -61.33 143.3 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.703 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -86.36 137.32 32.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.007 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.594 ' ND1' ' N ' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -63.6 -40.9 98.11 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.543 -0.463 . . . . 0.0 109.774 179.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 115' ' ' HIS . 96.0 m-70 -158.37 146.4 18.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.818 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -131.02 122.25 26.47 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -120.95 -81.99 0.64 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.336 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.684 179.884 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 65.4 mtt -86.12 139.4 31.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.824 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -95.48 151.3 19.42 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.274 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -65.35 -38.9 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.349 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 0.8 OUTLIER -84.14 -13.71 52.17 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.822 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -72.14 83.46 0.52 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.07 136.12 57.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.984 0.421 . . . . 0.0 110.419 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.28 135.87 43.12 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.022 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.447 ' H ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -65.18 155.37 35.21 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.004 0.431 . . . . 0.0 111.12 -179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.72 98.38 0.17 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 13' ' ' THR . 2.1 p -62.64 157.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' VAL . 25.2 p -57.69 86.89 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.792 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 ' N ' ' O ' ' A' ' 11' ' ' VAL . 26.8 p -61.24 -83.21 0.02 OUTLIER 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -74.91 123.93 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -129.42 165.51 21.43 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.56 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -122.38 13.09 10.22 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.192 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -69.19 131.5 45.03 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.912 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -76.65 134.47 39.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.703 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -141.45 154.09 45.37 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -88.57 109.5 29.8 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 119.214 -0.422 . . . . 0.0 111.045 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -72.67 158.14 51.08 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.13 1.22 . . . . 0.0 111.071 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 45' ' ' THR . 18.5 t0 -171.47 102.52 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.355 0.598 . . . . 0.0 111.582 177.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.421 HG22 HG12 ' A' ' 44' ' ' VAL . 2.6 pp -85.11 146.4 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.002 -178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.494 ' C ' HD13 ' A' ' 25' ' ' LEU . 55.1 t -119.59 137.33 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.529 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.718 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -147.14 -154.77 0.57 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.411 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -111.62 94.89 25.12 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.49 -17.24 53.1 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.301 1.334 . . . . 0.0 111.04 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -95.58 119.28 65.43 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.512 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -60.34 146.39 96.69 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 CA-C-N 119.954 1.019 . . . . 0.0 109.98 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.8 t -131.55 132.73 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 121.225 0.535 . . . . 0.0 110.826 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -128.55 138.05 52.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.559 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.7 p -130.8 161.4 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 55.6 mt -98.09 131.13 44.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.17 0.51 . . . . 0.0 111.493 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 80.8 tt0 -38.06 124.49 1.18 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.55 6.83 35.2 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' A' ' 33' ' ' LEU . 7.5 mp0 -122.61 127.28 49.18 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -78.52 157.85 28.74 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -134.47 168.53 18.77 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.087 0.47 . . . . 0.0 110.672 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -145.56 125.74 13.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.208 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -132.48 149.34 52.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -123.47 139.69 53.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.207 0.527 . . . . 0.0 110.77 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 78.6 m -140.65 114.15 8.72 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 59.2 ttp180 -130.09 173.44 10.74 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.421 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 35.2 m -130.79 173.41 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 22' ' ' ASP . 73.3 p -142.54 156.49 45.13 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.736 0.698 . . . . 0.0 110.438 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.76 -96.25 0.4 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.647 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -128.81 162.5 51.25 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 120.738 0.304 . . . . 0.0 110.896 -177.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -44.72 156.21 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 123.244 2.629 . . . . 0.0 114.11 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -4.08 83.72 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 CA-C-N 113.3 -1.773 . . . . 0.0 114.757 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -79.26 -157.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.484 2.123 . . . . 0.0 108.999 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -102.29 118.94 37.95 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.64 163.33 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.039 0.447 . . . . 0.0 111.039 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 18.1 p-10 -158.8 151.56 22.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.494 178.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.539 ' CD1' ' CD2' ' A' ' 75' ' ' HIS . 3.8 p-90 -141.79 162.05 36.45 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.482 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.512 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 2.7 m-85 -133.86 119.8 19.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.6 mp -86.83 141.34 28.88 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 57' ' ' ASN . 15.1 t-20 49.27 8.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.835 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.92 19.23 24.88 Favored Glycine 0 CA--C 1.535 1.328 0 N-CA-C 112.198 -0.361 . . . . 0.0 112.198 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -123.1 126.88 47.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.494 -0.415 . . . . 0.0 110.131 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' H ' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -74.25 151.71 39.86 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 122.248 0.219 . . . . 0.0 110.862 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.797 ' H ' HD23 ' A' ' 60' ' ' LEU . 6.8 tp 61.43 111.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.918 0.866 . . . . 0.0 113.022 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.799 HH12 ' H ' ' A' ' 78' ' ' ASP . 68.1 ttt180 -98.52 156.17 16.91 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.864 176.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.437 ' N ' ' HG2' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -62.61 148.83 45.01 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.205 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 66' ' ' ARG . 11.4 p -73.74 -140.15 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.635 -177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 99.2 mttt -9.84 -40.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.682 ' N ' ' O ' ' A' ' 64' ' ' SER . 77.9 mtp85 -62.02 -34.63 76.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.717 0.689 . . . . 0.0 110.577 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.542 ' CD2' ' NH2' ' A' ' 62' ' ' ARG . 75.3 m-85 -122.34 150.01 42.98 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -70.17 108.83 4.31 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.897 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.9 p -146.65 138.99 19.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.403 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 74' ' ' ILE . 68.6 ttt180 -144.12 101.55 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -70.15 91.33 0.7 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.407 0.622 . . . . 0.0 109.603 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -172.5 28.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.739 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.71 -19.43 44.57 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 70' ' ' ARG . 88.5 mt -109.78 122.23 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.631 ' ND1' ' N ' ' A' ' 75' ' ' HIS . 0.1 OUTLIER -139.95 109.36 6.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.884 178.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' ' CG2' ' A' ' 74' ' ' ILE . 68.4 m-85 -97.17 121.7 39.36 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 HD11 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -92.0 80.98 5.11 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.799 ' H ' HH12 ' A' ' 62' ' ' ARG . 68.1 t0 -103.83 119.73 39.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 38' ' ' ALA . 5.7 pt -104.46 163.12 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.588 HG22 ' N ' ' A' ' 81' ' ' ASP . 11.1 p -137.73 173.44 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.588 ' N ' HG22 ' A' ' 80' ' ' VAL . 94.2 m-20 -68.26 55.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.283 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.417 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 m -114.19 -70.27 0.81 Allowed 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -139.76 126.47 20.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.761 178.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -145.09 -36.15 0.31 Allowed 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.305 -178.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.9 OUTLIER -52.2 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -178.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' N ' ' O ' ' A' ' 84' ' ' SER . 29.7 t70 -160.98 120.21 2.59 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.984 0.421 . . . . 0.0 110.673 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 45.3 p -85.38 133.75 34.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.326 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -143.03 -155.66 6.5 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -139.18 134.98 33.52 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.754 0.312 . . . . 0.0 110.805 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.639 HG21 HD12 ' A' ' 107' ' ' LEU . 54.7 t -113.24 133.26 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -134.43 126.07 28.75 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.876 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 43.8 t -113.63 131.46 65.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 t -150.94 152.15 33.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.277 0.561 . . . . 0.0 111.104 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.31 176.18 7.29 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.08 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -161.83 91.59 0.82 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.07 0.462 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.1 OUTLIER -88.96 172.21 7.83 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.685 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -71.72 -17.95 29.04 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.453 1.435 . . . . 0.0 111.771 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -105.2 -6.05 20.13 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -173.96 -179.6 44.7 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.854 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.8 143.2 24.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.709 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 102' ' ' GLU . 80.0 mt -134.92 153.01 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.05 0.452 . . . . 0.0 111.166 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 101' ' ' ILE . 80.9 tt0 -153.57 131.12 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.068 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -132.1 130.98 41.93 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.78 131.26 53.33 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.005 0.431 . . . . 0.0 111.433 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.7 p -141.78 146.04 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -117.86 132.59 56.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.674 0.749 . . . . 0.0 112.656 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.639 HD12 HG21 ' A' ' 90' ' ' VAL . 52.1 mt -119.1 125.66 49.81 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.161 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -120.09 117.15 27.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.304 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' O ' ' A' ' 84' ' ' SER . 73.1 mt -101.5 117.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.097 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -94.72 -127.18 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.462 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 5.9 pt20 -153.1 154.17 34.29 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.998 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.7 tp -84.38 130.95 34.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.135 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -149.11 -50.09 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.771 0.32 . . . . 0.0 110.589 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -87.15 127.53 35.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -155.36 166.63 32.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.551 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -89.79 133.04 34.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.351 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -66.19 -41.48 90.17 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.533 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -77.38 130.56 37.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.489 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.0 t60 . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.522 -179.762 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.526 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.6 mpt? -62.41 -40.23 95.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.51 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -62.13 134.23 56.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.719 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -82.13 -19.44 40.04 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.479 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -135.7 -70.09 0.48 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.199 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.29 170.58 43.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.92 145.33 56.03 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.163 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.714 ' N ' HD22 ' A' ' 8' ' ' LEU . 2.5 mm? -75.26 138.56 41.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.09 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.43 ' H ' HG22 ' A' ' 9' ' ' THR . 0.7 OUTLIER -69.96 144.87 52.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.91 -129.2 3.32 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 72.0 t -94.27 128.28 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.556 ' OG1' ' N ' ' A' ' 13' ' ' THR . 29.4 p -119.56 -77.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.104 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.556 ' N ' ' OG1' ' A' ' 12' ' ' THR . 2.4 m 65.42 -133.37 0.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 13' ' ' THR . 11.9 t0 -168.56 -169.3 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.569 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -76.91 152.65 35.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.307 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -124.72 11.55 8.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.056 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -71.66 177.83 3.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.185 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -53.86 147.26 12.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.721 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 46' ' ' GLY . 84.5 mt-30 -145.28 146.41 31.64 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' ' 20' ' ' LYS . 13.0 ptmt -93.3 107.92 29.43 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-O 119.169 -0.444 . . . . 0.0 110.129 178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -72.51 139.97 32.31 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 120.859 1.343 . . . . 0.0 110.962 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 64.7 t0 179.59 106.27 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.324 0.39 . . . . 0.0 111.064 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG12 HG21 ' A' ' 101' ' ' ILE . 19.3 pt -82.52 150.43 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.458 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.619 ' C ' HD13 ' A' ' 25' ' ' LEU . 47.9 t -114.83 134.5 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.787 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -150.18 -167.38 2.81 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 111.586 -179.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 107' ' ' LEU . 41.5 m-85 -43.29 104.44 0.37 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.91 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -66.09 -20.33 56.86 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.203 1.268 . . . . 0.0 112.148 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -159.7 134.0 5.29 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -46.45 152.93 1.3 Allowed 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.174 1.249 . . . . 0.0 110.679 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.06 139.94 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.412 0.625 . . . . 0.0 112.233 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -126.0 139.65 53.25 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.607 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -129.41 160.36 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.4 mt -101.53 135.25 43.36 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.704 0.287 . . . . 0.0 110.444 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 78.4 tt0 -41.5 125.87 2.75 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.029 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.42 5.11 54.61 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -115.77 123.2 47.64 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.4 p -80.76 130.27 34.98 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.869 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.598 ' HB3' ' CG1' ' A' ' 79' ' ' ILE . . . -103.34 169.83 8.31 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.207 0.527 . . . . 0.0 110.484 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -152.91 122.04 6.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.776 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.437 ' CG ' ' CE1' ' A' ' 26' ' ' TYR . 51.7 m-85 -130.93 155.98 45.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' C ' ' SG ' ' A' ' 42' ' ' CYS . 1.5 mpp_? -129.0 149.04 50.99 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' C ' ' A' ' 41' ' ' ARG . 6.2 m -147.69 125.16 11.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 44' ' ' VAL . 69.9 ttp85 -133.46 173.34 11.59 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.407 ' N ' ' HG2' ' A' ' 43' ' ' ARG . 27.3 m -128.2 171.54 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 56.0 m -130.3 130.33 44.37 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 118.654 0.661 . . . . 0.0 109.791 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' OE1' ' A' ' 19' ' ' GLN . . . 155.73 -98.81 0.18 Allowed Glycine 0 CA--C 1.522 0.479 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.71 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.453 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.46 172.8 6.24 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 121.341 -0.143 . . . . 0.0 111.352 -178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -73.76 153.71 48.49 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.607 2.205 . . . . 0.0 114.213 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 46.14 68.23 3.59 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.288 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -88.03 -175.33 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.101 2.534 . . . . 0.0 109.695 176.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 95' ' ' GLU . 52.7 mttp -109.28 111.03 22.39 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' O ' ' CE2' ' A' ' 71' ' ' TYR . 12.5 m -150.29 165.74 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.001 0.429 . . . . 0.0 111.799 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' O ' ' CE3' ' A' ' 54' ' ' TRP . 13.5 p-10 -161.61 170.08 20.45 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.633 ' CZ2' ' CD2' ' A' ' 75' ' ' HIS . 0.9 OUTLIER -144.15 168.91 18.92 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.535 -178.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.405 ' CE1' HD13 ' A' ' 60' ' ' LEU . 37.9 m-85 -123.47 104.9 9.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.76 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' N ' ' A' ' 58' ' ' GLY . 11.0 mp -84.21 135.81 34.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.0 m120 45.57 10.82 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.138 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 98.7 23.95 11.43 Favored Glycine 0 CA--C 1.538 1.529 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 56' ' ' LEU . 57.6 tt0 -124.22 128.12 48.72 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.705 0.402 . . . . 0.0 110.484 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 54' ' ' TRP . 50.7 tp -82.7 154.3 24.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.318 0.647 . . . . 0.0 112.093 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 60' ' ' LEU . 4.1 tp 62.27 109.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 O-C-N 124.206 0.941 . . . . 0.0 111.966 -179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.742 ' HE ' ' N ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -91.6 153.4 19.75 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.759 178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -70.91 148.59 47.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.09 0.471 . . . . 0.0 110.166 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.648 ' O ' ' N ' ' A' ' 66' ' ' ARG . 9.8 p -76.66 -140.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.932 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' OG ' ' A' ' 64' ' ' SER . 50.4 mtpt -16.43 -36.89 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' N ' ' O ' ' A' ' 64' ' ' SER . 60.4 ttt85 -61.4 -40.45 94.42 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.466 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 64' ' ' SER . 71.0 m-85 -120.78 147.79 44.87 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -70.52 118.02 12.79 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.363 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.7 p -154.54 138.17 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.706 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.478 ' O ' ' O ' ' A' ' 74' ' ' ILE . 84.6 mtp180 -135.37 101.43 4.82 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.537 ' CE2' ' O ' ' A' ' 52' ' ' VAL . 27.7 t80 -69.58 87.84 0.49 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.752 -178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.7 p30 -174.22 29.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.625 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 105.35 -21.87 34.13 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.478 ' O ' ' O ' ' A' ' 70' ' ' ARG . 96.7 mt -108.72 119.82 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 112.161 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.633 ' CD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.3 OUTLIER -138.29 106.48 5.75 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.221 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -92.33 115.54 28.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 mt -98.0 95.0 7.17 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 23.8 p-10 -118.88 151.07 38.79 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.598 ' CG1' ' HB3' ' A' ' 38' ' ' ALA . 5.0 pt -126.12 166.45 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.345 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 81' ' ' ASP . 22.0 t -134.36 170.48 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.571 ' N ' HG12 ' A' ' 80' ' ' VAL . 94.4 m-20 -62.68 66.83 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.272 0.558 . . . . 0.0 110.363 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.534 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER 176.32 129.38 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.94 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.8 mttt 63.72 64.01 0.81 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.617 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.3 m -132.75 -38.58 1.0 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.93 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.545 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 21.4 t80 -55.11 64.57 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 84' ' ' SER . 48.3 t0 -164.06 119.59 1.57 Allowed 'General case' 0 C--N 1.327 -0.412 0 O-C-N 121.999 -0.438 . . . . 0.0 110.259 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' ILE . 45.9 p -85.13 128.26 34.58 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.29 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -139.33 -154.99 6.5 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -140.29 139.24 35.45 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.853 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.537 HG21 HD22 ' A' ' 107' ' ' LEU . 54.1 t -115.31 139.11 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -144.95 137.35 26.1 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.5 m -115.34 131.43 67.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.385 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 53' ' ' ASN . 7.1 t -129.07 135.49 48.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.254 0.549 . . . . 0.0 110.538 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.28 146.49 51.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HG2' HG13 ' A' ' 100' ' ' VAL . 88.4 mt-10 -145.5 107.67 4.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.187 0.518 . . . . 0.0 111.868 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.56 171.84 5.38 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.96 -19.33 26.94 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 121.328 1.352 . . . . 0.0 112.565 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -103.9 -10.14 18.4 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -171.03 179.57 42.81 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 119.489 -1.339 . . . . 0.0 111.692 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 95' ' ' GLU . 62.0 t -142.93 135.79 25.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.232 -0.484 . . . . 0.0 110.295 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG21 HG12 ' A' ' 23' ' ' ILE . 61.4 mt -131.92 150.34 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.475 ' N ' ' CD ' ' A' ' 102' ' ' GLU . 3.3 pm0 -159.53 148.35 17.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.867 0.365 . . . . 0.0 111.154 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -142.04 136.39 30.17 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.297 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -105.58 128.71 53.77 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.344 0.592 . . . . 0.0 110.76 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 33.1 m -135.15 160.01 40.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.557 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.669 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.2 mttt -120.12 126.23 50.21 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.988 0.899 . . . . 0.0 111.886 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 106' ' ' LYS . 11.2 mp -121.39 123.86 43.13 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -126.13 125.38 42.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.046 0.45 . . . . 0.0 110.698 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.617 HG21 ' O ' ' A' ' 84' ' ' SER . 71.7 mt -104.56 114.49 44.3 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.554 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -87.56 -135.57 0.09 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.425 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 15.6 pt20 -148.72 152.33 36.43 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.113 0.482 . . . . 0.0 111.441 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.615 HD13 ' N ' ' A' ' 113' ' ' GLU . 1.0 OUTLIER -93.24 118.4 31.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.618 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.615 ' N ' HD13 ' A' ' 112' ' ' LEU . 41.9 tp10 -61.22 110.73 1.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -100.85 98.85 9.3 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.763 0.316 . . . . 0.0 110.375 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -66.94 -40.68 87.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.689 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -84.9 147.84 26.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.702 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -67.22 123.73 21.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.815 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -103.84 133.72 48.34 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.473 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.6 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.104 -0.951 . . . . 0.0 110.269 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 ttp -91.02 120.04 31.68 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.57 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.42 155.26 18.59 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -110.72 147.38 34.51 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.946 0.403 . . . . 0.0 110.836 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -141.35 157.96 44.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.827 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -162.37 -171.41 28.49 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.9 143.07 52.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.797 0.332 . . . . 0.0 110.863 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.537 HD12 ' N ' ' A' ' 8' ' ' LEU . 10.0 mp -88.79 126.6 35.42 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.185 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 ' OG1' ' OE2' ' A' ' 17' ' ' GLU . 7.3 p -85.55 160.07 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.174 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -175.18 -142.79 4.24 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 55.5 t 54.17 94.93 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-O 120.726 0.298 . . . . 0.0 110.812 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.9 p 44.98 -160.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m 56.33 15.21 1.86 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.523 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.1 p30 -89.15 9.87 23.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.242 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -63.37 -44.6 94.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.931 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -122.99 12.65 9.7 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' OE2' ' OG1' ' A' ' 9' ' ' THR . 76.9 tt0 -76.64 154.53 34.22 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.079 0.466 . . . . 0.0 110.736 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -68.25 151.89 46.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.789 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -142.08 169.17 18.1 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -81.72 112.84 37.92 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 141.54 87.27 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.932 1.088 . . . . 0.0 111.559 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 23' ' ' ILE . 26.0 t0 -155.24 154.95 32.97 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.909 0.385 . . . . 0.0 110.676 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.509 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 8.3 tt -140.06 132.02 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.792 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.9 t -110.08 130.06 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.79 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.504 HD11 ' ND1' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -149.25 -156.15 0.69 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -114.24 92.64 27.92 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -68.71 -17.13 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.026 1.818 . . . . 0.0 112.515 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.66 125.02 35.92 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.189 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.49 147.22 95.04 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 120.847 1.032 . . . . 0.0 111.482 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.7 t -131.71 145.8 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.7 mtt85 -133.12 135.38 45.19 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' C ' HD12 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -127.81 154.91 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 33' ' ' LEU . 10.5 mp -101.96 135.51 43.4 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.186 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 79.2 tt0 -38.89 124.43 1.4 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.912 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.98 2.49 39.3 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -113.87 166.14 11.88 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 t -117.39 140.13 49.98 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.86 162.66 19.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.835 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -128.95 110.6 12.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.406 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -131.84 150.61 52.1 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.813 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -142.22 155.1 45.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.165 0.507 . . . . 0.0 110.959 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.78 112.47 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -122.8 170.66 9.85 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 45' ' ' THR . 24.6 t -133.05 174.55 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.52 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.6 m -157.78 166.79 31.81 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.621 0.646 . . . . 0.0 110.762 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' HG22 ' A' ' 45' ' ' THR . . . 114.45 -86.12 0.41 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.69 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.9 147.56 40.3 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 2.6 Cg_endo -53.83 166.43 1.43 Allowed 'Trans proline' 0 N--CA 1.488 1.15 0 C-N-CA 121.608 1.539 . . . . 0.0 110.834 177.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' PRO . 60.6 tt0 30.37 70.91 0.59 Allowed Pre-proline 0 N--CA 1.469 0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.572 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.75 166.53 21.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 123.103 2.536 . . . . 0.0 111.4 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -92.61 109.44 20.85 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 p -148.19 139.69 17.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.468 0.651 . . . . 0.0 111.856 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -137.04 147.15 46.0 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.663 ' CD2' ' CE1' ' A' ' 75' ' ' HIS . 4.1 p-90 -137.21 161.5 36.01 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.565 -178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' CE1' HD12 ' A' ' 60' ' ' LEU . 3.2 m-85 -137.45 121.49 17.82 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.3 mp -89.11 139.91 29.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 89' ' ' GLU . 89.4 m-20 50.29 7.98 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.959 0.8 . . . . 0.0 111.142 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . 97.93 17.94 28.7 Favored Glycine 0 CA--C 1.535 1.332 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -120.2 125.88 49.27 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.909 HD23 ' N ' ' A' ' 61' ' ' ILE . 2.5 tt -79.64 153.47 29.35 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.846 0.458 . . . . 0.0 111.886 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.909 ' N ' HD23 ' A' ' 60' ' ' LEU . 5.1 tp 60.1 113.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 56' ' ' LEU . 29.1 mmt180 -115.07 151.25 34.6 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.433 -1.258 . . . . 0.0 108.559 176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -54.05 147.87 11.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.716 0.77 . . . . 0.0 112.012 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.736 ' O ' ' N ' ' A' ' 66' ' ' ARG . 54.1 p -74.3 -137.25 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.461 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' N ' ' OG ' ' A' ' 64' ' ' SER . 2.9 mtmp? -10.93 -36.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.736 ' N ' ' O ' ' A' ' 64' ' ' SER . 56.1 ttp180 -62.34 -37.11 84.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' SER . 70.7 m-85 -121.36 147.64 45.43 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.53 ' NH1' HH12 ' A' ' 70' ' ' ARG . 58.6 ttt85 -71.09 107.84 4.34 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.602 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.0 p -155.18 137.31 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.374 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.53 HH12 ' NH1' ' A' ' 68' ' ' ARG . 91.5 mtm-85 -135.87 112.14 9.8 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.501 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 9.9 t80 -73.5 89.62 1.69 Allowed 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 110.891 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 71' ' ' TYR . 66.8 m-20 -169.16 24.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.669 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.0 -17.63 34.94 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 70' ' ' ARG . 93.2 mt -106.72 118.26 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 121.254 0.549 . . . . 0.0 110.924 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.774 ' CE1' HD22 ' A' ' 77' ' ' LEU . 2.4 t-80 -138.69 107.12 5.82 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.275 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.586 ' C ' HD23 ' A' ' 77' ' ' LEU . 3.1 m-85 -98.38 132.11 44.11 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 121.095 0.474 . . . . 0.0 111.808 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.799 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.1 OUTLIER -115.48 91.58 3.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -109.06 139.35 44.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.232 0.539 . . . . 0.0 111.91 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 80' ' ' VAL . 91.9 mt -105.1 154.17 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.275 178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 82' ' ' CYS . 2.4 p -125.93 159.21 34.54 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' OD2' ' O ' ' A' ' 81' ' ' ASP . 55.2 p30 -57.44 68.04 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.22 0.325 . . . . 0.0 111.226 -178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.632 ' N ' ' O ' ' A' ' 80' ' ' VAL . 1.8 p 153.77 152.03 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.803 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.2 mttp 63.98 62.94 0.84 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.842 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASP . 10.2 p -149.75 -34.24 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.414 -179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.679 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -48.17 66.44 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -176.227 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 84' ' ' SER . 41.3 t0 -163.97 121.83 1.81 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.858 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 71.8 p -82.0 127.46 33.09 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.363 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 107' ' ' LEU . . . -144.41 -154.31 6.1 Favored Glycine 0 C--N 1.349 1.288 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.04 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.48 ' H ' ' HA ' ' A' ' 57' ' ' ASN . 56.2 mp0 -144.31 143.05 30.8 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.818 0.342 . . . . 0.0 111.451 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.914 HG21 HD12 ' A' ' 107' ' ' LEU . 41.7 t -117.84 128.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.167 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -133.06 139.84 47.38 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.43 147.29 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 110.357 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.2 t -146.3 143.06 28.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.065 179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . . . -140.58 155.53 46.55 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -149.26 109.26 4.09 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.218 -0.593 . . . . 0.0 110.677 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.636 ' H ' ' ND2' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -87.57 172.94 7.12 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -70.09 -16.89 36.33 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 121.758 1.639 . . . . 0.0 113.52 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -121.22 2.13 10.31 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -161.33 161.18 32.85 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 119.847 -1.168 . . . . 0.0 111.346 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 50.8 t -131.47 131.58 62.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.382 -0.409 . . . . 0.0 110.528 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.646 ' CD1' ' HB3' ' A' ' 94' ' ' ALA . 1.5 pp -142.69 155.97 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.266 0.555 . . . . 0.0 112.484 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' CD2' ' A' ' 103' ' ' HIS . 8.7 pt-20 -173.25 159.41 3.81 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.643 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 102' ' ' GLU . 38.6 m80 -154.45 146.96 24.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.538 0.209 . . . . 0.0 111.15 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -103.1 132.84 49.06 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.0 t -128.03 137.16 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.712 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -106.25 118.3 36.28 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.064 0.459 . . . . 0.0 112.02 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.914 HD12 HG21 ' A' ' 90' ' ' VAL . 81.0 mt -123.6 120.31 32.44 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.558 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -129.33 130.19 45.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.1 125.93 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.773 0.796 . . . . 0.0 109.654 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -86.61 -124.46 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.408 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.434 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 11.9 pt20 -156.85 159.79 38.54 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 0.0 110.767 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 41.2 tp -73.34 122.37 21.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.937 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -113.48 124.26 51.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.952 0.406 . . . . 0.0 110.867 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -157.81 161.76 38.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.096 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -81.05 -9.31 59.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.691 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.505 ' CE1' ' O ' ' A' ' 117' ' ' HIS . 49.8 t-80 -75.88 138.39 41.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 110.959 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.505 ' O ' ' CE1' ' A' ' 116' ' ' HIS . 92.5 m-70 -96.94 141.39 30.18 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.699 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.592 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -75.79 -17.29 59.92 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.271 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 118' ' ' HIS . 72.4 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.635 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 99.8 mtp -82.59 147.5 28.55 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.198 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -148.82 149.21 30.94 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 121.177 -0.209 . . . . 0.0 110.636 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -87.01 169.27 12.57 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.959 0.409 . . . . 0.0 111.547 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 6' ' ' GLY . 2.8 pp20? -68.08 -35.71 78.62 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.953 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.497 ' N ' ' CD ' ' A' ' 5' ' ' GLU . . . -134.13 123.72 3.35 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.38 53.27 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.03 0.443 . . . . 0.0 111.45 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.1 tp -72.35 133.82 45.16 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.9 m -72.55 133.27 44.67 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.1 166.21 12.19 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' THR . 26.8 m -102.43 7.89 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 122.256 0.222 . . . . 0.0 110.82 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 12' ' ' THR . 7.8 t -65.62 66.68 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.356 0.598 . . . . 0.0 111.721 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 11' ' ' VAL . 41.6 p -130.6 -84.27 0.53 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.921 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 46' ' ' GLY . 66.3 t0 45.61 30.36 0.77 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.112 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -68.43 -42.21 79.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.265 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -124.46 -32.06 3.19 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.839 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' O ' ' OD2' ' A' ' 14' ' ' ASP . 81.0 tt0 -65.57 128.55 36.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.256 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -82.34 128.94 34.71 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -107.33 177.67 4.77 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.03 0.443 . . . . 0.0 111.011 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -84.46 130.38 53.95 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.448 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -60.16 142.92 99.36 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 CA-C-N 120.202 1.108 . . . . 0.0 112.551 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -170.82 103.59 0.24 Allowed 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.944 0.402 . . . . 0.0 110.896 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' CG2' ' ND1' ' A' ' 103' ' ' HIS . 1.5 tt -75.41 136.78 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.143 -178.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.05 134.11 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB3' ' H ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -159.76 -153.5 0.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.509 ' O ' HG21 ' A' ' 105' ' ' VAL . 39.0 m-85 -111.25 93.77 19.54 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -67.68 -25.0 40.57 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.785 1.657 . . . . 0.0 112.04 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -90.89 129.73 43.19 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-O 119.575 -0.25 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -58.61 146.77 90.22 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.948 1.017 . . . . 0.0 111.819 178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 79.2 t -132.72 136.83 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.657 ' HE ' ' NE2' ' A' ' 110' ' ' GLN . 16.1 ptm180 -138.11 142.17 40.19 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.639 0.257 . . . . 0.0 110.44 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -134.46 160.21 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 110.637 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.0 mt -94.23 132.52 38.71 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.669 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' H ' ' HA ' ' A' ' 111' ' ' GLN . 86.1 tt0 -42.42 129.48 3.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.365 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.17 0.73 44.57 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -116.17 138.2 51.47 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.338 0.589 . . . . 0.0 110.141 179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.465 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 1.1 t -90.21 141.91 28.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.769 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.697 ' HB3' HD11 ' A' ' 79' ' ' ILE . . . -123.34 170.81 9.93 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.47 122.92 16.05 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.776 0.322 . . . . 0.0 110.51 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -137.98 152.81 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -149.28 164.55 34.53 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.4 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 69.7 m -138.29 101.55 4.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 -110.93 163.82 13.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 45' ' ' THR . 46.8 t -127.53 172.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 27.5 m -134.46 139.84 45.8 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 14' ' ' ASP . . . 147.15 -95.78 0.17 Allowed Glycine 0 N--CA 1.468 0.783 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.771 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -137.44 168.81 15.03 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -71.53 147.39 51.74 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.791 1.661 . . . . 0.0 112.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.8 68.15 2.8 Favored Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.487 -0.779 . . . . 0.0 113.014 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -84.56 -174.42 1.79 Allowed 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 123.593 2.862 . . . . 0.0 109.587 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 95' ' ' GLU . 98.5 mttt -107.02 108.24 19.64 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.91 160.9 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-O 121.477 0.656 . . . . 0.0 111.381 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -146.72 154.37 41.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.69 ' HE1' ' CD2' ' A' ' 75' ' ' HIS . 6.0 p-90 -137.77 163.7 30.71 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.492 0.663 . . . . 0.0 112.007 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD2' ' N ' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -140.29 114.27 8.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.844 -178.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.87 HD13 ' H ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -98.15 154.58 17.65 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 177.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 47.17 7.84 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 O-C-N 122.057 -0.402 . . . . 0.0 112.077 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 56' ' ' LEU . . . 97.41 2.91 58.78 Favored Glycine 0 N--CA 1.471 0.968 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.54 143.09 39.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.2 151.54 20.31 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.176 0.298 . . . . 0.0 111.241 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 60' ' ' LEU . 7.6 tp 55.43 114.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.348 0.523 0 CA-C-O 122.07 0.938 . . . . 0.0 111.996 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' O ' ' A' ' 76' ' ' TYR . 61.4 ttp180 -105.28 154.86 19.68 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.818 177.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 149.75 4.22 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.431 0.634 . . . . 0.0 110.972 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.72 ' O ' ' N ' ' A' ' 66' ' ' ARG . 15.7 m -72.45 -138.24 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 114.955 -1.02 . . . . 0.0 112.128 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -19.18 -28.91 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.72 ' N ' ' O ' ' A' ' 64' ' ' SER . 58.5 ttm-85 -62.52 -40.17 95.91 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -121.4 151.11 40.54 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.325 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.82 116.27 10.92 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.157 0.503 . . . . 0.0 112.026 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 m -151.59 132.68 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.734 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 74' ' ' ILE . 11.9 tpp85 -132.32 103.02 5.99 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -72.79 88.51 1.32 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.12 -0.632 . . . . 0.0 111.257 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 -173.93 29.57 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 108.05 -18.8 33.43 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.564 ' O ' ' O ' ' A' ' 70' ' ' ARG . 4.7 mp -114.22 119.54 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.69 ' CD2' ' HE1' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -134.6 106.39 6.96 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.548 ' O ' ' NH2' ' A' ' 62' ' ' ARG . 3.3 m-30 -83.64 138.89 33.13 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.134 0.493 . . . . 0.0 111.936 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.469 HD23 ' CZ ' ' A' ' 62' ' ' ARG . 93.9 mt -132.72 84.96 2.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.809 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -113.67 141.8 46.79 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.643 0.735 . . . . 0.0 112.758 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 38' ' ' ALA . 9.1 pt -120.14 163.48 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 81' ' ' ASP . 18.1 t -133.14 173.51 14.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' H ' HG12 ' A' ' 80' ' ' VAL . 74.5 m-20 -67.02 65.76 0.06 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.001 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 80' ' ' VAL . 7.9 t 176.54 133.26 0.05 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.485 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm 61.77 64.81 0.98 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.989 0.359 . . . . 0.0 110.572 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.619 ' O ' HG21 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -135.22 -34.16 0.87 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.701 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 85' ' ' TYR . 15.7 t80 -51.33 64.03 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' N ' ' O ' ' A' ' 84' ' ' SER . 40.9 t0 -158.7 115.91 2.81 Favored 'General case' 0 N--CA 1.464 0.243 0 O-C-N 121.586 -0.696 . . . . 0.0 110.264 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 p -83.8 129.36 34.94 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.722 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -142.45 -159.97 8.15 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 58' ' ' GLY . 12.1 pt-20 -138.42 135.66 35.47 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.91 -0.17 . . . . 0.0 110.877 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 92.3 t -108.6 103.8 16.08 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 110.38 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -116.64 132.31 56.72 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 93' ' ' THR . 90.0 t -137.9 158.2 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 121.146 0.498 . . . . 0.0 111.049 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.469 ' N ' HG12 ' A' ' 92' ' ' VAL . 1.3 t -148.28 144.28 27.51 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.58 135.17 40.07 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 51' ' ' LYS . 19.9 pt-20 -150.16 139.32 21.19 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 122.027 0.918 . . . . 0.0 112.999 -178.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.695 HD21 ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -106.96 175.47 2.03 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 114.279 -1.328 . . . . 0.0 107.75 178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -67.82 -13.59 39.01 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 121.227 1.285 . . . . 0.0 113.649 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -111.56 2.72 17.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.695 ' N ' HD21 ' A' ' 96' ' ' ASN . . . -170.99 173.76 44.7 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 119.787 -1.197 . . . . 0.0 112.933 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.06 157.18 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.195 -0.502 . . . . 0.0 110.022 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 6.4 mt -143.12 154.84 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.287 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.539 ' O ' ' ND1' ' A' ' 103' ' ' HIS . 17.0 pt-20 -134.4 169.56 17.06 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.539 ' ND1' ' O ' ' A' ' 102' ' ' GLU . 0.5 OUTLIER -176.65 107.71 0.07 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.72 123.61 49.71 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.348 0.595 . . . . 0.0 111.512 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.509 HG21 ' O ' ' A' ' 26' ' ' TYR . 7.6 p -145.14 140.05 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.729 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' C ' HD12 ' A' ' 107' ' ' LEU . 99.6 mttt -105.39 134.33 48.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.453 0.644 . . . . 0.0 111.492 -178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.66 HD12 ' C ' ' A' ' 106' ' ' LYS . 10.9 mp -124.17 124.23 42.01 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.42 130.0 53.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.323 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.619 HG21 ' O ' ' A' ' 84' ' ' SER . 7.6 mm -106.41 111.86 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.657 ' NE2' ' HE ' ' A' ' 31' ' ' ARG . 1.7 mp0 -85.86 -128.57 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.666 0.27 . . . . 0.0 110.699 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.467 ' HA ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -156.26 160.86 40.16 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.351 0.596 . . . . 0.0 112.449 -179.73 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 114' ' ' HIS . 2.2 pp -63.97 134.41 55.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.61 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -41.02 90.27 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.168 0 CA-C-O 121.082 0.468 . . . . 0.0 110.758 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 112' ' ' LEU . 42.7 t60 -63.51 -39.91 95.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -60.93 137.69 58.21 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.602 0.239 . . . . 0.0 110.476 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.426 ' CD2' ' N ' ' A' ' 116' ' ' HIS . 2.6 p80 -149.75 -45.72 0.13 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -136.74 34.55 2.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 0.0 111.507 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -62.82 140.31 58.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.118 0.485 . . . . 0.0 110.614 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.518 ' CD2' ' OXT' ' A' ' 119' ' ' HIS . 22.5 p-80 . . . . . 0 C--O 1.216 -0.709 0 CA-C-O 116.92 -1.514 . . . . 0.0 111.115 179.886 . . . . . . . . 1 1 . 1 stop_ save_